{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "executionInfo": {
     "elapsed": 18956,
     "status": "ok",
     "timestamp": 1610616869075,
     "user": {
      "displayName": "Marco Pietro Abrate",
      "photoUrl": "https://lh3.googleusercontent.com/a-/AOh14Gjh-8YF-8BlnrkN9mLZ0xfVOWfOh7kYncpYRv-Y=s64",
      "userId": "15422244832836998434"
     },
     "user_tz": -60
    },
    "id": "au5Z9XQAC7C-"
   },
   "outputs": [],
   "source": [
    "magma_dir = '/home/marco/epfl/magma/'"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### AWS"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "magma_dir = '/home/ubuntu/magma/'\n",
    "bucket_dir = '/home/ubuntu/s3/'\n",
    "transformers_dir = '/home/ubuntu/transformers/'\n",
    "cache_dir = bucket_dir+'.cache/'"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "S0FByNNOIRvG"
   },
   "source": [
    "### **Config**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "executionInfo": {
     "elapsed": 45120,
     "status": "ok",
     "timestamp": 1610616895249,
     "user": {
      "displayName": "Marco Pietro Abrate",
      "photoUrl": "https://lh3.googleusercontent.com/a-/AOh14Gjh-8YF-8BlnrkN9mLZ0xfVOWfOh7kYncpYRv-Y=s64",
      "userId": "15422244832836998434"
     },
     "user_tz": -60
    },
    "id": "3BHImWfNKpDN"
   },
   "outputs": [],
   "source": [
    "import os\n",
    "import sys\n",
    "\n",
    "sys.path.insert(0, magma_dir)\n",
    "import config\n",
    "\n",
    "from torch import cuda\n",
    "device = 'cuda' if cuda.is_available() else 'cpu'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {
    "executionInfo": {
     "elapsed": 45119,
     "status": "ok",
     "timestamp": 1610616895251,
     "user": {
      "displayName": "Marco Pietro Abrate",
      "photoUrl": "https://lh3.googleusercontent.com/a-/AOh14Gjh-8YF-8BlnrkN9mLZ0xfVOWfOh7kYncpYRv-Y=s64",
      "userId": "15422244832836998434"
     },
     "user_tz": -60
    },
    "id": "82WSp6khIcua"
   },
   "outputs": [],
   "source": [
    "MODEL = 'pegasus'\n",
    "MODELS = {}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {
    "executionInfo": {
     "elapsed": 45117,
     "status": "ok",
     "timestamp": 1610616895252,
     "user": {
      "displayName": "Marco Pietro Abrate",
      "photoUrl": "https://lh3.googleusercontent.com/a-/AOh14Gjh-8YF-8BlnrkN9mLZ0xfVOWfOh7kYncpYRv-Y=s64",
      "userId": "15422244832836998434"
     },
     "user_tz": -60
    },
    "id": "5ti6XKYnFzSr"
   },
   "outputs": [],
   "source": [
    "# Dataset path\n",
    "data_dir = magma_dir + 'datasets/karger_books_para_wordembed/'+MODEL+'/'\n",
    "\n",
    "# Output path\n",
    "OUTPUT_PATH = magma_dir+'summarization/assign_bullets_para_wordembed/'+MODEL+'/'\n",
    "if not os.path.exists(OUTPUT_PATH):\n",
    "    os.makedirs(OUTPUT_PATH)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### AWS"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "data_dir = bucket_dir + 'datasets/karger_books_para_wordembed/'+MODEL+'/'"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "JFd0ppeJyX1o"
   },
   "source": [
    "### **Init**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {
    "executionInfo": {
     "elapsed": 45115,
     "status": "ok",
     "timestamp": 1610616895253,
     "user": {
      "displayName": "Marco Pietro Abrate",
      "photoUrl": "https://lh3.googleusercontent.com/a-/AOh14Gjh-8YF-8BlnrkN9mLZ0xfVOWfOh7kYncpYRv-Y=s64",
      "userId": "15422244832836998434"
     },
     "user_tz": -60
    },
    "id": "yCzod0OizR5U"
   },
   "outputs": [],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "import numpy as np\n",
    "import torch\n",
    "import re\n",
    "import pandas as pd\n",
    "from tqdm import tqdm\n",
    "from textwrap import fill\n",
    "tqdm.pandas()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "from datasets import load_metric\n",
    "metric = load_metric(\"rouge\")\n",
    "\n",
    "from sentence_transformers import SentenceTransformer\n",
    "sentence_distilroberta = SentenceTransformer('paraphrase-distilroberta-base-v1')\n",
    "\n",
    "import gensim"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "dllOnKR9Os5i"
   },
   "source": [
    "### **Function Definition**"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "U2mpXoSaQiQE"
   },
   "source": [
    "##### Import Model and Tok"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {
    "executionInfo": {
     "elapsed": 45113,
     "status": "ok",
     "timestamp": 1610616895255,
     "user": {
      "displayName": "Marco Pietro Abrate",
      "photoUrl": "https://lh3.googleusercontent.com/a-/AOh14Gjh-8YF-8BlnrkN9mLZ0xfVOWfOh7kYncpYRv-Y=s64",
      "userId": "15422244832836998434"
     },
     "user_tz": -60
    },
    "id": "XhBGMJVFOs5l"
   },
   "outputs": [],
   "source": [
    "def import_model_tok(model_name_or_path, verbose=False):\n",
    "    global MODELS\n",
    "\n",
    "    if model_name_or_path in MODELS.keys():\n",
    "        if verbose : print('[+] model already present in cache\\n')\n",
    "        return MODELS[model_name_or_path]\n",
    "    if verbose : print('[*] importing the model\\n')\n",
    "    \n",
    "    from transformers import PegasusForConditionalGeneration, PegasusTokenizer\n",
    "    model = PegasusForConditionalGeneration.from_pretrained(model_name_or_path, cache_dir=cache_dir)\n",
    "    tokenizer = PegasusTokenizer.from_pretrained(model_name_or_path, cache_dir=cache_dir)\n",
    "\n",
    "    if verbose : print(model.config)\n",
    "    MODELS[model_name_or_path] = model, tokenizer\n",
    "    if verbose : print('[+] the model is now present in cache\\n')\n",
    "    return MODELS[model_name_or_path]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "heading_collapsed": true,
    "id": "JiYIkI5xN2VA"
   },
   "source": [
    "##### Print Examples"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "hidden": true
   },
   "outputs": [],
   "source": [
    "def evaluate_prediction(pred, ref):\n",
    "    rouge_res =\\\n",
    "        metric.compute(\n",
    "            predictions = [pred],\n",
    "            references = [ref],\n",
    "            rouge_types = config.ROUGE_TYPES,\n",
    "            use_agregator = False)\n",
    "    \n",
    "    rouge = {}\n",
    "    for r in config.ROUGE_TYPES:\n",
    "        for i, prf in enumerate(['precision', 'recall', 'fmeasure']):\n",
    "            rouge[r+'_'+prf] =\\\n",
    "                100*rouge_res[r][0][i]\n",
    "    \n",
    "    cosine_sim = lambda a, b: (np.dot(a, b) / (np.linalg.norm(a)*np.linalg.norm(b)))\n",
    "    \n",
    "    sent_trans_res = 100*cosine_sim(\n",
    "            sentence_distilroberta.encode(pred),\n",
    "            sentence_distilroberta.encode(ref))\n",
    "    \n",
    "    def cosine_sim_w2v(s, b):\n",
    "        s = gensim.utils.simple_preprocess(s, deacc=True)\n",
    "        b = gensim.utils.simple_preprocess(b, deacc=True)\n",
    "        corpus = [s, b]\n",
    "        w2v = gensim.models.Word2Vec(\n",
    "            corpus,\n",
    "            min_count=1,\n",
    "            sg=1,\n",
    "            seed = config.SEED)\n",
    "        s_embed = np.mean([w2v.wv[word] for word in s], axis=0)\n",
    "        b_embed = np.mean([w2v.wv[word] for word in b], axis=0)\n",
    "        return cosine_sim(s_embed, b_embed)\n",
    "        \n",
    "    w2v_res = 100*cosine_sim_w2v(pred, ref)\n",
    "    \n",
    "    return rouge, sent_trans_res, w2v_res"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {
    "executionInfo": {
     "elapsed": 45112,
     "status": "ok",
     "timestamp": 1610616895257,
     "user": {
      "displayName": "Marco Pietro Abrate",
      "photoUrl": "https://lh3.googleusercontent.com/a-/AOh14Gjh-8YF-8BlnrkN9mLZ0xfVOWfOh7kYncpYRv-Y=s64",
      "userId": "15422244832836998434"
     },
     "user_tz": -60
    },
    "hidden": true,
    "id": "dxsXYs1kN5HX"
   },
   "outputs": [],
   "source": [
    "def print_examples(model_name_list, df, n_examples=10):\n",
    "    \n",
    "    df_examples = df.sample(n_examples, axis='index', random_state=config.SEED)\n",
    "    \n",
    "    for idx, row in df_examples.iterrows():\n",
    "        print(idx)\n",
    "        print(fill(row.text, 100))\n",
    "        print()\n",
    "        print('Reference:')\n",
    "        print(fill(row.bullets, 100))\n",
    "        print()\n",
    "        for model_name in model_name_list:\n",
    "            model, tokenizer = import_model_tok(model_name)\n",
    "            model = model.to(device)\n",
    "            \n",
    "            summ_enc_list = model.generate(\n",
    "                tokenizer.encode(row.text, return_tensors='pt').to(device),\n",
    "                min_length = config.ONE_BULLET_MIN_LEN,\n",
    "                max_length = config.ONE_BULLET_MAX_LEN,\n",
    "                length_penalty = config.LENGTH_PENALTY,\n",
    "                num_beams = config.NUM_BEAMS,\n",
    "                no_repeat_ngram_size = config.NO_REPEAT_NGRAM_SIZE,\n",
    "                num_return_sequences = config.NUM_BEAMS,\n",
    "                early_stopping = True)\n",
    "            \n",
    "            for summ_enc in summ_enc_list:\n",
    "                summ_num_tok = len(tokenizer.convert_ids_to_tokens(summ_enc, skip_special_tokens=True))\n",
    "                summ = tokenizer.decode(summ_enc, skip_special_tokens=True)\n",
    "\n",
    "                rouge, sent_trans, w2v = evaluate_prediction(summ, row.bullets)\n",
    "                \n",
    "                print('%s (%d tok):'%(model_name, summ_num_tok))\n",
    "                print('R1\\tp: %.2f \\tr: %.2f \\tf: %.2f\\nR2\\tp: %.2f \\tr: %.2f \\tf: %.2f\\nRL\\tp: %.2f \\tr: %.2f \\tf: %.2f'%(\n",
    "                rouge['rouge1_precision'], rouge['rouge1_recall'], rouge['rouge1_fmeasure'],\n",
    "                rouge['rouge2_precision'], rouge['rouge2_recall'], rouge['rouge2_fmeasure'],\n",
    "                rouge['rougeL_precision'], rouge['rougeL_recall'], rouge['rougeL_fmeasure']))\n",
    "                print('ST\\t%.2f\\t\\tW2V\\t%.2f'%(sent_trans, w2v))\n",
    "                print()\n",
    "                print(fill(summ, 100))\n",
    "                print()\n",
    "            print()\n",
    "            \n",
    "        print(''.join(['#']*100))\n",
    "        print()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "heading_collapsed": true,
    "id": "KV669nVZQnzT"
   },
   "source": [
    "##### Plot Evaluation"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {
    "hidden": true
   },
   "outputs": [],
   "source": [
    "def plot_evaluation_bullet_by_bullet(model_name_or_path):\n",
    "    df = pd.read_csv(OUTPUT_PATH+model_name_or_path.replace('/', '?')+\\\n",
    "        '_bullet_by_bullet.csv').set_index(['book', 'chapter'])\n",
    "\n",
    "    prf = ['precision', 'recall', 'fmeasure']\n",
    "    num_rouge = len(config.ROUGE_TYPES)\n",
    "\n",
    "    from matplotlib.cm import get_cmap\n",
    "    color = get_cmap('tab10')(range(num_rouge))\n",
    "    def set_box_color(b, c):\n",
    "        for k in b.keys():\n",
    "            plt.setp(b[k], color=c)\n",
    "    \n",
    "    xticks = 2*np.array(np.arange(1, num_rouge+3))\n",
    "    \n",
    "    box_plt_list = []\n",
    "\n",
    "    fig, ax = plt.subplots(figsize=(10, 6))\n",
    "    for r, var in zip(prf, np.linspace(-0.15*num_rouge, 0.15*num_rouge, num_rouge)):\n",
    "    \n",
    "        box_plt_list.append(\n",
    "            plt.boxplot(\n",
    "            [df[rouge+'_'+r].tolist() for rouge in config.ROUGE_TYPES],\n",
    "            positions= xticks[:-2]+var,\n",
    "            sym='+',\n",
    "            widths=0.4,\n",
    "            patch_artist=False,\n",
    "            meanline=True,\n",
    "            showmeans=True))\n",
    "        \n",
    "    box_plt_list.append(\n",
    "        plt.boxplot(\n",
    "        df['st_cosine_sim'].tolist(),\n",
    "        positions=[xticks[-2]],\n",
    "        sym='+',\n",
    "        widths=0.4,\n",
    "        patch_artist=False,\n",
    "        meanline=True,\n",
    "        showmeans=True))\n",
    "    \n",
    "    box_plt_list.append(\n",
    "        plt.boxplot(\n",
    "        df['w2v_cosine_sim'].tolist(),\n",
    "        positions=[xticks[-1]],\n",
    "        sym='+',\n",
    "        widths=0.4,\n",
    "        patch_artist=False,\n",
    "        meanline=True,\n",
    "        showmeans=True))\n",
    "\n",
    "    for i, bp in enumerate(box_plt_list[:-2]):\n",
    "        set_box_color(bp, color[i])\n",
    "        plt.plot([], c=color[i], label=prf[i])\n",
    "    plt.legend()\n",
    "\n",
    "    ax.grid(True, axis='y', alpha=0.7, linestyle='--')\n",
    "    ax.set_title('Evaluation Results', fontsize='xx-large')\n",
    "    ax.set_ylabel('Rouge', fontsize='x-large')\n",
    "    plt.xticks(xticks, config.ROUGE_TYPES+['ST Cosine', 'W2V Cosine'], fontsize='x-large')\n",
    "    plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {
    "executionInfo": {
     "elapsed": 45379,
     "status": "ok",
     "timestamp": 1610616895526,
     "user": {
      "displayName": "Marco Pietro Abrate",
      "photoUrl": "https://lh3.googleusercontent.com/a-/AOh14Gjh-8YF-8BlnrkN9mLZ0xfVOWfOh7kYncpYRv-Y=s64",
      "userId": "15422244832836998434"
     },
     "user_tz": -60
    },
    "hidden": true,
    "id": "PrKd0tI7PBi5"
   },
   "outputs": [],
   "source": [
    "def plot_evaluation_grouping_bullets(model_name_or_path):\n",
    "    df = pd.read_csv(OUTPUT_PATH+model_name_or_path.replace('/', '?')+\\\n",
    "        '_grouped.csv').set_index(['book', 'chapter'])\n",
    "\n",
    "    prf = ['precision', 'recall', 'fmeasure']\n",
    "    num_rouge = len(config.ROUGE_TYPES)\n",
    "\n",
    "    from matplotlib.cm import get_cmap\n",
    "    color = get_cmap('tab10')(range(num_rouge))\n",
    "    def set_box_color(b, c):\n",
    "        for k in b.keys():\n",
    "            plt.setp(b[k], color=c)\n",
    "    \n",
    "    xticks = 2*np.array(np.arange(1, num_rouge+3))\n",
    "    \n",
    "    box_plt_list = []\n",
    "\n",
    "    fig, ax = plt.subplots(figsize=(10, 6))\n",
    "    for r, var in zip(prf, np.linspace(-0.15*num_rouge, 0.15*num_rouge, num_rouge)):\n",
    "    \n",
    "        box_plt_list.append(\n",
    "            plt.boxplot(\n",
    "            [df[rouge+'_'+r].tolist() for rouge in config.ROUGE_TYPES],\n",
    "            positions= xticks[:-2]+var,\n",
    "            sym='+',\n",
    "            widths=0.4,\n",
    "            patch_artist=False,\n",
    "            meanline=True,\n",
    "            showmeans=True))\n",
    "    \n",
    "    box_plt_list.append(\n",
    "        plt.boxplot(\n",
    "        df['st_cosine_sim'].tolist(),\n",
    "        positions=[xticks[-2]],\n",
    "        sym='+',\n",
    "        widths=0.4,\n",
    "        patch_artist=False,\n",
    "        meanline=True,\n",
    "        showmeans=True))\n",
    "    \n",
    "    box_plt_list.append(\n",
    "        plt.boxplot(\n",
    "        df['w2v_cosine_sim'].tolist(),\n",
    "        positions=[xticks[-1]],\n",
    "        sym='+',\n",
    "        widths=0.4,\n",
    "        patch_artist=False,\n",
    "        meanline=True,\n",
    "        showmeans=True))\n",
    "\n",
    "    for i, bp in enumerate(box_plt_list[:-2]):\n",
    "        set_box_color(bp, color[i])\n",
    "        plt.plot([], c=color[i], label=prf[i])\n",
    "    plt.legend()\n",
    "\n",
    "    ax.grid(True, axis='y', alpha=0.7, linestyle='--')\n",
    "    ax.set_title('Evaluation Results', fontsize='xx-large')\n",
    "    ax.set_ylabel('Rouge', fontsize='x-large')\n",
    "    plt.xticks(xticks, config.ROUGE_TYPES+['ST Cosine', 'W2V Cosine'], fontsize='x-large')\n",
    "    plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "vb_MdivVauzb"
   },
   "source": [
    "## **Sentence-Transformers**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "data_dir_st = data_dir + 'st/base/'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {
    "executionInfo": {
     "elapsed": 18765,
     "status": "ok",
     "timestamp": 1610616898502,
     "user": {
      "displayName": "Marco Pietro Abrate",
      "photoUrl": "https://lh3.googleusercontent.com/a-/AOh14Gjh-8YF-8BlnrkN9mLZ0xfVOWfOh7kYncpYRv-Y=s64",
      "userId": "15422244832836998434"
     },
     "user_tz": -60
    },
    "id": "K98cwOLys0XX"
   },
   "outputs": [],
   "source": [
    "df_train = pd.read_csv(data_dir_st + 'train.csv').set_index(['book', 'chapter'])\n",
    "df_val = pd.read_csv(data_dir_st + 'val.csv').set_index(['book', 'chapter'])\n",
    "df_test = pd.read_csv(data_dir_st + 'test.csv').set_index(['book', 'chapter'])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "dpNmnjXn3u2U"
   },
   "source": [
    "### **Print and Summarization**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "from transformers import AutoConfig\n",
    "model_config = AutoConfig.from_pretrained(model_name_or_path)\n",
    "model_config.min_length = config.ONE_BULLET_MIN_LEN\n",
    "model_config.max_length = config.ONE_BULLET_MAX_LEN\n",
    "\n",
    "model_config_dir = bucket_dir+'fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/'\n",
    "model_config.save_pretrained(model_config_dir)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "heading_collapsed": true,
    "id": "WIiEnpvbMkJa"
   },
   "source": [
    "#### Print Train Examples"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 1000,
     "referenced_widgets": [
      "addb9bfe4b084b61a77f19962f2919d1",
      "01e3a51fe914437187fb471f042cbc4e",
      "8ef14e9327d84807a95686427993ebcd",
      "0795dec75e4f4a9cad293877eddef047",
      "37bb8348b38e45b981c8e2c580de608b"
     ]
    },
    "executionInfo": {
     "elapsed": 78849,
     "status": "ok",
     "timestamp": 1610617032580,
     "user": {
      "displayName": "Marco Pietro Abrate",
      "photoUrl": "https://lh3.googleusercontent.com/a-/AOh14Gjh-8YF-8BlnrkN9mLZ0xfVOWfOh7kYncpYRv-Y=s64",
      "userId": "15422244832836998434"
     },
     "user_tz": -60
    },
    "hidden": true,
    "id": "wgZKNh2f3u2l",
    "outputId": "fabe9770-ee41-42bc-9726-a13e121e11ab",
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(9781912776696, 'hh-5')\n",
      "Kaplan-Meier curves provide a way of plotting the distribution of a time-to-event endpoint. In\n",
      "Figure 2.1 the dashed line shows that at 24 months' follow-up the estimated survival probability is\n",
      "54%. Kaplan-Meier survival curves are often used to compare the data between two groups of subjects.\n",
      "Figure 2.2 shows Kaplan-Meier curves for OS in a randomized study of patients with human epidermal\n",
      "growth factor receptor 2 (HER2)-positive metastatic breast cancer treated either with or without\n",
      "trastuzumab. The Kaplan-Meier curve steps down at time points at which deaths occur, while censored\n",
      "observations are denoted by notches on the curve. In this study, the follow-up period ranged from 3\n",
      "months to 74 months.\n",
      "\n",
      "Reference:\n",
      "Kaplan-Meier curves plot the probability of being event free over time. The curves from different\n",
      "treatment groups can be plotted against each other to show the differences in outcome.\n",
      "\n",
      "google/pegasus-large (41 tok):\n",
      "R1\tp: 15.15 \tr: 16.67 \tf: 15.87\n",
      "R2\tp: 6.25 \tr: 6.90 \tf: 6.56\n",
      "RL\tp: 12.12 \tr: 13.33 \tf: 12.70\n",
      "ST\t47.94\t\tW2V\t18.98\n",
      "\n",
      "Figure 2.2 shows Kaplan-Meier curves for OS in a randomized study of patients with human epidermal\n",
      "growth factor receptor 2 (HER2)-positive metastatic breast cancer treated either with or without\n",
      "trastuzumab.\n",
      "\n",
      "google/pegasus-large (41 tok):\n",
      "R1\tp: 15.15 \tr: 16.67 \tf: 15.87\n",
      "R2\tp: 6.25 \tr: 6.90 \tf: 6.56\n",
      "RL\tp: 12.12 \tr: 13.33 \tf: 12.70\n",
      "ST\t48.01\t\tW2V\t15.67\n",
      "\n",
      "Figures 2.2 shows Kaplan-Meier curves for OS in a randomized study of patients with human epidermal\n",
      "growth factor receptor 2 (HER2)-positive metastatic breast cancer treated either with or without\n",
      "trastuzumab.\n",
      "\n",
      "google/pegasus-large (27 tok):\n",
      "R1\tp: 21.74 \tr: 16.67 \tf: 18.87\n",
      "R2\tp: 4.55 \tr: 3.45 \tf: 3.92\n",
      "RL\tp: 17.39 \tr: 13.33 \tf: 15.09\n",
      "ST\t64.37\t\tW2V\t22.29\n",
      "\n",
      "The Kaplan-Meier curve steps down at time points at which deaths occur, while censored observations\n",
      "are denoted by notches on the curve.\n",
      "\n",
      "google/pegasus-large (22 tok):\n",
      "R1\tp: 20.00 \tr: 13.33 \tf: 16.00\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 10.00 \tr: 6.67 \tf: 8.00\n",
      "ST\t41.41\t\tW2V\t39.98\n",
      "\n",
      "In Figure 2.1 the dashed line shows that at 24 months' follow-up the estimated survival probability\n",
      "is 54%.\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (21 tok):\n",
      "R1\tp: 50.00 \tr: 26.67 \tf: 34.78\n",
      "R2\tp: 13.33 \tr: 6.90 \tf: 9.09\n",
      "RL\tp: 43.75 \tr: 23.33 \tf: 30.43\n",
      "ST\t75.96\t\tW2V\t43.56\n",
      "\n",
      "Kaplan-Meier curves provide a way of plotting the distribution of a time-to-event endpoint.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (20 tok):\n",
      "R1\tp: 53.33 \tr: 26.67 \tf: 35.56\n",
      "R2\tp: 14.29 \tr: 6.90 \tf: 9.30\n",
      "RL\tp: 46.67 \tr: 23.33 \tf: 31.11\n",
      "ST\t77.14\t\tW2V\t40.77\n",
      "\n",
      "Kaplan-Meier curves provide a way of plotting the distribution of time-to-event endpoints.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (17 tok):\n",
      "R1\tp: 42.86 \tr: 20.00 \tf: 27.27\n",
      "R2\tp: 15.38 \tr: 6.90 \tf: 9.52\n",
      "RL\tp: 42.86 \tr: 20.00 \tf: 27.27\n",
      "ST\t76.33\t\tW2V\t42.05\n",
      "\n",
      "Kaplan-Meier curves provide a way of plotting the distribution of an event endpoint.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (16 tok):\n",
      "R1\tp: 38.46 \tr: 16.67 \tf: 23.26\n",
      "R2\tp: 16.67 \tr: 6.90 \tf: 9.76\n",
      "RL\tp: 38.46 \tr: 16.67 \tf: 23.26\n",
      "ST\t70.99\t\tW2V\t37.76\n",
      "\n",
      "Kaplan-Meier curves provide a way of plotting the distribution of an endpoint.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781908541062, 'ch_9')\n",
      "The traditional 'pyramid' approach to the treatment of RA was to begin with symptomatic treatment of\n",
      "inflammation using NSAIDs in addition to rest and corticosteroid injections. If the disease did not\n",
      "significantly improve with these simple treatments, then more potent DMARDs were added. It is now\n",
      "clear, however, that effective therapy early in the course of RA results in a long-term reduction in\n",
      "joint damage compared to delayed therapy, the so-called window of opportunity. This has led to the\n",
      "general principle that inflammation should be controlled as completely and as soon as possible by\n",
      "the early and aggressive introduction of DMARDs. The currently approved non-biological drugs for\n",
      "treating RA are listed in Table 8.1. Most of these require monitoring for the prompt detection of\n",
      "potential adverse effects, although the precise monitoring recommendations vary from center to\n",
      "center. The British Society for Rheumatology, the European League Against Rheumatism and the\n",
      "American College of Rheumatology have each developed guidelines for the use and monitoring of RA\n",
      "therapies.\n",
      "\n",
      "Reference:\n",
      "Treatment-to-target strategies, including combination DMARD therapy, rapidly suppress inflammation\n",
      "and minimize long-term damage and disability.\n",
      "\n",
      "google/pegasus-large (30 tok):\n",
      "R1\tp: 14.81 \tr: 22.22 \tf: 17.78\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 14.81 \tr: 22.22 \tf: 17.78\n",
      "ST\t54.02\t\tW2V\t34.64\n",
      "\n",
      "This has led to the general principle that inflammation should be controlled as completely and as\n",
      "soon as possible by the early and aggressive introduction of DMARDs.\n",
      "\n",
      "google/pegasus-large (62 tok):\n",
      "R1\tp: 7.27 \tr: 22.22 \tf: 10.96\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 7.27 \tr: 22.22 \tf: 10.96\n",
      "ST\t51.35\t\tW2V\t31.25\n",
      "\n",
      "This has led to the general principle that inflammation should be controlled as completely and as\n",
      "soon as possible by the early and aggressive introduction of DMARDs. The British Society for\n",
      "Rheumatology, the European League Against Rheumatism and the American College of Rheumatology have\n",
      "each developed guidelines for the use and monitoring of RA therapies.\n",
      "\n",
      "google/pegasus-large (39 tok):\n",
      "R1\tp: 15.15 \tr: 27.78 \tf: 19.61\n",
      "R2\tp: 3.12 \tr: 5.88 \tf: 4.08\n",
      "RL\tp: 12.12 \tr: 22.22 \tf: 15.69\n",
      "ST\t57.93\t\tW2V\t12.03\n",
      "\n",
      "It is now clear, however, that effective therapy early in the course of RA results in a long-term\n",
      "reduction in joint damage compared to delayed therapy, the so-called window of opportunity.\n",
      "\n",
      "google/pegasus-large (32 tok):\n",
      "R1\tp: 7.14 \tr: 11.11 \tf: 8.70\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 7.14 \tr: 11.11 \tf: 8.70\n",
      "ST\t33.32\t\tW2V\t15.04\n",
      "\n",
      "The British Society for Rheumatology, the European League Against Rheumatism and the American\n",
      "College of Rheumatology have each developed guidelines for the use and monitoring of RA therapies.\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (16 tok):\n",
      "R1\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "ST\t44.47\t\tW2V\t10.60\n",
      "\n",
      "DMARDs should be used as early as possible in the course of RA.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (17 tok):\n",
      "R1\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "ST\t49.95\t\tW2V\t2.83\n",
      "\n",
      "DMARDs should be used as early as possible in the course of the disease.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (12 tok):\n",
      "R1\tp: 11.11 \tr: 5.56 \tf: 7.41\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 11.11 \tr: 5.56 \tf: 7.41\n",
      "ST\t47.94\t\tW2V\t2.50\n",
      "\n",
      "DMARDs are the mainstay of the treatment of RA.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (11 tok):\n",
      "R1\tp: 12.50 \tr: 5.56 \tf: 7.69\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 12.50 \tr: 5.56 \tf: 7.69\n",
      "ST\t51.45\t\tW2V\t1.23\n",
      "\n",
      "DMARDs are the mainstay of treatment for RA.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781910797495, 'chp8')\n",
      "Postincisional pain. Postincisional syndrome is defined as pain at or close to the site of a\n",
      "surgical incision that persists beyond the usual healing period. As with other neuropathic pain\n",
      "syndromes, patients exhibit allodynia and sometimes also edema in the vicinity of the surgical\n",
      "wound, which is typical of temporary peripheral sensitization. Postamputation persistent pain.\n",
      "Postamputation persistent pain is a special case of PPSP because large nerves are deliberately cut\n",
      "in all patients. It is interesting, then, that only 30-50% develop PPSP, whereas 100% have nerve\n",
      "injury (see Table 8.1). This emphasizes the multifactorial basis of PPSP. A surprising omission in\n",
      "studies of amputation pain is information about how the nerves amputated are managed (id est clean\n",
      "cut or ligature tied). Use of a ligature tie in animal studies is known to generate neuropathic\n",
      "pain.\n",
      "\n",
      "Reference:\n",
      "Persistent postsurgical pain (PPSP) is defined as pain at or close to the site of surgical incision\n",
      "that persists beyond the expected healing period.\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "google/pegasus-large (22 tok):\n",
      "R1\tp: 27.78 \tr: 20.83 \tf: 23.81\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 22.22 \tr: 16.67 \tf: 19.05\n",
      "ST\t69.64\t\tW2V\t22.20\n",
      "\n",
      "Postamputation persistent pain is a special case of PPSP because large nerves are deliberately cut\n",
      "in all patients.\n",
      "\n",
      "google/pegasus-large (48 tok):\n",
      "R1\tp: 19.05 \tr: 33.33 \tf: 24.24\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 11.90 \tr: 20.83 \tf: 15.15\n",
      "ST\t64.00\t\tW2V\t34.45\n",
      "\n",
      "Postamputation persistent pain is a special case of PPSP because large nerves are deliberately cut\n",
      "in all patients. A surprising omission in studies of amputation pain is information about how the\n",
      "nerves amputated are managed (id est clean cut or ligature tied).\n",
      "\n",
      "google/pegasus-large (26 tok):\n",
      "R1\tp: 20.83 \tr: 20.83 \tf: 20.83\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 12.50 \tr: 12.50 \tf: 12.50\n",
      "ST\t40.35\t\tW2V\t33.53\n",
      "\n",
      "A surprising omission in studies of amputation pain is information about how the nerves amputated\n",
      "are managed (id est clean cut or ligature tied).\n",
      "\n",
      "google/pegasus-large (48 tok):\n",
      "R1\tp: 19.05 \tr: 33.33 \tf: 24.24\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 11.90 \tr: 20.83 \tf: 15.15\n",
      "ST\t63.32\t\tW2V\t34.28\n",
      "\n",
      "Postamputation persistent pain is a special case of PPSP because large nerves are deliberately cut\n",
      "in all patients. A surprising omission in studies of amputation pain is information about how the\n",
      "amputated nerves are managed (id est clean cut or ligature tied).\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (31 tok):\n",
      "R1\tp: 88.00 \tr: 91.67 \tf: 89.80\n",
      "R2\tp: 75.00 \tr: 78.26 \tf: 76.60\n",
      "RL\tp: 88.00 \tr: 91.67 \tf: 89.80\n",
      "ST\t94.93\t\tW2V\t93.15\n",
      "\n",
      "Postamputation persistent pain (PPSP) is defined as pain at or close to the site of a surgical\n",
      "incision that persists beyond the usual healing period.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (31 tok):\n",
      "R1\tp: 83.33 \tr: 83.33 \tf: 83.33\n",
      "R2\tp: 73.91 \tr: 73.91 \tf: 73.91\n",
      "RL\tp: 83.33 \tr: 83.33 \tf: 83.33\n",
      "ST\t91.32\t\tW2V\t83.31\n",
      "\n",
      "Postincisional syndrome (PPSP) is defined as pain at or close to the site of a surgical incision\n",
      "that persists beyond the usual healing period.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (30 tok):\n",
      "R1\tp: 91.67 \tr: 91.67 \tf: 91.67\n",
      "R2\tp: 82.61 \tr: 82.61 \tf: 82.61\n",
      "RL\tp: 91.67 \tr: 91.67 \tf: 91.67\n",
      "ST\t94.89\t\tW2V\t93.15\n",
      "\n",
      "Postamputation persistent pain (PPSP) is defined as pain at or close to the site of surgical\n",
      "incision that persists beyond the usual healing period.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (27 tok):\n",
      "R1\tp: 82.61 \tr: 79.17 \tf: 80.85\n",
      "R2\tp: 72.73 \tr: 69.57 \tf: 71.11\n",
      "RL\tp: 82.61 \tr: 79.17 \tf: 80.85\n",
      "ST\t81.61\t\tW2V\t80.12\n",
      "\n",
      "Postincisional syndrome is defined as pain at or close to the site of a surgical incision that\n",
      "persists beyond the usual healing period.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781908541666, 'ch_12')\n",
      "Treatment. Immediate treatment of any identifiable cause of the DKA should be undertaken without\n",
      "delay. Until recently, standard management of DKA focused on reducing blood glucose levels with\n",
      "insulin and intravenous fluids. There is still universal agreement that the initial cornerstone of\n",
      "treatment is fluid replacement and insulin administration. The intravascular volume should be\n",
      "expanded to correct a typical deficit of 100 mL/kg of water with intravenous isotonic saline, which\n",
      "will also improve renal perfusion. Infusion rates of 1 L per hour for the first hour, 1 L for the\n",
      "next 2 hours and 1 L over the next 4 hours are usually adequate except in those patients with\n",
      "profound hypovolemia and hypotension, who may need twice this amount (Table 11.3). If the initial\n",
      "systolic blood pressure is below 90 mmHg, 500 mL of normal saline should be given over 15 minutes.\n",
      "In the presence of significant hypernatremia, isotonic saline can be replaced with 0.45% saline. The\n",
      "aim is to replace total body deficits of water and electrolytes, with half the estimated deficit\n",
      "being replaced in 12-24 hours (see Table 11.3). Once the blood glucose has fallen to about 14 mmol/L\n",
      "(252 mg/dL), saline should be replaced with 5% dextrose (or an infusion of 10% glucose given at 125\n",
      "mL/hour started alongside the infusion of normal saline to correct circulatory volume) to allow\n",
      "continued insulin administration to suppress ketogenesis while avoiding hypoglycemia.\n",
      "\n",
      "Reference:\n",
      "Treatment of DKA is by fluid and electrolyte replacement, intravenous insulin and treatment of the\n",
      "underlying cause, when known.\n",
      "\n",
      "google/pegasus-large (65 tok):\n",
      "R1\tp: 7.41 \tr: 21.05 \tf: 10.96\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 3.70 \tr: 10.53 \tf: 5.48\n",
      "ST\t41.89\t\tW2V\t21.41\n",
      "\n",
      "Once the blood glucose has fallen to about 14 mmol/L (252 mg/dL), saline should be replaced with 5%\n",
      "dextrose (or an infusion of 10% glucose given at 125 mL/hour started alongside the infusion of\n",
      "normal saline to correct circulatory volume) to allow continued insulin administration to suppress\n",
      "ketogenesis while avoiding hypoglycemia.\n",
      "\n",
      "google/pegasus-large (94 tok):\n",
      "R1\tp: 7.41 \tr: 31.58 \tf: 12.00\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 4.94 \tr: 21.05 \tf: 8.00\n",
      "ST\t44.64\t\tW2V\t31.80\n",
      "\n",
      "The aim is to replace total body deficits of water and electrolytes, with half the estimated deficit\n",
      "being replaced in 12-24 hours (see Table 11.3). Once the blood glucose has fallen to about 14 mmol/L\n",
      "(252 mg/dL), saline should be replaced with 5% dextrose (or an infusion of 10% glucose given at 125\n",
      "mL/hour started alongside the infusion of normal saline to correct circulatory volume) to allow\n",
      "continued insulin administration to suppress ketogenesis while avoiding hypoglycemia.\n",
      "\n",
      "google/pegasus-large (96 tok):\n",
      "R1\tp: 6.17 \tr: 26.32 \tf: 10.00\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 4.94 \tr: 21.05 \tf: 8.00\n",
      "ST\t36.63\t\tW2V\t24.83\n",
      "\n",
      "The intravascular volume should be expanded to correct a typical deficit of 100 mL/kg of water with\n",
      "intravenous isotonic saline, which will also improve renal perfusion. Once the blood glucose has\n",
      "fallen to about 14 mmol/L (252 mg/dL), saline should be replaced with 5% dextrose (or an infusion of\n",
      "10% glucose given at 125 mL/hour started alongside the infusion of normal saline to correct\n",
      "circulatory volume) to allow continued insulin administration to suppress ketosis while avoiding\n",
      "hypoglycemia.\n",
      "\n",
      "google/pegasus-large (66 tok):\n",
      "R1\tp: 7.41 \tr: 21.05 \tf: 10.96\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 3.70 \tr: 10.53 \tf: 5.48\n",
      "ST\t39.20\t\tW2V\t21.41\n",
      "\n",
      "Once the blood glucose has fallen to about 14 mmol/L (252 mg/dL), saline should be replaced with 5%\n",
      "dextrose (or an infusion of 10% glucose given at 125 mL/hour started alongside the infusion of\n",
      "normal saline to correct circulatory volume) to allow continued insulin administration to suppress\n",
      "ketogenesis while avoiding hypoglycemia..\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (15 tok):\n",
      "R1\tp: 38.46 \tr: 26.32 \tf: 31.25\n",
      "R2\tp: 16.67 \tr: 11.11 \tf: 13.33\n",
      "RL\tp: 23.08 \tr: 15.79 \tf: 18.75\n",
      "ST\t64.47\t\tW2V\t31.56\n",
      "\n",
      "Immediate treatment of any identifiable cause of DKA should be undertaken without delay.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (26 tok):\n",
      "R1\tp: 52.17 \tr: 63.16 \tf: 57.14\n",
      "R2\tp: 9.09 \tr: 11.11 \tf: 10.00\n",
      "RL\tp: 30.43 \tr: 36.84 \tf: 33.33\n",
      "ST\t77.27\t\tW2V\t63.63\n",
      "\n",
      "Immediate treatment of any identifiable cause of DKA should be undertaken without delay. The\n",
      "cornerstone of treatment is fluid replacement and insulin administration.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (16 tok):\n",
      "R1\tp: 42.86 \tr: 31.58 \tf: 36.36\n",
      "R2\tp: 15.38 \tr: 11.11 \tf: 12.90\n",
      "RL\tp: 28.57 \tr: 21.05 \tf: 24.24\n",
      "ST\t63.50\t\tW2V\t41.06\n",
      "\n",
      "Immediate treatment of any identifiable cause of the DKA should be undertaken without delay.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (27 tok):\n",
      "R1\tp: 50.00 \tr: 63.16 \tf: 55.81\n",
      "R2\tp: 8.70 \tr: 11.11 \tf: 9.76\n",
      "RL\tp: 29.17 \tr: 36.84 \tf: 32.56\n",
      "ST\t77.79\t\tW2V\t67.22\n",
      "\n",
      "Immediate treatment of any identifiable cause of the DKA should be undertaken without delay. The\n",
      "cornerstone of treatment is fluid replacement and insulin administration.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781910797495, 'chp1')\n",
      "Because it is an experience, pain itself cannot be measured directly. Pain, like consciousness\n",
      "itself, is constructed by complex brain processes that are strongly affected by a person's\n",
      "attitudes, beliefs, personality and interpretation of the significance of nociceptive stimuli.\n",
      "Central to the understanding of clinical pain is the concept that pain may be present without an\n",
      "obvious peripheral source or cause. Mechanisms of neuropathic pain. Definition. Neuropathic pain is\n",
      "initiated or caused by a primary lesion of the PNS or CNS. Patients often complain not only of\n",
      "spontaneous pain, but also of pain from stimuli that are not normally painful (allodynia). For\n",
      "example, a light touch may be described as painful.\n",
      "\n",
      "Reference:\n",
      "Neuropathic pain is produced by a lesion of the peripheral or central nervous system (CNS).\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "google/pegasus-large (25 tok):\n",
      "R1\tp: 10.00 \tr: 13.33 \tf: 11.43\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 10.00 \tr: 13.33 \tf: 11.43\n",
      "ST\t48.54\t\tW2V\t26.39\n",
      "\n",
      "Patients often complain not only of spontaneous pain, but also of pain from stimuli that are not\n",
      "normally painful (allodynia).\n",
      "\n",
      "google/pegasus-large (23 tok):\n",
      "R1\tp: 31.82 \tr: 46.67 \tf: 37.84\n",
      "R2\tp: 4.76 \tr: 7.14 \tf: 5.71\n",
      "RL\tp: 22.73 \tr: 33.33 \tf: 27.03\n",
      "ST\t53.86\t\tW2V\t56.82\n",
      "\n",
      "Central to the understanding of clinical pain is the concept that pain may be present without an\n",
      "obvious peripheral source or cause.\n",
      "\n",
      "google/pegasus-large (37 tok):\n",
      "R1\tp: 10.00 \tr: 20.00 \tf: 13.33\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 6.67 \tr: 13.33 \tf: 8.89\n",
      "ST\t49.00\t\tW2V\t23.41\n",
      "\n",
      "Patients often complain not only of spontaneous pain, but also of pain from stimuli that are not\n",
      "normally painful (allodynia). For example, a light touch may be described as painful.\n",
      "\n",
      "google/pegasus-large (25 tok):\n",
      "R1\tp: 10.00 \tr: 13.33 \tf: 11.43\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 10.00 \tr: 13.33 \tf: 11.43\n",
      "ST\t45.93\t\tW2V\t27.00\n",
      "\n",
      "Patient often complain not only of spontaneous pain, but also of pain from stimuli that are not\n",
      "normally painful (allodynia).\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (19 tok):\n",
      "R1\tp: 66.67 \tr: 66.67 \tf: 66.67\n",
      "R2\tp: 35.71 \tr: 35.71 \tf: 35.71\n",
      "RL\tp: 66.67 \tr: 66.67 \tf: 66.67\n",
      "ST\t87.09\t\tW2V\t65.80\n",
      "\n",
      "Neuropathic pain is initiated or caused by a primary lesion of the PNS or CNS.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (20 tok):\n",
      "R1\tp: 76.47 \tr: 86.67 \tf: 81.25\n",
      "R2\tp: 62.50 \tr: 71.43 \tf: 66.67\n",
      "RL\tp: 76.47 \tr: 86.67 \tf: 81.25\n",
      "ST\t90.12\t\tW2V\t79.58\n",
      "\n",
      "Neuropathic pain is initiated or caused by a primary lesion of the peripheral or central nervous\n",
      "system.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (12 tok):\n",
      "R1\tp: 27.27 \tr: 20.00 \tf: 23.08\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 27.27 \tr: 20.00 \tf: 23.08\n",
      "ST\t43.83\t\tW2V\t31.69\n",
      "\n",
      "Pain may be present without an obvious peripheral source or cause.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (11 tok):\n",
      "R1\tp: 20.00 \tr: 13.33 \tf: 16.00\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 20.00 \tr: 13.33 \tf: 16.00\n",
      "ST\t36.69\t\tW2V\t22.63\n",
      "\n",
      "Pain may be present without an obvious source or cause.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781910797662, 'ch03')\n",
      "Delay in diagnosis. Although it is difficult to prove that delay in diagnosis affects prognosis,\n",
      "screening for asymptomatic microscopic hematuria is associated with a shift towards more favorable\n",
      "tumor characteristics of lower stage and grade at diagnosis, and better survival. Delays may occur\n",
      "for a variety of reasons.\n",
      "\n",
      "Reference:\n",
      "Delay in treatment adversely affects prognosis.\n",
      "\n",
      "google/pegasus-large (42 tok):\n",
      "R1\tp: 10.81 \tr: 66.67 \tf: 18.60\n",
      "R2\tp: 5.56 \tr: 40.00 \tf: 9.76\n",
      "RL\tp: 10.81 \tr: 66.67 \tf: 18.60\n",
      "ST\t55.21\t\tW2V\t20.82\n",
      "\n",
      "Although it is difficult to prove that delay in diagnosis affects prognosis, screening for\n",
      "asymptomatic microscopic hematuria is associated with a shift towards more favorable tumor\n",
      "characteristics of lower stage and grade at diagnosis, and better survival.\n",
      "\n",
      "google/pegasus-large (42 tok):\n",
      "R1\tp: 10.81 \tr: 66.67 \tf: 18.60\n",
      "R2\tp: 5.56 \tr: 40.00 \tf: 9.76\n",
      "RL\tp: 10.81 \tr: 66.67 \tf: 18.60\n",
      "ST\t54.88\t\tW2V\t21.52\n",
      "\n",
      "Despite it is difficult to prove that delay in diagnosis affects prognosis, screening for\n",
      "asymptomatic microscopic hematuria is associated with a shift towards more favorable tumor\n",
      "characteristics of lower stage and grade at diagnosis, and better survival.\n",
      "\n",
      "google/pegasus-large (42 tok):\n",
      "R1\tp: 10.81 \tr: 66.67 \tf: 18.60\n",
      "R2\tp: 5.56 \tr: 40.00 \tf: 9.76\n",
      "RL\tp: 10.81 \tr: 66.67 \tf: 18.60\n",
      "ST\t55.61\t\tW2V\t22.88\n",
      "\n",
      "Although it is difficult to prove that delay in diagnosis affects prognosis, screening for\n",
      "asymptomatic micro hematuria is associated with a shift towards more favorable tumor characteristics\n",
      "of lower stage and grade at diagnosis, and better survival.\n",
      "\n",
      "google/pegasus-large (10 tok):\n",
      "R1\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "ST\t37.18\t\tW2V\t10.32\n",
      "\n",
      "Delays may occur for a variety of reasons.\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (12 tok):\n",
      "R1\tp: 18.18 \tr: 33.33 \tf: 23.53\n",
      "R2\tp: 10.00 \tr: 20.00 \tf: 13.33\n",
      "RL\tp: 18.18 \tr: 33.33 \tf: 23.53\n",
      "ST\t53.95\t\tW2V\t33.61\n",
      "\n",
      "Delay in diagnosis may be due to a variety of reasons.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (9 tok):\n",
      "R1\tp: 37.50 \tr: 50.00 \tf: 42.86\n",
      "R2\tp: 14.29 \tr: 20.00 \tf: 16.67\n",
      "RL\tp: 37.50 \tr: 50.00 \tf: 42.86\n",
      "ST\t64.99\t\tW2V\t48.38\n",
      "\n",
      "Delay in diagnosis is associated with better prognosis.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (9 tok):\n",
      "R1\tp: 25.00 \tr: 33.33 \tf: 28.57\n",
      "R2\tp: 14.29 \tr: 20.00 \tf: 16.67\n",
      "RL\tp: 25.00 \tr: 33.33 \tf: 28.57\n",
      "ST\t61.00\t\tW2V\t24.75\n",
      "\n",
      "Delay in diagnosis is associated with better survival.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (12 tok):\n",
      "R1\tp: 18.18 \tr: 33.33 \tf: 23.53\n",
      "R2\tp: 10.00 \tr: 20.00 \tf: 13.33\n",
      "RL\tp: 18.18 \tr: 33.33 \tf: 23.53\n",
      "ST\t55.29\t\tW2V\t32.03\n",
      "\n",
      "Delay in diagnosis may be due to a variety of factors.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781910797310, 'chp2')\n",
      "Well-differentiated tumors with adenocarcinoma morphology (acinar, papillary, lepidic,\n",
      "micropapillary) or squamous cell carcinoma (unequivocal keratinization and well-formed classical\n",
      "bridges) on routine light microscopy can be diagnosed as adenocarcinoma or squamous cell carcinoma,\n",
      "respectively, without immunohistochemistry. Poorly differentiated tumors should undergo limited\n",
      "immuno-histochemistry. A single adenocarcinoma marker (exempli gratia thyroid transcription factor 1\n",
      "[TTF1] or Napsin-A) or squamous cell carcinoma marker (exempli gratia p40, cytokeratin 5/6 or p63)\n",
      "can be used to classify most tumors. Carcinomas lacking clear differentiation by morphology and\n",
      "immunohistochemistry are classified as 'NSCLC, not otherwise specified (NOS)'. NOS carcinomas that\n",
      "stain with adenocarcinoma markers are classified as 'NSCLC, favor adenocarcinoma'; tumors that stain\n",
      "with squamous markers are classified as 'NSCLC, favor squamous cell carcinoma'. In this way, a\n",
      "diagnosis of NSCLC-NOS can be avoided in up to 90% of cases.\n",
      "\n",
      "Reference:\n",
      "Classification of NSCLC further into specific pathological subtypes (exempli gratia adenocarcinoma\n",
      "versus squamous cell carcinoma) will determine eligibility for certain types of molecular testing\n",
      "and aid therapeutic decisions based on the specific histological and genetic characteristics of the\n",
      "tumor.\n",
      "\n",
      "google/pegasus-large (60 tok):\n",
      "R1\tp: 16.22 \tr: 15.38 \tf: 15.79\n",
      "R2\tp: 5.56 \tr: 5.26 \tf: 5.41\n",
      "RL\tp: 16.22 \tr: 15.38 \tf: 15.79\n",
      "ST\t55.23\t\tW2V\t41.07\n",
      "\n",
      "Well-differentiated tumors with adenocarcinoma morphology (acinar, papillary, lepidic,\n",
      "micropapillary) or squamous cell carcinoma (unequivocal keratinization and well-formed classical\n",
      "bridges) on routine light microscopy can be diagnosed as adenocarcinoma or squamous cell carcinoma,\n",
      "respectively, without immunohistochemistry.\n",
      "\n",
      "google/pegasus-large (59 tok):\n",
      "R1\tp: 16.67 \tr: 15.38 \tf: 16.00\n",
      "R2\tp: 5.71 \tr: 5.26 \tf: 5.48\n",
      "RL\tp: 16.67 \tr: 15.38 \tf: 16.00\n",
      "ST\t55.35\t\tW2V\t39.51\n",
      "\n",
      "Well-differentiated tumors with adenocarcinoma morphology (acinar, papillary, lepidic,\n",
      "micropapillary) or squamous cell carcinoma (unequivocalization and well-formed classical bridges) on\n",
      "routine light microscopy can be diagnosed as adenocarcinoma or squamous cell carcinoma,\n",
      "respectively, without immunohistochemistry.\n",
      "\n",
      "google/pegasus-large (98 tok):\n",
      "R1\tp: 10.94 \tr: 17.95 \tf: 13.59\n",
      "R2\tp: 3.17 \tr: 5.26 \tf: 3.96\n",
      "RL\tp: 9.38 \tr: 15.38 \tf: 11.65\n",
      "ST\t61.54\t\tW2V\t30.61\n",
      "\n",
      "Well-differentiated tumors with adenocarcinoma morphology (acinar, papillary, lepidic,\n",
      "micropapillary) or squamous cell carcinoma (unequivocal keratinization and well-formed classical\n",
      "bridges) on routine light microscopy can be diagnosed as adenocarcinoma or squamous cell carcinoma,\n",
      "respectively, without immunohistochemistry. NOS carcinomas that stain with adenocarcinoma markers\n",
      "are classified as 'NSCLC, favor adenocarcinoma'; tumors that stain with squamous markers are\n",
      "classified as ‘NSCLC, favor squamous cell carcinoma'.\n",
      "\n",
      "google/pegasus-large (98 tok):\n",
      "R1\tp: 10.94 \tr: 17.95 \tf: 13.59\n",
      "R2\tp: 3.17 \tr: 5.26 \tf: 3.96\n",
      "RL\tp: 9.38 \tr: 15.38 \tf: 11.65\n",
      "ST\t61.64\t\tW2V\t34.66\n",
      "\n",
      "Well-differentiated tumors with adenocarcinoma morphology (acinar, papillary, lepidic,\n",
      "micropapillary) or squamous cell carcinoma (unequivocal keratinization and well-formed classical\n",
      "bridges) on routine light microscopy can be diagnosed as adenocarcinoma or squamous cell carcinoma,\n",
      "respectively, without immunohistochemistry. NOS carcinomas that stain with adenocarcinoma markers\n",
      "are classified as 'NSCLC, favor adenocarcinoma'; tumors that stain with squamous markers are\n",
      "classified in 'NSCLC, favour squamous cell carcinoma'.\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (34 tok):\n",
      "R1\tp: 13.64 \tr: 7.69 \tf: 9.84\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 9.09 \tr: 5.13 \tf: 6.56\n",
      "ST\t55.56\t\tW2V\t12.76\n",
      "\n",
      "Non-small-cell lung cancer (NSCLC) that lacks clear differentiation by morphology and\n",
      "immunohistochemistry is classified as 'NSCLC, not otherwise specified' (NOS).\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (32 tok):\n",
      "R1\tp: 14.29 \tr: 7.69 \tf: 10.00\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 9.52 \tr: 5.13 \tf: 6.67\n",
      "ST\t53.94\t\tW2V\t14.49\n",
      "\n",
      "Non-small-cell lung cancer (NSCLC) that lacks clear differentiation by morphology and\n",
      "immunohistochemistry is classified as 'NSCLC, not otherwise specified'.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (33 tok):\n",
      "R1\tp: 13.64 \tr: 7.69 \tf: 9.84\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 9.09 \tr: 5.13 \tf: 6.56\n",
      "ST\t55.81\t\tW2V\t12.76\n",
      "\n",
      "Non-small-cell lung cancer (NSCLC) that lacks clear differentiation by morphology and\n",
      "immunohistochemistry is classified as 'NSCLC, not otherwise specified (NOS).\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (34 tok):\n",
      "R1\tp: 13.64 \tr: 7.69 \tf: 9.84\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 9.09 \tr: 5.13 \tf: 6.56\n",
      "ST\t54.17\t\tW2V\t12.76\n",
      "\n",
      "Non-small-cell lung cancer (NSCLC) that lacks clear differentiation by morphology and\n",
      "immunohistochemistry is classified as 'NSCLC, not otherwise specified (NOS).'\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781910797587, 'chp03')\n",
      "Estimates of incidence and prevalence also vary according to the definition of OA used; for example,\n",
      "symptomatic versus radiographic criteria. Even when radiographic definitions are used, different\n",
      "radiographic features may be emphasized (exempli gratia osteophytes vs joint-space narrowing). It is\n",
      "interesting to note that the correlation between pain and radiographic OA features is not as strong\n",
      "as expected, for reasons discussed in Chapter 4 (see page 50).\n",
      "\n",
      "Reference:\n",
      "Although radiographic OA is common, it is not always symptomatic.\n",
      "\n",
      "google/pegasus-large (26 tok):\n",
      "R1\tp: 5.56 \tr: 10.00 \tf: 7.14\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 5.56 \tr: 10.00 \tf: 7.14\n",
      "ST\t44.10\t\tW2V\t12.53\n",
      "\n",
      "Even when radiographic definitions are used, different radiographic features may be emphasized\n",
      "(exempli gratiaphytes vs joint-space narrowing).\n",
      "\n",
      "google/pegasus-large (32 tok):\n",
      "R1\tp: 20.69 \tr: 60.00 \tf: 30.77\n",
      "R2\tp: 10.71 \tr: 33.33 \tf: 16.22\n",
      "RL\tp: 13.79 \tr: 40.00 \tf: 20.51\n",
      "ST\t54.90\t\tW2V\t49.93\n",
      "\n",
      "It is interesting to note that the correlation between pain and radiographic OA features is not as\n",
      "strong as expected, for reasons discussed in Chapter 4 (see page 50).\n",
      "\n",
      "google/pegasus-large (27 tok):\n",
      "R1\tp: 5.26 \tr: 10.00 \tf: 6.90\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 5.26 \tr: 10.00 \tf: 6.90\n",
      "ST\t47.75\t\tW2V\t8.61\n",
      "\n",
      "Even when radiographic definitions are used, different radiographic features may be emphasized\n",
      "(exempli gratiaphytes vs joint osteo-space narrowing).\n",
      "\n",
      "google/pegasus-large (27 tok):\n",
      "R1\tp: 5.26 \tr: 10.00 \tf: 6.90\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 5.26 \tr: 10.00 \tf: 6.90\n",
      "ST\t48.00\t\tW2V\t8.57\n",
      "\n",
      "Even when radiographic definitions are used, different radiographic features may be emphasized\n",
      "(exempli gratiaphytes vs joint-space narrowing osteo).\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (21 tok):\n",
      "R1\tp: 15.79 \tr: 30.00 \tf: 20.69\n",
      "R2\tp: 5.56 \tr: 11.11 \tf: 7.41\n",
      "RL\tp: 15.79 \tr: 30.00 \tf: 20.69\n",
      "ST\t47.91\t\tW2V\t46.40\n",
      "\n",
      "The correlation between pain and radiographic features is not as strong as expected, for reasons\n",
      "discussed in Chapter 4.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (15 tok):\n",
      "R1\tp: 28.57 \tr: 40.00 \tf: 33.33\n",
      "R2\tp: 15.38 \tr: 22.22 \tf: 18.18\n",
      "RL\tp: 28.57 \tr: 40.00 \tf: 33.33\n",
      "ST\t64.99\t\tW2V\t48.05\n",
      "\n",
      "The correlation between pain and radiographic OA features is not as strong as expected.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (16 tok):\n",
      "R1\tp: 26.67 \tr: 40.00 \tf: 32.00\n",
      "R2\tp: 14.29 \tr: 22.22 \tf: 17.39\n",
      "RL\tp: 26.67 \tr: 40.00 \tf: 32.00\n",
      "ST\t66.98\t\tW2V\t47.35\n",
      "\n",
      "The correlation between pain and radiographic features of OA is not as strong as expected.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (14 tok):\n",
      "R1\tp: 23.08 \tr: 30.00 \tf: 26.09\n",
      "R2\tp: 8.33 \tr: 11.11 \tf: 9.52\n",
      "RL\tp: 23.08 \tr: 30.00 \tf: 26.09\n",
      "ST\t50.70\t\tW2V\t45.87\n",
      "\n",
      "The correlation between pain and radiographic features is not as strong as expected.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781908541963, 'chapter10')\n",
      "Hepatocellular carcinoma. Epidemiology and pathogenesis. Hepatocellular carcinoma (hepatoma, HCC) is\n",
      "a malignancy of hepatocytes. HCC is a common cause of mortality in the developing world. Although\n",
      "currently less common in the developed world, the incidence is expected to rise as patients with\n",
      "cirrhosis due to chronic hepatitis C age. Marked geographic variation in incidence is largely due to\n",
      "variation in the risk factors that predispose an individual to the tumor (Table 10.1). Most cases of\n",
      "HCC occur in liver that is already cirrhotic. Thus, patients with advanced viral hepatitis,\n",
      "hemochromatosis or alcoholic liver disease are at risk. Hepatitis B presents a unique risk, as there\n",
      "is evidence that a tumor may develop in the absence of cirrhosis - presumably via direct integration\n",
      "of viral DNA into the host genome.\n",
      "\n",
      "Reference:\n",
      "Hepatocellular carcinoma often has few specific symptoms or signs.\n",
      "\n",
      "google/pegasus-large (26 tok):\n",
      "R1\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "ST\t31.88\t\tW2V\t-4.73\n",
      "\n",
      "Although currently less common in the developed world, the incidence is expected to rise as patients\n",
      "with cirrhosis due to chronic hepatitis C age.\n",
      "\n",
      "google/pegasus-large (34 tok):\n",
      "R1\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "ST\t46.67\t\tW2V\t8.82\n",
      "\n",
      "Hepatitis B presents a unique risk, as there is evidence that a tumor may develop in the absence of\n",
      "cirrhosis - presumably via direct integration of viral DNA into the host genome.\n",
      "\n",
      "google/pegasus-large (46 tok):\n",
      "R1\tp: 2.63 \tr: 11.11 \tf: 4.26\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 2.63 \tr: 11.11 \tf: 4.26\n",
      "ST\t37.38\t\tW2V\t-0.23\n",
      "\n",
      "Although currently less common in the developed world, the incidence is expected to rise as patients\n",
      "with cirrhosis due to chronic hepatitis C age. Thus, patients with advanced viral hepatitis,\n",
      "hemochromatosis or alcoholic liver disease are at risk.\n",
      "\n",
      "google/pegasus-large (27 tok):\n",
      "R1\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "ST\t33.63\t\tW2V\t-2.86\n",
      "\n",
      "However, currently less common in the developed world, the incidence is expected to rise as patients\n",
      "with cirrhosis due to chronic hepatitis C age.\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (18 tok):\n",
      "R1\tp: 15.38 \tr: 22.22 \tf: 18.18\n",
      "R2\tp: 8.33 \tr: 12.50 \tf: 10.00\n",
      "RL\tp: 15.38 \tr: 22.22 \tf: 18.18\n",
      "ST\t65.88\t\tW2V\t29.37\n",
      "\n",
      "Hepatocellular carcinoma (HCC) is a common cause of mortality in the developing world.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (15 tok):\n",
      "R1\tp: 16.67 \tr: 22.22 \tf: 19.05\n",
      "R2\tp: 9.09 \tr: 12.50 \tf: 10.53\n",
      "RL\tp: 16.67 \tr: 22.22 \tf: 19.05\n",
      "ST\t66.68\t\tW2V\t29.56\n",
      "\n",
      "Hepatocellular carcinoma is a common cause of mortality in the developing world.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (20 tok):\n",
      "R1\tp: 15.38 \tr: 22.22 \tf: 18.18\n",
      "R2\tp: 8.33 \tr: 12.50 \tf: 10.00\n",
      "RL\tp: 15.38 \tr: 22.22 \tf: 18.18\n",
      "ST\t69.23\t\tW2V\t28.41\n",
      "\n",
      "Hepatocellular carcinoma (hepatoma) is a common cause of mortality in the developing world.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (17 tok):\n",
      "R1\tp: 16.67 \tr: 22.22 \tf: 19.05\n",
      "R2\tp: 9.09 \tr: 12.50 \tf: 10.53\n",
      "RL\tp: 16.67 \tr: 22.22 \tf: 19.05\n",
      "ST\t65.70\t\tW2V\t22.99\n",
      "\n",
      "Hepatocellular carcinoma (HCC) is a common cause of mortality in developing countries.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781910797273, 'chp6')\n",
      "Promoting repair has been an unexplored sphere of MS therapy. Recently, in animal models of\n",
      "demyelination, LINGO antagonists have been shown to promote oligodendrocyte differentiation and\n",
      "myelination in vitro. Initiated in 2013, the first multinational Phase II trial of anti-LINGO-1\n",
      "antibodies in patients with acute optic neuritis has shown an effect on promoting nerve repair\n",
      "following optic neuritis. Ultimately, therapies that successfully promote remyelination and repair\n",
      "may be applicable across the spectrum of MS subtypes, including progressive forms of the disease.\n",
      "Tyrosine kinase inhibitors. Mastinib has completed a positive Phase IIb study in patients with\n",
      "primary and secondary progressive MS, the results of which are reported to include improvement in\n",
      "the Multiple Sclerosis Functional Composite (see pages 54 -). A Phase III trial in this population\n",
      "is now in progress, and it may prove to be an oral treatment option for this more rare type of MS.\n",
      "Mastinib targets mast cells and inhibits several biochemical processes. It is used in the treatment\n",
      "of canine diseases and is also being evaluated in stroke, amyotrophic lateral sclerosis and\n",
      "Alzheimer's disease.\n",
      "\n",
      "Reference:\n",
      "Anti-LINGO antibody is the first remyelination-promoting therapy to reach Phase II clinical trials\n",
      "in optic neuritis. Treatments that overcome molecular obstacles to remyelination may complement\n",
      "immune-directed therapies for MS in the future.\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "google/pegasus-large (29 tok):\n",
      "R1\tp: 30.43 \tr: 20.00 \tf: 24.14\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 21.74 \tr: 14.29 \tf: 17.24\n",
      "ST\t60.04\t\tW2V\t37.68\n",
      "\n",
      "Ultimately, therapies that successfully promote remyelination and repair may be applicable across\n",
      "the spectrum of MS subtypes, including progressive forms of the disease.\n",
      "\n",
      "google/pegasus-large (40 tok):\n",
      "R1\tp: 35.48 \tr: 31.43 \tf: 33.33\n",
      "R2\tp: 13.33 \tr: 11.76 \tf: 12.50\n",
      "RL\tp: 22.58 \tr: 20.00 \tf: 21.21\n",
      "ST\t60.80\t\tW2V\t50.06\n",
      "\n",
      "Initiated in 2013, the first multinational Phase II trial of anti-LINGO-1 antibodies in patients\n",
      "with acute optic neuritis has shown an effect on promoting nerve repair following optic neuritis.\n",
      "\n",
      "google/pegasus-large (40 tok):\n",
      "R1\tp: 20.59 \tr: 20.00 \tf: 20.29\n",
      "R2\tp: 3.03 \tr: 2.94 \tf: 2.99\n",
      "RL\tp: 14.71 \tr: 14.29 \tf: 14.49\n",
      "ST\t40.60\t\tW2V\t31.20\n",
      "\n",
      "Mastinib has completed a positive Phase IIb study in patients with primary and secondary progressive\n",
      "MS, the results of which are reported to include improvement in the Multiple Sclerosis Functional\n",
      "Composite (see pages 54 -).\n",
      "\n",
      "google/pegasus-large (39 tok):\n",
      "R1\tp: 21.21 \tr: 20.00 \tf: 20.59\n",
      "R2\tp: 3.12 \tr: 2.94 \tf: 3.03\n",
      "RL\tp: 15.15 \tr: 14.29 \tf: 14.71\n",
      "ST\t41.32\t\tW2V\t32.02\n",
      "\n",
      "Mastinib has completed a positive Phase IIb study in patients with primary and secondary progressive\n",
      "MS, the results of which are reported to include improvement in the Multiple Functional Composite\n",
      "(see pages 54 -).\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (26 tok):\n",
      "R1\tp: 33.33 \tr: 20.00 \tf: 25.00\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 23.81 \tr: 14.29 \tf: 17.86\n",
      "ST\t57.89\t\tW2V\t31.27\n",
      "\n",
      "Therapies that promote remyelination and repair may be applicable across the spectrum of MS\n",
      "subtypes, including progressive forms of the disease.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (44 tok):\n",
      "R1\tp: 25.00 \tr: 25.71 \tf: 25.35\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 13.89 \tr: 14.29 \tf: 14.08\n",
      "ST\t63.67\t\tW2V\t32.10\n",
      "\n",
      "Therapies that promote remyelination and repair may be applicable across the spectrum of MS\n",
      "subtypes, including progressive forms of the disease. Mastinib has completed a Phase IIb study in\n",
      "patients with primary and secondary progressive MS.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (19 tok):\n",
      "R1\tp: 40.00 \tr: 17.14 \tf: 24.00\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 26.67 \tr: 11.43 \tf: 16.00\n",
      "ST\t54.31\t\tW2V\t23.63\n",
      "\n",
      "Therapies that promote remyelination and repair may be applicable across the spectrum of MS\n",
      "subtypes.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (23 tok):\n",
      "R1\tp: 33.33 \tr: 17.14 \tf: 22.64\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 22.22 \tr: 11.43 \tf: 15.09\n",
      "ST\t51.90\t\tW2V\t23.16\n",
      "\n",
      "Therapies that promote remyelination and repair may be applicable across the spectrum of MS\n",
      "subtypes, including progressive forms.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n"
     ]
    }
   ],
   "source": [
    "print_examples([\n",
    "    'google/pegasus-large',\n",
    "    bucket_dir+'fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/'],\n",
    "    df_train)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "heading_collapsed": true,
    "id": "fSqOx7kdMoNJ"
   },
   "source": [
    "#### Print Val Examples"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/"
    },
    "executionInfo": {
     "elapsed": 7134,
     "status": "ok",
     "timestamp": 1610617100643,
     "user": {
      "displayName": "Marco Pietro Abrate",
      "photoUrl": "https://lh3.googleusercontent.com/a-/AOh14Gjh-8YF-8BlnrkN9mLZ0xfVOWfOh7kYncpYRv-Y=s64",
      "userId": "15422244832836998434"
     },
     "user_tz": -60
    },
    "hidden": true,
    "id": "f7k8RzJgMoNK",
    "outputId": "34bc6750-7383-42d4-8a7a-f30b9e35a3bb",
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(9781908541178, 'ch_6')\n",
      "Many anatomic factors can play a primary or a secondary role in the development and progression of\n",
      "low back pain syndromes. The most common causes of low back pain are mechanical in origin.\n",
      "Mechanical disorders of the lumbar spine are related to injury, overuse or deformity of a spinal\n",
      "structure. The most important traumatic factors in low back pain relate to soft tissue structures.\n",
      "Precise identification of the injured tissue, and the role of that injury in the consequent pain and\n",
      "dysfunction, can be frustratingly difficult. Problems occur in muscles, intervertebral discs, facet\n",
      "joints, ligaments or spinal nerves. Aging causes modification of these structures over time, and\n",
      "different parts of the spine tend to be at greater risk for change or injury during different\n",
      "decades of life. Early in life, muscle injuries are more frequent, while joint problems occur in the\n",
      "sixth decade of life (Table 3.1).\n",
      "\n",
      "Reference:\n",
      "Mechanical disorders - muscle strain, spondylolisthesis, herniated intervertebral disc,\n",
      "osteoarthritis, spinal stenosis - are the most common causes of low back pain.\n",
      "\n",
      "google/pegasus-large (15 tok):\n",
      "R1\tp: 35.71 \tr: 25.00 \tf: 29.41\n",
      "R2\tp: 23.08 \tr: 15.79 \tf: 18.75\n",
      "RL\tp: 35.71 \tr: 25.00 \tf: 29.41\n",
      "ST\t56.32\t\tW2V\t38.06\n",
      "\n",
      "The most important traumatic factors in low back pain relate to soft tissue structures.\n",
      "\n",
      "google/pegasus-large (31 tok):\n",
      "R1\tp: 10.34 \tr: 15.00 \tf: 12.24\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 6.90 \tr: 10.00 \tf: 8.16\n",
      "ST\t44.23\t\tW2V\t10.56\n",
      "\n",
      "Aging causes modification of these structures over time, and different parts of the spine tend to be\n",
      "at greater risk for change or injury during different decades of life.\n",
      "\n",
      "google/pegasus-large (19 tok):\n",
      "R1\tp: 35.29 \tr: 30.00 \tf: 32.43\n",
      "R2\tp: 6.25 \tr: 5.26 \tf: 5.71\n",
      "RL\tp: 23.53 \tr: 20.00 \tf: 21.62\n",
      "ST\t66.01\t\tW2V\t35.85\n",
      "\n",
      "Mechanical disorders of the lumbar spine are related to injury, overuse or deformity of a spinal\n",
      "structure.\n",
      "\n",
      "google/pegasus-large (24 tok):\n",
      "R1\tp: 19.05 \tr: 20.00 \tf: 19.51\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 19.05 \tr: 20.00 \tf: 19.51\n",
      "ST\t50.40\t\tW2V\t21.82\n",
      "\n",
      "Early in life, muscle injuries are more frequent, while joint problems occur in the sixth decade of\n",
      "life (Table 3.1).\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (23 tok):\n",
      "R1\tp: 23.81 \tr: 25.00 \tf: 24.39\n",
      "R2\tp: 15.00 \tr: 15.79 \tf: 15.38\n",
      "RL\tp: 23.81 \tr: 25.00 \tf: 24.39\n",
      "ST\t58.81\t\tW2V\t11.55\n",
      "\n",
      "Many anatomic factors can play a primary or a secondary role in the development and progression of\n",
      "low back pain syndromes.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (22 tok):\n",
      "R1\tp: 25.00 \tr: 25.00 \tf: 25.00\n",
      "R2\tp: 15.79 \tr: 15.79 \tf: 15.79\n",
      "RL\tp: 25.00 \tr: 25.00 \tf: 25.00\n",
      "ST\t59.26\t\tW2V\t11.55\n",
      "\n",
      "Many anatomic factors can play a primary or secondary role in the development and progression of low\n",
      "back pain syndromes.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (32 tok):\n",
      "R1\tp: 27.59 \tr: 40.00 \tf: 32.65\n",
      "R2\tp: 17.86 \tr: 26.32 \tf: 21.28\n",
      "RL\tp: 17.24 \tr: 25.00 \tf: 20.41\n",
      "ST\t63.55\t\tW2V\t22.01\n",
      "\n",
      "Many anatomic factors can play a primary or a secondary role in the development and progression of\n",
      "low back pain syndromes; mechanical in origin is the most common cause.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (17 tok):\n",
      "R1\tp: 62.50 \tr: 50.00 \tf: 55.56\n",
      "R2\tp: 46.67 \tr: 36.84 \tf: 41.18\n",
      "RL\tp: 50.00 \tr: 40.00 \tf: 44.44\n",
      "ST\t71.22\t\tW2V\t42.65\n",
      "\n",
      "The most common causes of low back pain are mechanical in origin and traumatic in origin.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781912776726, 'ch4')\n",
      "Patients with glioblastoma have specific information needs. While the amount of information that\n",
      "patients want varies from person to person, and in some cases understanding may be impaired by\n",
      "cognitive deficits, patients and their carers need frank but compassionate information on diagnosis,\n",
      "prognosis, treatment options, recurrence and end-of-life care. News of a poor prognosis can be\n",
      "difficult to process initially. Patients need time to ask questions and receive honest answers. A\n",
      "combination of written and verbal information over several consultations and ongoing access to a\n",
      "well-resourced specialist nurse and psychologist or counselor are all important in this respect.\n",
      "Standard of care for newly diagnosed glioblastoma. The current standard of care for newly diagnosed\n",
      "glioblastoma is maximum surgical resection followed by radiotherapy and concomitant temozolomide and\n",
      "adjuvant temozolomide.\n",
      "\n",
      "Reference:\n",
      "Radiotherapy and temozolomide is suitable for fit elderly patients with glioblastoma.\n",
      "\n",
      "google/pegasus-large (52 tok):\n",
      "R1\tp: 4.55 \tr: 18.18 \tf: 7.27\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 4.55 \tr: 18.18 \tf: 7.27\n",
      "ST\t24.62\t\tW2V\t10.30\n",
      "\n",
      "While the amount of information that patients want varies from person to person, and in some cases\n",
      "understanding may be impaired by cognitive deficits, patients and their carers need frank but\n",
      "compassionate information on diagnosis, prognosis, treatment options, recurrence and end-of-life\n",
      "care.\n",
      "\n",
      "google/pegasus-large (29 tok):\n",
      "R1\tp: 27.27 \tr: 54.55 \tf: 36.36\n",
      "R2\tp: 4.76 \tr: 10.00 \tf: 6.45\n",
      "RL\tp: 13.64 \tr: 27.27 \tf: 18.18\n",
      "ST\t67.43\t\tW2V\t57.56\n",
      "\n",
      "The current standard of care for newly diagnosed glioblastoma is maximum surgical resection followed\n",
      "by radiotherapy and concomitant temozolomide and adjuvant temozolomide.\n",
      "\n",
      "google/pegasus-large (29 tok):\n",
      "R1\tp: 22.73 \tr: 45.45 \tf: 30.30\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 9.09 \tr: 18.18 \tf: 12.12\n",
      "ST\t65.94\t\tW2V\t52.32\n",
      "\n",
      "The current standard of care for newly diagnosed glioblastoma is maximum surgical resection followed\n",
      "by radiation and concomitant temozolomide and adjuvant temozolomide.\n",
      "\n",
      "google/pegasus-large (29 tok):\n",
      "R1\tp: 28.57 \tr: 54.55 \tf: 37.50\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 14.29 \tr: 27.27 \tf: 18.75\n",
      "ST\t66.72\t\tW2V\t55.53\n",
      "\n",
      "The current standard of care for newly diagnosed glioblastoma is maximum surgical resection followed\n",
      "by radiotherapy, concomitant temozolomide and adjuvant temozolomide.\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (29 tok):\n",
      "R1\tp: 27.27 \tr: 54.55 \tf: 36.36\n",
      "R2\tp: 4.76 \tr: 10.00 \tf: 6.45\n",
      "RL\tp: 13.64 \tr: 27.27 \tf: 18.18\n",
      "ST\t67.43\t\tW2V\t57.56\n",
      "\n",
      "The current standard of care for newly diagnosed glioblastoma is maximum surgical resection followed\n",
      "by radiotherapy and concomitant temozolomide and adjuvant temozolomide.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (26 tok):\n",
      "R1\tp: 10.00 \tr: 18.18 \tf: 12.90\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 5.00 \tr: 9.09 \tf: 6.45\n",
      "ST\t40.24\t\tW2V\t18.87\n",
      "\n",
      "Patients and their carers need frank but compassionate information on diagnosis, prognosis,\n",
      "treatment options, recurrence and end-of-life care.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (23 tok):\n",
      "R1\tp: 11.76 \tr: 18.18 \tf: 14.29\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 5.88 \tr: 9.09 \tf: 7.14\n",
      "ST\t39.99\t\tW2V\t10.81\n",
      "\n",
      "Patients need frank but compassionate information on diagnosis, prognosis, treatment options,\n",
      "recurrence and end-of-life care.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (25 tok):\n",
      "R1\tp: 21.05 \tr: 36.36 \tf: 26.67\n",
      "R2\tp: 11.11 \tr: 20.00 \tf: 14.29\n",
      "RL\tp: 15.79 \tr: 27.27 \tf: 20.00\n",
      "ST\t56.29\t\tW2V\t33.77\n",
      "\n",
      "Patients with glioblastoma need frank but compassionate information on diagnosis, prognosis,\n",
      "treatment options, recurrence and end-of-life care.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9783318066241, 'ch6')\n",
      "Fluid type. Both an open-label and a triple-blind RCT have demonstrated that fluid resuscitation\n",
      "using lactated Ringer's solution (a balanced salt solution) is associated with a decreased\n",
      "inflammatory response when compared with fluid resuscitation with normal saline (with a high\n",
      "chloride content). According to in vitro experiments, it seems that this anti-inflammatory effect\n",
      "depends on lactate. However, both studies included a small number of patients, and the influence of\n",
      "lactated Ringer's solution on important outcomes such as OF or mortality is unknown. In studies\n",
      "addressing other clinical scenarios, balanced fluids such as lactated Ringer's solution seem to be\n",
      "associated with a decreased need for blood products and a lower incidence of renal replacement\n",
      "therapy, hyperkalemia and postoperative infections when compared with normal saline. For the time\n",
      "being, it seems that lactated Ringer's solution is a good choice for fluid resuscitation in AP.\n",
      "\n",
      "Reference:\n",
      "Lactated Ringer's solution is associated with a decreased inflammatory response in AP when compared\n",
      "with normal saline.\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "google/pegasus-large (52 tok):\n",
      "R1\tp: 37.21 \tr: 88.89 \tf: 52.46\n",
      "R2\tp: 33.33 \tr: 82.35 \tf: 47.46\n",
      "RL\tp: 37.21 \tr: 88.89 \tf: 52.46\n",
      "ST\t73.95\t\tW2V\t61.40\n",
      "\n",
      "Both an open-label and a triple-blind RCT have demonstrated that fluid resuscitation using lactated\n",
      "Ringer's solution (a balanced salt solution) is associated with a decreased inflammatory response\n",
      "when compared with fluid resuscitation with normal saline (with a high chloride content).\n",
      "\n",
      "google/pegasus-large (50 tok):\n",
      "R1\tp: 33.33 \tr: 77.78 \tf: 46.67\n",
      "R2\tp: 24.39 \tr: 58.82 \tf: 34.48\n",
      "RL\tp: 30.95 \tr: 72.22 \tf: 43.33\n",
      "ST\t60.66\t\tW2V\t51.90\n",
      "\n",
      "In studies addressing other clinical scenarios, balanced fluids such as lactated Ringer's solution\n",
      "seem to be associated with a decreased need for blood products and a lower incidence of renal\n",
      "replacement therapy, hyperkalemia and postoperative infections when compared with normal saline.\n",
      "\n",
      "google/pegasus-large (53 tok):\n",
      "R1\tp: 36.36 \tr: 88.89 \tf: 51.61\n",
      "R2\tp: 32.56 \tr: 82.35 \tf: 46.67\n",
      "RL\tp: 36.36 \tr: 88.89 \tf: 51.61\n",
      "ST\t72.60\t\tW2V\t58.76\n",
      "\n",
      "Both an open-label RCT and a triple-blind RCT have demonstrated that fluid resuscitation using\n",
      "lactated Ringer's solution (a balanced salt solution) is associated with a decreased inflammatory\n",
      "response when compared with fluid resuscitation with normal saline (with a high chloride content).\n",
      "\n",
      "google/pegasus-large (52 tok):\n",
      "R1\tp: 37.21 \tr: 88.89 \tf: 52.46\n",
      "R2\tp: 33.33 \tr: 82.35 \tf: 47.46\n",
      "RL\tp: 37.21 \tr: 88.89 \tf: 52.46\n",
      "ST\t74.07\t\tW2V\t61.40\n",
      "\n",
      "both an open-label and a triple-blind RCT have demonstrated that fluid resuscitation using lactated\n",
      "Ringer's solution (a balanced salt solution) is associated with a decreased inflammatory response\n",
      "when compared with fluid resuscitation with normal saline (with a high chloride content).\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (30 tok):\n",
      "R1\tp: 66.67 \tr: 88.89 \tf: 76.19\n",
      "R2\tp: 60.87 \tr: 82.35 \tf: 70.00\n",
      "RL\tp: 66.67 \tr: 88.89 \tf: 76.19\n",
      "ST\t84.16\t\tW2V\t83.78\n",
      "\n",
      "Lactated Ringer's solution is associated with a decreased inflammatory response when compared with\n",
      "fluid resuscitation with normal saline (with a high chloride content).\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (26 tok):\n",
      "R1\tp: 72.73 \tr: 88.89 \tf: 80.00\n",
      "R2\tp: 66.67 \tr: 82.35 \tf: 73.68\n",
      "RL\tp: 72.73 \tr: 88.89 \tf: 80.00\n",
      "ST\t76.23\t\tW2V\t76.25\n",
      "\n",
      "Fluid resuscitation using lactated Ringer's solution is associated with a decreased inflammatory\n",
      "response when compared with fluid resuscitation with normal saline.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (30 tok):\n",
      "R1\tp: 69.57 \tr: 88.89 \tf: 78.05\n",
      "R2\tp: 63.64 \tr: 82.35 \tf: 71.79\n",
      "RL\tp: 69.57 \tr: 88.89 \tf: 78.05\n",
      "ST\t85.66\t\tW2V\t84.20\n",
      "\n",
      "Lactated Ringer's solution (a balanced salt solution) is associated with a decreased inflammatory\n",
      "response when compared with fluid resuscitation with normal saline.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (24 tok):\n",
      "R1\tp: 84.21 \tr: 88.89 \tf: 86.49\n",
      "R2\tp: 77.78 \tr: 82.35 \tf: 80.00\n",
      "RL\tp: 84.21 \tr: 88.89 \tf: 86.49\n",
      "ST\t86.64\t\tW2V\t87.16\n",
      "\n",
      "Lactated Ringer's solution is associated with a decreased inflammatory response when compared with\n",
      "fluid resuscitation with normal saline.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781910797662, 'ch07')\n",
      "Management of advanced and metastatic disease. A core principle in the management of solid tumors is\n",
      "to consider control of both the primary and metastatic disease. Several clinical scenarios occur in\n",
      "bladder cancer. Cancers that are clearly confined to the bladder can potentially be cured if the\n",
      "primary tumor can be removed or ablated, through surgery, radiation therapy or multimodality\n",
      "approaches, and there is no metastatic disease; 5-year survival rates are about 70%. Management of\n",
      "these cancers is discussed in chapter on 'Management of non-muscle-invasive disease'.\n",
      "\n",
      "Reference:\n",
      "Management of both local and distant metastatic disease should be considered.\n",
      "\n",
      "google/pegasus-large (49 tok):\n",
      "R1\tp: 9.76 \tr: 36.36 \tf: 15.38\n",
      "R2\tp: 2.50 \tr: 10.00 \tf: 4.00\n",
      "RL\tp: 7.32 \tr: 27.27 \tf: 11.54\n",
      "ST\t50.03\t\tW2V\t26.90\n",
      "\n",
      "Cancers that are clearly confined to the bladder can potentially be cured if the primary tumor can\n",
      "be removed or ablated, through surgery, radiation therapy or multimodality approaches, and there is\n",
      "no metastatic disease; 5-year survival rates are about 70%.\n",
      "\n",
      "google/pegasus-large (21 tok):\n",
      "R1\tp: 30.00 \tr: 54.55 \tf: 38.71\n",
      "R2\tp: 15.79 \tr: 30.00 \tf: 20.69\n",
      "RL\tp: 30.00 \tr: 54.55 \tf: 38.71\n",
      "ST\t66.43\t\tW2V\t28.36\n",
      "\n",
      "A core principle in the management of solid tumors is to consider control of both the primary and\n",
      "metastatic disease.\n",
      "\n",
      "google/pegasus-large (42 tok):\n",
      "R1\tp: 16.67 \tr: 54.55 \tf: 25.53\n",
      "R2\tp: 8.57 \tr: 30.00 \tf: 13.33\n",
      "RL\tp: 16.67 \tr: 54.55 \tf: 25.53\n",
      "ST\t62.85\t\tW2V\t20.02\n",
      "\n",
      "A core principle in the management of solid tumors is to consider control of both the primary and\n",
      "metastatic disease. The management of these cancers is discussed in chapter on 'Management of non-\n",
      "muscle-invasive disease'.\n",
      "\n",
      "google/pegasus-large (20 tok):\n",
      "R1\tp: 20.00 \tr: 27.27 \tf: 23.08\n",
      "R2\tp: 7.14 \tr: 10.00 \tf: 8.33\n",
      "RL\tp: 20.00 \tr: 27.27 \tf: 23.08\n",
      "ST\t51.43\t\tW2V\t13.01\n",
      "\n",
      "Management of these cancers is discussed in chapter on 'Management of non-muscle-invasive disease'.\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (21 tok):\n",
      "R1\tp: 30.00 \tr: 54.55 \tf: 38.71\n",
      "R2\tp: 15.79 \tr: 30.00 \tf: 20.69\n",
      "RL\tp: 30.00 \tr: 54.55 \tf: 38.71\n",
      "ST\t66.43\t\tW2V\t28.36\n",
      "\n",
      "A core principle in the management of solid tumors is to consider control of both the primary and\n",
      "metastatic disease.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (19 tok):\n",
      "R1\tp: 33.33 \tr: 54.55 \tf: 41.38\n",
      "R2\tp: 11.76 \tr: 20.00 \tf: 14.81\n",
      "RL\tp: 33.33 \tr: 54.55 \tf: 41.38\n",
      "ST\t64.70\t\tW2V\t29.59\n",
      "\n",
      "A core principle in the management of solid tumors is to consider both the primary and metastatic\n",
      "disease.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (22 tok):\n",
      "R1\tp: 28.57 \tr: 54.55 \tf: 37.50\n",
      "R2\tp: 15.00 \tr: 30.00 \tf: 20.00\n",
      "RL\tp: 28.57 \tr: 54.55 \tf: 37.50\n",
      "ST\t64.84\t\tW2V\t21.59\n",
      "\n",
      "A core principle in the management of solid tumors is to consider control of both the primary and\n",
      "the metastatic disease.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (20 tok):\n",
      "R1\tp: 31.58 \tr: 54.55 \tf: 40.00\n",
      "R2\tp: 16.67 \tr: 30.00 \tf: 21.43\n",
      "RL\tp: 31.58 \tr: 54.55 \tf: 40.00\n",
      "ST\t67.13\t\tW2V\t35.18\n",
      "\n",
      "A core principle in the management of solid tumors is to consider control of both primary and\n",
      "metastatic disease.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781910797723, 'chp3')\n",
      "What types of tumor are potentially susceptible to immuno-oncology?. Clearly, the potential\n",
      "sensitivity of a given cancer to immuno-oncology therapies will depend on the ability of the tumor\n",
      "to trigger an immune response (immunogenicity). Cancer is characterized by an accumulation of\n",
      "genetic mutations, many of which result in the expression of cancer-specific antigens that can bind\n",
      "to major histocompatibility complex (MHC) class I molecules on the cancer cell surface. These\n",
      "antigen-MHC complexes can be recognized by cytotoxic CD8+ lymphocytes, that, if activated, could\n",
      "potentially mount an immune response against the tumor. As a result, tumors with high somatic\n",
      "mutation rates may be more susceptible to immuno-oncology therapies than those with lower mutation\n",
      "rates. Somatic mutation rates differ markedly, both between tumor types and within an individual\n",
      "tumor type: the rate may vary more than 1000-fold between tumors with the highest and lowest rates\n",
      "(Figure 3.2). The highest rates are seen in cancers of the skin, lung, bladder and stomach, while\n",
      "the lowest are seen in hematologic and pediatric cancers. It is noteworthy that the highest rates\n",
      "occur in tumors that are induced by carcinogens such as tobacco smoke or ultraviolet light.\n",
      "\n",
      "Reference:\n",
      "The potential sensitivity of a given cancer to immunotherapy depends on the immunogenicity of the\n",
      "tumor, which is related to the somatic mutation rate within tumor cells.- The highest mutation rates\n",
      "are seen in cancers of the skin, lung, bladder and stomach, rendering these tumor types more\n",
      "sensitive to immunotherapy.\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "google/pegasus-large (26 tok):\n",
      "R1\tp: 30.43 \tr: 14.00 \tf: 19.18\n",
      "R2\tp: 9.09 \tr: 4.08 \tf: 5.63\n",
      "RL\tp: 26.09 \tr: 12.00 \tf: 16.44\n",
      "ST\t75.38\t\tW2V\t33.60\n",
      "\n",
      "As a result, tumors with high somatic mutation rates may be more susceptible to immuno-oncology\n",
      "therapies than those with lower mutation rates.\n",
      "\n",
      "google/pegasus-large (65 tok):\n",
      "R1\tp: 28.07 \tr: 32.00 \tf: 29.91\n",
      "R2\tp: 7.14 \tr: 8.16 \tf: 7.62\n",
      "RL\tp: 15.79 \tr: 18.00 \tf: 16.82\n",
      "ST\t74.99\t\tW2V\t49.03\n",
      "\n",
      "As a result, tumors with high somatic mutation rates may be more susceptible to immuno-oncology\n",
      "therapies than those with lower mutation rates. Somatic mutation rates differ markedly, both between\n",
      "tumor types and within an individual tumor type: the rate may vary more than 1000-fold between\n",
      "tumors with the highest and lowest rates (Figure 3.2).\n",
      "\n",
      "google/pegasus-large (39 tok):\n",
      "R1\tp: 38.24 \tr: 26.00 \tf: 30.95\n",
      "R2\tp: 12.12 \tr: 8.16 \tf: 9.76\n",
      "RL\tp: 20.59 \tr: 14.00 \tf: 16.67\n",
      "ST\t65.98\t\tW2V\t43.71\n",
      "\n",
      "Somatic mutation rates differ markedly, both between tumor types and within an individual tumor\n",
      "type: the rate may vary more than 1000-fold between tumors with the highest and lowest rates (Figure\n",
      "3.2).\n",
      "\n",
      "google/pegasus-large (65 tok):\n",
      "R1\tp: 27.59 \tr: 32.00 \tf: 29.63\n",
      "R2\tp: 7.02 \tr: 8.16 \tf: 7.55\n",
      "RL\tp: 15.52 \tr: 18.00 \tf: 16.67\n",
      "ST\t74.57\t\tW2V\t49.03\n",
      "\n",
      "As a result, tumors with high somatic mutation rates may be more susceptible to immuno-oncology\n",
      "therapies than those with lower mutation rates. Somatic mutation rates differ markedly, both between\n",
      "tumor types and within an individual tumor type: the rate may vary more than 1,000-fold between\n",
      "tumors with the highest and lowest rates (Figure 3.2).\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (43 tok):\n",
      "R1\tp: 30.56 \tr: 22.00 \tf: 25.58\n",
      "R2\tp: 2.86 \tr: 2.04 \tf: 2.38\n",
      "RL\tp: 16.67 \tr: 12.00 \tf: 13.95\n",
      "ST\t58.66\t\tW2V\t54.12\n",
      "\n",
      "Cancer is characterized by an accumulation of genetic mutations, many of which result in the\n",
      "expression of cancer-specific antigens that can bind to major histocompatibility complex (MHC) class\n",
      "I molecules on the cancer cell surface.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (43 tok):\n",
      "R1\tp: 31.43 \tr: 22.00 \tf: 25.88\n",
      "R2\tp: 2.94 \tr: 2.04 \tf: 2.41\n",
      "RL\tp: 17.14 \tr: 12.00 \tf: 14.12\n",
      "ST\t61.12\t\tW2V\t50.10\n",
      "\n",
      "Tumors are characterized by an accumulation of genetic mutations, many of which result in the\n",
      "expression of cancer-specific antigens that bind to major histocompatibility complex (MHC) class I\n",
      "molecules on the cancer cell surface.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (23 tok):\n",
      "R1\tp: 30.00 \tr: 12.00 \tf: 17.14\n",
      "R2\tp: 10.53 \tr: 4.08 \tf: 5.88\n",
      "RL\tp: 25.00 \tr: 10.00 \tf: 14.29\n",
      "ST\t68.42\t\tW2V\t31.65\n",
      "\n",
      "Tumors with high somatic mutation rates may be more susceptible to immuno-oncology therapies than\n",
      "those with lower mutation rates.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (24 tok):\n",
      "R1\tp: 28.57 \tr: 12.00 \tf: 16.90\n",
      "R2\tp: 10.00 \tr: 4.08 \tf: 5.80\n",
      "RL\tp: 23.81 \tr: 10.00 \tf: 14.08\n",
      "ST\t66.37\t\tW2V\t34.62\n",
      "\n",
      "Tumors with high somatic mutation rates may be more susceptible to immuno-oncology therapies than\n",
      "those with lower somatic mutation rates.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781910797471, 'ch02')\n",
      "Advances in the management of heart failure (HF) over the past 20 years have been informed by a\n",
      "better understanding of its pathophysiology. There are few situations in cardiology where treatment\n",
      "has been as closely linked to an appreciation of the underlying science. Vicious cycle of heart\n",
      "failure. HF is a disease of inappropriate adaptation to injury. The body has a limited range of\n",
      "compensatory responses to circulatory impairment, mainly vasoconstriction and sodium and water\n",
      "retention (see below). In general, however, these adjustments to hypovolemia are poorly suited to\n",
      "pump failure, and increases in the preload and afterload of the failing heart lead to worsening HF\n",
      "(Figure 2.1).\n",
      "\n",
      "Reference:\n",
      "Heart failure (HF) is a disease of response to injury, which is initially appropriate and becomes\n",
      "inappropriate.\n",
      "\n",
      "google/pegasus-large (39 tok):\n",
      "R1\tp: 19.35 \tr: 35.29 \tf: 25.00\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 9.68 \tr: 17.65 \tf: 12.50\n",
      "ST\t56.61\t\tW2V\t16.09\n",
      "\n",
      "In general, however, these adjustments to hypovolemia are poorly suited to pump failure, and\n",
      "increases in the preload and afterload of the failing heart lead to worsening HF (Figure 2.1).\n",
      "\n",
      "google/pegasus-large (26 tok):\n",
      "R1\tp: 21.74 \tr: 29.41 \tf: 25.00\n",
      "R2\tp: 9.09 \tr: 12.50 \tf: 10.53\n",
      "RL\tp: 21.74 \tr: 29.41 \tf: 25.00\n",
      "ST\t60.03\t\tW2V\t8.05\n",
      "\n",
      "Advances in the management of heart failure (HF) over the past 20 years have been informed by a\n",
      "better understanding of its pathophysiology.\n",
      "\n",
      "google/pegasus-large (33 tok):\n",
      "R1\tp: 17.86 \tr: 29.41 \tf: 22.22\n",
      "R2\tp: 7.41 \tr: 12.50 \tf: 9.30\n",
      "RL\tp: 17.86 \tr: 29.41 \tf: 22.22\n",
      "ST\t61.68\t\tW2V\t16.94\n",
      "\n",
      "Advances in the management of heart failure (HF) over the past 20 years have been informed by a\n",
      "better understanding of its pathophysiology. Vicious cycle of heart failure.\n",
      "\n",
      "google/pegasus-large (40 tok):\n",
      "R1\tp: 19.35 \tr: 35.29 \tf: 25.00\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 9.68 \tr: 17.65 \tf: 12.50\n",
      "ST\t55.42\t\tW2V\t16.09\n",
      "\n",
      "In general, however, these adjustments to hypovolemia are poorly suited to pump failure, and\n",
      "increases in the preload and afterload of the failing heart lead to worsening HF (Figure 2.1)..\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (14 tok):\n",
      "R1\tp: 90.91 \tr: 58.82 \tf: 71.43\n",
      "R2\tp: 70.00 \tr: 43.75 \tf: 53.85\n",
      "RL\tp: 81.82 \tr: 52.94 \tf: 64.29\n",
      "ST\t86.62\t\tW2V\t75.24\n",
      "\n",
      "Heart failure (HF) is a disease of inappropriate adaptation to injury.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (24 tok):\n",
      "R1\tp: 50.00 \tr: 58.82 \tf: 54.05\n",
      "R2\tp: 36.84 \tr: 43.75 \tf: 40.00\n",
      "RL\tp: 45.00 \tr: 52.94 \tf: 48.65\n",
      "ST\t77.69\t\tW2V\t51.88\n",
      "\n",
      "Heart failure (HF) is a disease of inappropriate adaptation to injury. The body has limited\n",
      "compensatory responses to circulatory impairment.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (12 tok):\n",
      "R1\tp: 77.78 \tr: 41.18 \tf: 53.85\n",
      "R2\tp: 50.00 \tr: 25.00 \tf: 33.33\n",
      "RL\tp: 77.78 \tr: 41.18 \tf: 53.85\n",
      "ST\t77.39\t\tW2V\t55.86\n",
      "\n",
      "Heart failure (HF) is a vicious cycle of injury.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (12 tok):\n",
      "R1\tp: 66.67 \tr: 35.29 \tf: 46.15\n",
      "R2\tp: 50.00 \tr: 25.00 \tf: 33.33\n",
      "RL\tp: 66.67 \tr: 35.29 \tf: 46.15\n",
      "ST\t72.48\t\tW2V\t45.43\n",
      "\n",
      "Heart failure (HF) is a vicious cycle of dysfunction.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781910797815, 'chp9')\n",
      "There are no specific diagnostic criteria for MPN-BP. The principal criterion is the same as for de\n",
      "novo acute myeloid leukemia (AML): more than 20% blasts in bone marrow or peripheral blood.\n",
      "Persistence is also important if only peripheral blood blasts are considered. Importantly,\n",
      "acceleration or progression of myelofibrosis is usually apparent before the development of overt\n",
      "leukemia. Signs of this include.\n",
      "\n",
      "Reference:\n",
      "Signs of accelerating myelofibrosis may precede the development of overt leukemia.\n",
      "\n",
      "google/pegasus-large (28 tok):\n",
      "R1\tp: 8.33 \tr: 18.18 \tf: 11.43\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 8.33 \tr: 18.18 \tf: 11.43\n",
      "ST\t42.50\t\tW2V\t32.95\n",
      "\n",
      "The principal criterion is the same as for de novo acute myeloid leukemia (AML): more than 20%\n",
      "blasts in bone marrow or peripheral blood.\n",
      "\n",
      "google/pegasus-large (13 tok):\n",
      "R1\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "ST\t26.00\t\tW2V\t-6.31\n",
      "\n",
      "Persistence is also important if only peripheral blood blasts are considered.\n",
      "\n",
      "google/pegasus-large (29 tok):\n",
      "R1\tp: 8.33 \tr: 18.18 \tf: 11.43\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 8.33 \tr: 18.18 \tf: 11.43\n",
      "ST\t42.03\t\tW2V\t33.89\n",
      "\n",
      "The principal criterion is the same as for de novo acute myelogenous leukemia (AML): more than 20%\n",
      "blasts in bone marrow or peripheral blood.\n",
      "\n",
      "google/pegasus-large (29 tok):\n",
      "R1\tp: 8.33 \tr: 18.18 \tf: 11.43\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 8.33 \tr: 18.18 \tf: 11.43\n",
      "ST\t41.84\t\tW2V\t32.95\n",
      "\n",
      "The principal criterion is the same as for de novo acute myeloid leukemia (AML): more than 20%\n",
      "blasts in bone marrow or peripheral blood..\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (12 tok):\n",
      "R1\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "ST\t7.89\t\tW2V\t-9.79\n",
      "\n",
      "There are no specific diagnostic criteria for MPN-BP.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (12 tok):\n",
      "R1\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "ST\t7.77\t\tW2V\t-1.59\n",
      "\n",
      "There is no specific diagnostic criteria for MPN-BP.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (14 tok):\n",
      "R1\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "ST\t24.43\t\tW2V\t4.61\n",
      "\n",
      "There are no specific diagnostic criteria for myeloproliferative neoplasms-BP.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (14 tok):\n",
      "R1\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "ST\t24.47\t\tW2V\t13.10\n",
      "\n",
      "There is no specific diagnostic criteria for myeloproliferative neoplasms-BP.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9783318068207, 'hh-7')\n",
      "NGS testing for predictive biomarkers. EGFR activation of the RAS/RAF/MEK/ERK pathway (see Chapter\n",
      "1) plays an important role in oncogenesis in CRC. Up to 50% of CRCs show activating mutations of\n",
      "KRAS. Anti-EGFR antibodies, such as cetuximab and panitumumab, can be beneficial in patients with\n",
      "metastatic CRC provided that there is no downstream mutation activating the RAS/RAF/MEK/ERK pathway.\n",
      "Initially, patients with codon 12/13 KRAS mutations did not benefit in clinical trials, and\n",
      "subsequently mutations in other codons of KRAS and in NRAS were also shown to confer resistance to\n",
      "antibody-based therapies., Thus, guidelines require an 'extended' RAS analysis be performed. At\n",
      "present, the minimum testing required to determine whether anti-EGFR therapy may be of benefit is\n",
      "this extended RAS testing of KRAS and NRAS. codons 12 and 13 of exon 2. codons 59 and 61 of exon 3.\n",
      "codons 117 and 146 of exon 4. Wild-type phenotype for KRAS and NRAS is thus an indication for anti-\n",
      "EGFR therapy.\n",
      "\n",
      "Reference:\n",
      "The minimum testing required to determine whether anti-EGFR therapy may be of benefit in CRC is\n",
      "extended RAS testing of KRAS and NRAS: codons 12 and 13 of exon 2; codons 59 and 61 of exon 3; and\n",
      "codons 117 and 146 of exon 4.\n",
      "\n",
      "google/pegasus-large (58 tok):\n",
      "R1\tp: 31.82 \tr: 30.43 \tf: 31.11\n",
      "R2\tp: 9.30 \tr: 8.89 \tf: 9.09\n",
      "RL\tp: 13.64 \tr: 13.04 \tf: 13.33\n",
      "ST\t63.59\t\tW2V\t23.46\n",
      "\n",
      "Initially, patients with codon 12/13 KRAS mutations did not benefit in clinical trials, and\n",
      "subsequently mutations in other codons of KRAS and in NRAS were also shown to confer resistance to\n",
      "antibody-based therapies., Thus, guidelines require an 'extended' RAS analysis be performed.\n",
      "\n",
      "google/pegasus-large (45 tok):\n",
      "R1\tp: 30.00 \tr: 19.57 \tf: 23.68\n",
      "R2\tp: 3.45 \tr: 2.22 \tf: 2.70\n",
      "RL\tp: 23.33 \tr: 15.22 \tf: 18.42\n",
      "ST\t49.68\t\tW2V\t24.50\n",
      "\n",
      "Anti-EGFR antibodies, such as cetuximab and panitumumab, can be beneficial in patients with\n",
      "metastatic CRC provided that there is no downstream mutation activating the RAS/RAF/MEK/ERK pathway.\n",
      "\n",
      "google/pegasus-large (58 tok):\n",
      "R1\tp: 31.82 \tr: 30.43 \tf: 31.11\n",
      "R2\tp: 9.30 \tr: 8.89 \tf: 9.09\n",
      "RL\tp: 13.64 \tr: 13.04 \tf: 13.33\n",
      "ST\t64.07\t\tW2V\t24.56\n",
      "\n",
      "Initial, patients with codon 12/13 KRAS mutations did not benefit in clinical trials, and\n",
      "subsequently mutations in other codons of KRAS and in NRAS were also shown to confer resistance to\n",
      "antibody-based therapies., Thus, guidelines require an 'extended' RAS analysis be performed.\n",
      "\n",
      "google/pegasus-large (31 tok):\n",
      "R1\tp: 88.00 \tr: 47.83 \tf: 61.97\n",
      "R2\tp: 79.17 \tr: 42.22 \tf: 55.07\n",
      "RL\tp: 88.00 \tr: 47.83 \tf: 61.97\n",
      "ST\t76.95\t\tW2V\t71.88\n",
      "\n",
      "At present, the minimum testing required to determine whether anti-EGFR therapy may be of benefit is\n",
      "this extended RAS testing of KRAS and NRAS.\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (45 tok):\n",
      "R1\tp: 33.33 \tr: 26.09 \tf: 29.27\n",
      "R2\tp: 2.86 \tr: 2.22 \tf: 2.50\n",
      "RL\tp: 19.44 \tr: 15.22 \tf: 17.07\n",
      "ST\t51.29\t\tW2V\t38.64\n",
      "\n",
      "Up to 50% of CRCs show activating mutations of the RAS/RAF/MEK/ERK pathway, and anti-EGFR antibodies\n",
      "can be beneficial in patients with metastatic CRC provided there is no downstream mutation\n",
      "activating the pathway.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (44 tok):\n",
      "R1\tp: 31.43 \tr: 23.91 \tf: 27.16\n",
      "R2\tp: 2.94 \tr: 2.22 \tf: 2.53\n",
      "RL\tp: 20.00 \tr: 15.22 \tf: 17.28\n",
      "ST\t53.11\t\tW2V\t33.43\n",
      "\n",
      "Up to 50% of CRCs show activating mutations of the RAS/RAF/MEK/ERK pathway; anti-EGFR antibodies can\n",
      "be beneficial in patients with metastatic CRC provided there is no downstream mutation activating\n",
      "the pathway.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (67 tok):\n",
      "R1\tp: 40.00 \tr: 47.83 \tf: 43.56\n",
      "R2\tp: 25.93 \tr: 31.11 \tf: 28.28\n",
      "RL\tp: 30.91 \tr: 36.96 \tf: 33.66\n",
      "ST\t67.67\t\tW2V\t55.51\n",
      "\n",
      "Up to 50% of CRCs show activating mutations of the RAS/RAF/MEK/ERK pathway, and anti-EGFR antibodies\n",
      "can be beneficial in patients with metastatic CRC provided there is no downstream mutation\n",
      "activating the pathway. The minimum testing required to determine whether anti-EGFR therapy may be\n",
      "of benefit is this extended RAS analysis.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (69 tok):\n",
      "R1\tp: 39.29 \tr: 47.83 \tf: 43.14\n",
      "R2\tp: 25.45 \tr: 31.11 \tf: 28.00\n",
      "RL\tp: 30.36 \tr: 36.96 \tf: 33.33\n",
      "ST\t66.93\t\tW2V\t57.52\n",
      "\n",
      "Up to 50% of CRCs show activating mutations of the RAS/RAF/MEK/ERK pathway, and anti-EGFR antibodies\n",
      "can be beneficial in patients with metastatic CRC provided there is no downstream mutation\n",
      "activating the pathway. However, the minimum testing required to determine whether anti-EGFR therapy\n",
      "may be of benefit is this extended RAS analysis.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781910797815, 'chp4')\n",
      "Management of low-risk patients. Treatment to reduce cardiovascular risk factors, and promotion of a\n",
      "generally healthy lifestyle, may be sufficient intervention for very-low-risk patients. Smoking\n",
      "cessation should be actively promoted because cigarette smoking has been shown to be an independent\n",
      "risk factor for thrombosis in patients with ET. Low-dose aspirin has been shown to reduce both\n",
      "microvascular symptoms (exempli gratia erythromelalgia) and transient neurological and visual\n",
      "disturbances such as hemiparesis, scintillating scotomas, amaurosis fugax (transcient monocular\n",
      "blindness) and seizures. There is also evidence that antiplatelet therapy reduces the risk of venous\n",
      "thrombosis in patients with JAK2 V617F mutations and cardiovascular risk factors (arterial\n",
      "thrombosis). Higher doses of aspirin (up to 500 mg daily) may be required in patients with acute\n",
      "erythromelalgia.\n",
      "\n",
      "Reference:\n",
      "All patients should receive interventions to reduce cardiovascular risk factors, particularly\n",
      "smoking cessation advice.\n",
      "\n",
      "google/pegasus-large (27 tok):\n",
      "R1\tp: 27.27 \tr: 42.86 \tf: 33.33\n",
      "R2\tp: 19.05 \tr: 30.77 \tf: 23.53\n",
      "RL\tp: 22.73 \tr: 35.71 \tf: 27.78\n",
      "ST\t71.87\t\tW2V\t38.48\n",
      "\n",
      "Treatment to reduce cardiovascular risk factors, and promotion of a generally healthy lifestyle, may\n",
      "be sufficient intervention for very-low-risk patients.\n",
      "\n",
      "google/pegasus-large (61 tok):\n",
      "R1\tp: 12.77 \tr: 42.86 \tf: 19.67\n",
      "R2\tp: 8.70 \tr: 30.77 \tf: 13.56\n",
      "RL\tp: 10.64 \tr: 35.71 \tf: 16.39\n",
      "ST\t64.43\t\tW2V\t33.55\n",
      "\n",
      "Treatment to reduce cardiovascular risk factors, and promotion of a generally healthy lifestyle, may\n",
      "be sufficient intervention for very-low-risk patients. There is also evidence that antiplatelet\n",
      "therapy reduces the risk of venous thrombosis in patients with JAK2 V617F mutations and\n",
      "cardiovascular risk factors (arterial thrombosis).\n",
      "\n",
      "google/pegasus-large (34 tok):\n",
      "R1\tp: 16.00 \tr: 28.57 \tf: 20.51\n",
      "R2\tp: 8.33 \tr: 15.38 \tf: 10.81\n",
      "RL\tp: 16.00 \tr: 28.57 \tf: 20.51\n",
      "ST\t48.91\t\tW2V\t12.94\n",
      "\n",
      "There is also evidence that antiplatelet therapy reduces the risk of venous thrombosis in patients\n",
      "with JAK2 V617F mutations and cardiovascular risk factors (arterial thrombosis).\n",
      "\n",
      "google/pegasus-large (61 tok):\n",
      "R1\tp: 12.77 \tr: 42.86 \tf: 19.67\n",
      "R2\tp: 8.70 \tr: 30.77 \tf: 13.56\n",
      "RL\tp: 10.64 \tr: 35.71 \tf: 16.39\n",
      "ST\t64.29\t\tW2V\t34.80\n",
      "\n",
      "Treatment to reduce cardiovascular risk factors, and promotion of a generally healthy lifestyle, may\n",
      "be sufficient intervention for very-low-risk patients. There is also evidence that antiplatelet\n",
      "therapy reduces the risk of venous thrombosis in patients with JAK2 V617F mutation and\n",
      "cardiovascular risk factors (arterial thrombosis).\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (27 tok):\n",
      "R1\tp: 27.27 \tr: 42.86 \tf: 33.33\n",
      "R2\tp: 19.05 \tr: 30.77 \tf: 23.53\n",
      "RL\tp: 22.73 \tr: 35.71 \tf: 27.78\n",
      "ST\t71.87\t\tW2V\t38.48\n",
      "\n",
      "Treatment to reduce cardiovascular risk factors, and promotion of a generally healthy lifestyle, may\n",
      "be sufficient intervention for very-low-risk patients.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (33 tok):\n",
      "R1\tp: 10.00 \tr: 14.29 \tf: 11.76\n",
      "R2\tp: 5.26 \tr: 7.69 \tf: 6.25\n",
      "RL\tp: 10.00 \tr: 14.29 \tf: 11.76\n",
      "ST\t33.36\t\tW2V\t17.57\n",
      "\n",
      "Low-dose aspirin has been shown to reduce both microvascular symptoms (exempli gratia\n",
      "erythromelalgia) and transient neurological and visual disturbances.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (24 tok):\n",
      "R1\tp: 14.29 \tr: 21.43 \tf: 17.14\n",
      "R2\tp: 5.00 \tr: 7.69 \tf: 6.06\n",
      "RL\tp: 9.52 \tr: 14.29 \tf: 11.43\n",
      "ST\t38.64\t\tW2V\t26.16\n",
      "\n",
      "Low-dose aspirin has been shown to reduce both microvascular symptoms and transient neurological and\n",
      "visual disturbances in patients with ET.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (20 tok):\n",
      "R1\tp: 11.76 \tr: 14.29 \tf: 12.90\n",
      "R2\tp: 6.25 \tr: 7.69 \tf: 6.90\n",
      "RL\tp: 11.76 \tr: 14.29 \tf: 12.90\n",
      "ST\t37.42\t\tW2V\t20.69\n",
      "\n",
      "Low-dose aspirin has been shown to reduce both microvascular symptoms and transient neurological and\n",
      "visual disturbances.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781908541277, 'ch_11')\n",
      "There are no clear data indicating differences in safety among PHT, CBZ, PB and PRM. Current\n",
      "evidence suggests that the risk of major congenital malformations is two to four times higher with\n",
      "the use of VPA than with other AEDs such as CBZ and LTG. Absolute rates have ranged from 6% to 11%,\n",
      "although the risk may be minimized by keeping daily doses at or below 1000 mg. High-dose exposure to\n",
      "VPA in utero may impair later cognitive function. The teratogenic risk associated with LTG\n",
      "monotherapy is low and is similar to that associated with CBZ, although preliminary data suggest the\n",
      "possibility of greater risk of major malformations at higher dosage. There are still insufficient\n",
      "data regarding the safety of other modern AEDs.\n",
      "\n",
      "Reference:\n",
      "The risk of major malformations in babies exposed in utero seems to be greater with sodium valproate\n",
      "(VPA) than with other AEDs.\n",
      "\n",
      "google/pegasus-large (40 tok):\n",
      "R1\tp: 28.12 \tr: 40.91 \tf: 33.33\n",
      "R2\tp: 9.68 \tr: 14.29 \tf: 11.54\n",
      "RL\tp: 15.62 \tr: 22.73 \tf: 18.52\n",
      "ST\t58.25\t\tW2V\t50.85\n",
      "\n",
      "The teratogenic risk associated with LTG monotherapy is low and is similar to that associated with\n",
      "CBZ, although preliminary data suggest the possibility of greater risk of major malformations at\n",
      "higher dosage.\n",
      "\n",
      "google/pegasus-large (36 tok):\n",
      "R1\tp: 40.00 \tr: 54.55 \tf: 46.15\n",
      "R2\tp: 24.14 \tr: 33.33 \tf: 28.00\n",
      "RL\tp: 40.00 \tr: 54.55 \tf: 46.15\n",
      "ST\t73.07\t\tW2V\t52.32\n",
      "\n",
      "Current evidence suggests that the risk of major congenital malformations is two to four times\n",
      "higher with the use of VPA than with other AEDs such as CBZ and LTG.\n",
      "\n",
      "google/pegasus-large (40 tok):\n",
      "R1\tp: 28.12 \tr: 40.91 \tf: 33.33\n",
      "R2\tp: 9.68 \tr: 14.29 \tf: 11.54\n",
      "RL\tp: 15.62 \tr: 22.73 \tf: 18.52\n",
      "ST\t57.64\t\tW2V\t50.51\n",
      "\n",
      "A teratogenic risk associated with LTG monotherapy is low and is similar to that associated with\n",
      "CBZ, although preliminary data suggest the possibility of greater risk of major malformations at\n",
      "higher dosage.\n",
      "\n",
      "google/pegasus-large (41 tok):\n",
      "R1\tp: 28.12 \tr: 40.91 \tf: 33.33\n",
      "R2\tp: 9.68 \tr: 14.29 \tf: 11.54\n",
      "RL\tp: 15.62 \tr: 22.73 \tf: 18.52\n",
      "ST\t55.30\t\tW2V\t50.85\n",
      "\n",
      "The teratogenic risk associated with LTG monotherapy is low and is similar to that associated with\n",
      "CBZ, although preliminary data suggest the possibility of greater risk of major malformations at\n",
      "higher dosage..\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (14 tok):\n",
      "R1\tp: 16.67 \tr: 9.09 \tf: 11.76\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 16.67 \tr: 9.09 \tf: 11.76\n",
      "ST\t38.56\t\tW2V\t20.84\n",
      "\n",
      "There are no clear data indicating differences in safety among modern AEDs.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (14 tok):\n",
      "R1\tp: 16.67 \tr: 9.09 \tf: 11.76\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 16.67 \tr: 9.09 \tf: 11.76\n",
      "ST\t38.66\t\tW2V\t22.91\n",
      "\n",
      "There is no clear data indicating differences in safety among modern AEDs.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (14 tok):\n",
      "R1\tp: 16.67 \tr: 9.09 \tf: 11.76\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 16.67 \tr: 9.09 \tf: 11.76\n",
      "ST\t39.66\t\tW2V\t23.65\n",
      "\n",
      "There are no clear data indicating differences in safety between modern AEDs.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (13 tok):\n",
      "R1\tp: 18.18 \tr: 9.09 \tf: 12.12\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 18.18 \tr: 9.09 \tf: 12.12\n",
      "ST\t38.48\t\tW2V\t18.06\n",
      "\n",
      "There are no clear data indicating differences in safety among AEDs.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n"
     ]
    }
   ],
   "source": [
    "print_examples([\n",
    "    'google/pegasus-large',\n",
    "    bucket_dir+'fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/'],\n",
    "    df_val)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "heading_collapsed": true,
    "id": "UTUY8QgQa2WM"
   },
   "source": [
    "#### Print Test Examples"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/"
    },
    "executionInfo": {
     "elapsed": 7745,
     "status": "ok",
     "timestamp": 1610617121036,
     "user": {
      "displayName": "Marco Pietro Abrate",
      "photoUrl": "https://lh3.googleusercontent.com/a-/AOh14Gjh-8YF-8BlnrkN9mLZ0xfVOWfOh7kYncpYRv-Y=s64",
      "userId": "15422244832836998434"
     },
     "user_tz": -60
    },
    "hidden": true,
    "id": "D9rpcejOa2WO",
    "outputId": "c86cf9ed-eca7-4f92-ce7a-91f8661fdd29",
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(9781908541277, 'ch_8')\n",
      "Indications. OXC has a similar spectrum of efficacy to CBZ against partial and tonic-clonic\n",
      "seizures. It tends to be better tolerated than CBZ with fewer neurotoxic side effects. Dosage. The\n",
      "recommended starting dose for OXC in adults is 150-600 mg daily in two doses. The dose can be\n",
      "titrated upwards as clinically indicated to 3000-4000 mg daily. A starting dose of 5 mg/kg daily in\n",
      "children over 3 years of age can be prescribed, increasing gradually to a maintenance dose of about\n",
      "30 mg/kg daily. Patients already on CBZ may be switched immediately to OXC using a dosage ratio of\n",
      "1.5 OXC to 1 CBZ. Particular care in immediate switching needs to be taken when the daily CBZ dose\n",
      "exceeds 1200 mg. Plasma concentrations of the clinically active metabolite of OXC increase linearly\n",
      "with dose. No studies, however, have attempted to relate elevated plasma levels to efficacy or\n",
      "toxicity.\n",
      "\n",
      "Reference:\n",
      "This wider choice of AEDs permits pharmacological treatment to be better matched to the individual\n",
      "patient's circumstances.\n",
      "\n",
      "google/pegasus-large (34 tok):\n",
      "R1\tp: 10.00 \tr: 16.67 \tf: 12.50\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 10.00 \tr: 16.67 \tf: 12.50\n",
      "ST\t28.12\t\tW2V\t16.72\n",
      "\n",
      "A starting dose of 5 mg/kg daily in children over 3 years of age can be prescribed, increasing\n",
      "gradually to a maintenance dose of about 30 mg/kg daily.\n",
      "\n",
      "google/pegasus-large (25 tok):\n",
      "R1\tp: 19.05 \tr: 22.22 \tf: 20.51\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 9.52 \tr: 11.11 \tf: 10.26\n",
      "ST\t36.58\t\tW2V\t11.01\n",
      "\n",
      "Patients already on CBZ may be switched immediately to OXC using a dosage ratio of 1.5 OXC to 1 CBZ.\n",
      "\n",
      "google/pegasus-large (18 tok):\n",
      "R1\tp: 6.25 \tr: 5.56 \tf: 5.88\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 6.25 \tr: 5.56 \tf: 5.88\n",
      "ST\t30.41\t\tW2V\t-0.36\n",
      "\n",
      "The recommended starting dose for OXC in adults is 150-600 mg daily in two doses.\n",
      "\n",
      "google/pegasus-large (16 tok):\n",
      "R1\tp: 15.38 \tr: 11.11 \tf: 12.90\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 15.38 \tr: 11.11 \tf: 12.90\n",
      "ST\t23.90\t\tW2V\t0.46\n",
      "\n",
      "Plasma concentrations of the clinically active metabolite of OXC increase linearly with dose.\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (20 tok):\n",
      "R1\tp: 13.33 \tr: 11.11 \tf: 12.12\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 13.33 \tr: 11.11 \tf: 12.12\n",
      "ST\t34.39\t\tW2V\t-0.21\n",
      "\n",
      "OXC has a similar spectrum of efficacy to CBZ against partial and tonic-clonic seizures.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (19 tok):\n",
      "R1\tp: 14.29 \tr: 11.11 \tf: 12.50\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 14.29 \tr: 11.11 \tf: 12.50\n",
      "ST\t34.88\t\tW2V\t-0.21\n",
      "\n",
      "OXC has similar spectrum of efficacy to CBZ against partial and tonic-clonic seizures.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (16 tok):\n",
      "R1\tp: 7.14 \tr: 5.56 \tf: 6.25\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 7.14 \tr: 5.56 \tf: 6.25\n",
      "ST\t32.29\t\tW2V\t4.27\n",
      "\n",
      "The recommended starting dose for OXC is 150-600 mg daily in two doses.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (17 tok):\n",
      "R1\tp: 8.33 \tr: 5.56 \tf: 6.67\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 8.33 \tr: 5.56 \tf: 6.67\n",
      "ST\t32.01\t\tW2V\t-1.77\n",
      "\n",
      "OXC has similar efficacy to CBZ against partial and tonic-clonic seizures.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781910797426, 'ch03')\n",
      "Symptoms and signs include pain or tenderness and guarding in the right upper quadrant, nausea and\n",
      "vomiting, fever, fast pulse (tachycardia) and a positive Murphy's sign (transient cessation of\n",
      "breathing due to pain during inspiration while the right upper quadrant is palpated, but not the\n",
      "left upper quadrant). Complications include empyema, perforation of the gallbladder, liver abscess\n",
      "and emphysematous cholecystitis. An inflamed and distended gallbladder may obstruct the main bile\n",
      "duct by pressure from a gallstone causing obstructive jaundice (Mirizzi's syndrome). Laboratory\n",
      "tests. Leukocytosis and mild elevation in serum bilirubin and transaminases may be present.\n",
      "Transabdominal ultrasonography is the most useful test for acute cholecystitis as it establishes the\n",
      "presence of gallstones (Figure 3.5). A thickened gallbladder wall (> 4 mm) and pericholecystic fluid\n",
      "are highly suggestive of acute cholecystitis (Figure 3.6). Sonographic Murphy's sign (tenderness\n",
      "over the gallbladder from the ultrasound transducer during imaging) is also diagnostic. Radionuclide\n",
      "scanning is a useful test if ultrasound is non-diagnostic or inconclusive but there is clinical\n",
      "suspicion of acute cholecystitis. A Tc-HIDA (hepatobiliary iminodiacetic acid) scan uses a\n",
      "technetium-labeled analog of iminodiacetic acid. Non-visualization of the gallbladder with\n",
      "visualization of the tracer in the CBD and the small intestine is consistent with cystic duct\n",
      "obstruction. This test is about 95% accurate for the diagnosis of acute cholecystitis. Computed\n",
      "tomography is useful for identifying local complications of acute cholecystitis (Figure 3.7).\n",
      "Medical treatment of acute cholecystitis involves.\n",
      "\n",
      "Reference:\n",
      "Transabdominal ultrasound is the imaging test of choice, with an accuracy of over 95%, for the\n",
      "diagnosis of gallstones in either acute or chronic cholecystitis. A Tc-HIDA (hepatobiliary\n",
      "iminodiacetic acid) scan is 95% accurate for the diagnosis of acute cholecystitis.\n",
      "\n",
      "google/pegasus-large (27 tok):\n",
      "R1\tp: 50.00 \tr: 24.39 \tf: 32.79\n",
      "R2\tp: 15.79 \tr: 7.50 \tf: 10.17\n",
      "RL\tp: 45.00 \tr: 21.95 \tf: 29.51\n",
      "ST\t69.28\t\tW2V\t54.62\n",
      "\n",
      "Transabdominal ultrasonography is the most useful test for acute cholecystitis as it establishes the\n",
      "presence of gallstones (Figure 3.5).\n",
      "\n",
      "google/pegasus-large (19 tok):\n",
      "R1\tp: 35.71 \tr: 12.20 \tf: 18.18\n",
      "R2\tp: 15.38 \tr: 5.00 \tf: 7.55\n",
      "RL\tp: 35.71 \tr: 12.20 \tf: 18.18\n",
      "ST\t58.32\t\tW2V\t47.89\n",
      "\n",
      "Computed tomography is useful for identifying local complications of acute cholecystitis (Figure\n",
      "3.7).\n",
      "\n",
      "google/pegasus-large (56 tok):\n",
      "R1\tp: 39.02 \tr: 39.02 \tf: 39.02\n",
      "R2\tp: 12.50 \tr: 12.50 \tf: 12.50\n",
      "RL\tp: 29.27 \tr: 29.27 \tf: 29.27\n",
      "ST\t78.20\t\tW2V\t56.98\n",
      "\n",
      "Transabdominal ultrasonography is the most useful test for acute cholecystitis as it establishes the\n",
      "presence of gallstones (Figure 3.5). Radionuclide scanning is a useful test if ultrasound is non-\n",
      "diagnostic or inconclusive but there is clinical suspicion of acute cholecystiti.\n",
      "\n",
      "google/pegasus-large (56 tok):\n",
      "R1\tp: 41.46 \tr: 41.46 \tf: 41.46\n",
      "R2\tp: 12.50 \tr: 12.50 \tf: 12.50\n",
      "RL\tp: 31.71 \tr: 31.71 \tf: 31.71\n",
      "ST\t77.70\t\tW2V\t60.65\n",
      "\n",
      "Transabdominal ultrasonography is the most useful test for acute cholecystitis as it establishes the\n",
      "presence of gallstones (Figure 3.5). Radionuclide scanning is a useful test if ultrasound is non-\n",
      "diagnostic or inconclusive but there is clinical suspicion of acute Cholecystitis.\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (62 tok):\n",
      "R1\tp: 33.33 \tr: 34.15 \tf: 33.73\n",
      "R2\tp: 9.76 \tr: 10.00 \tf: 9.88\n",
      "RL\tp: 23.81 \tr: 24.39 \tf: 24.10\n",
      "ST\t74.66\t\tW2V\t42.49\n",
      "\n",
      "Transabdominal ultrasonography is the most useful test for acute cholecystitis as it establishes the\n",
      "presence of gallstones. A thickened gallbladder wall (> 4 mm) and pericholecystic fluid are highly\n",
      "suggestive. Radionuclide scanning is a useful test if ultrasound is non-diagnostic or inconclusive.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (43 tok):\n",
      "R1\tp: 54.84 \tr: 41.46 \tf: 47.22\n",
      "R2\tp: 40.00 \tr: 30.00 \tf: 34.29\n",
      "RL\tp: 48.39 \tr: 36.59 \tf: 41.67\n",
      "ST\t77.84\t\tW2V\t54.23\n",
      "\n",
      "Radionuclide scanning is a useful test if ultrasound is non-diagnostic or inconclusive but there is\n",
      "clinical suspicion of acute cholecystitis. A Tc-HIDA scan is 95% accurate for the diagnosis.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (84 tok):\n",
      "R1\tp: 29.31 \tr: 41.46 \tf: 34.34\n",
      "R2\tp: 7.02 \tr: 10.00 \tf: 8.25\n",
      "RL\tp: 17.24 \tr: 24.39 \tf: 20.20\n",
      "ST\t74.48\t\tW2V\t39.42\n",
      "\n",
      "Transabdominal ultrasonography is the most useful test for acute cholecystitis as it establishes the\n",
      "presence of gallstones. A thickened gallbladder wall (> 4 mm) and pericholecystic fluid are highly\n",
      "suggestive. A sonographic Murphy's sign (tenderness over the gallbladder from the ultrasound\n",
      "transducer during imaging) is also diagnostic. Radionuclide scanning is useful if ultrasound is non-\n",
      "diagnostic or inconclusive.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (44 tok):\n",
      "R1\tp: 37.93 \tr: 26.83 \tf: 31.43\n",
      "R2\tp: 10.71 \tr: 7.50 \tf: 8.82\n",
      "RL\tp: 31.03 \tr: 21.95 \tf: 25.71\n",
      "ST\t68.07\t\tW2V\t46.18\n",
      "\n",
      "Transabdominal ultrasonography is the most useful test for acute cholecystitis as it establishes the\n",
      "presence of gallstones. A thickened gallbladder wall (> 4 mm) and pericholecystic fluid are highly\n",
      "suggestive.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781910797907, 'chp2')\n",
      "As discussed in Chapter 1, mutations in the PKLR gene on chromosome 1 are responsible for PK\n",
      "deficiency. More than 300 different mutations have been reported; most are very rare, occurring only\n",
      "once. Currently, about 25% of patients diagnosed with PK deficiency appear to have a previously\n",
      "unrecorded mutation. Although many of the mutations associated with PK deficiency are rare, a few\n",
      "are recorded more frequently (Table 2.1). The variability in how PK deficiency manifests is thought\n",
      "to reflect the heterogeneity of these causative mutations, as well as the fact that most individuals\n",
      "with PK deficiency will be compound heterozygotes (id est they will have a different mutation in\n",
      "each copy of the PKLR gene).\n",
      "\n",
      "Reference:\n",
      "About one quarter of patients diagnosed with PK deficiency will have a previously unrecorded\n",
      "mutation in the PKLR gene.\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "google/pegasus-large (54 tok):\n",
      "R1\tp: 25.53 \tr: 63.16 \tf: 36.36\n",
      "R2\tp: 17.39 \tr: 44.44 \tf: 25.00\n",
      "RL\tp: 25.53 \tr: 63.16 \tf: 36.36\n",
      "ST\t78.01\t\tW2V\t55.99\n",
      "\n",
      "The variability in how PK deficiency manifests is thought to reflect the heterogeneity of these\n",
      "causative mutations, as well as the fact that most individuals with PK deficiency will be compound\n",
      "heterozygotes (id est they will have a different mutation in each copy of the PKLR gene).\n",
      "\n",
      "google/pegasus-large (74 tok):\n",
      "R1\tp: 18.46 \tr: 63.16 \tf: 28.57\n",
      "R2\tp: 14.06 \tr: 50.00 \tf: 21.95\n",
      "RL\tp: 18.46 \tr: 63.16 \tf: 28.57\n",
      "ST\t79.25\t\tW2V\t55.93\n",
      "\n",
      "As discussed in Chapter 1, mutations in the PKLR gene on chromosome 1 are responsible for PK\n",
      "deficiency. The variability in how PK deficiency manifests is thought to reflect the heterogeneity\n",
      "of these causative mutations, as well as the fact that most individuals with PK deficiency will be\n",
      "compound heterozygotes (id est they will have a different mutation in each copy of the PKLR gene).\n",
      "\n",
      "google/pegasus-large (74 tok):\n",
      "R1\tp: 18.46 \tr: 63.16 \tf: 28.57\n",
      "R2\tp: 14.06 \tr: 50.00 \tf: 21.95\n",
      "RL\tp: 18.46 \tr: 63.16 \tf: 28.57\n",
      "ST\t79.37\t\tW2V\t55.68\n",
      "\n",
      "As discussed in Chapter 1, mutations in the PKLR gene on chromosome 1 are responsible for PK\n",
      "deficiency. The variability in how PK deficiency manifests is thought to reflect the heterogeneity\n",
      "of these causative mutations, as well as the fact that most individuals with PK deficiency will be\n",
      "compound heterozygotes (id est them will have a different mutation in each copy of the PKLR gene).\n",
      "\n",
      "google/pegasus-large (55 tok):\n",
      "R1\tp: 25.53 \tr: 63.16 \tf: 36.36\n",
      "R2\tp: 17.39 \tr: 44.44 \tf: 25.00\n",
      "RL\tp: 25.53 \tr: 63.16 \tf: 36.36\n",
      "ST\t77.45\t\tW2V\t55.99\n",
      "\n",
      "The variability in how PK deficiency manifests is thought to reflect the heterogeneity of these\n",
      "causative mutations, as well as the fact that most individuals with PK deficiency will be compound\n",
      "heterozygotes (id est they will have a different mutation in each copy of the PKLR gene)..\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (16 tok):\n",
      "R1\tp: 46.15 \tr: 31.58 \tf: 37.50\n",
      "R2\tp: 33.33 \tr: 22.22 \tf: 26.67\n",
      "RL\tp: 30.77 \tr: 21.05 \tf: 25.00\n",
      "ST\t67.80\t\tW2V\t34.91\n",
      "\n",
      "Mutations in the PKLR gene on chromosome 1 are responsible for PK deficiency.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (14 tok):\n",
      "R1\tp: 54.55 \tr: 31.58 \tf: 40.00\n",
      "R2\tp: 40.00 \tr: 22.22 \tf: 28.57\n",
      "RL\tp: 36.36 \tr: 21.05 \tf: 26.67\n",
      "ST\t66.33\t\tW2V\t38.30\n",
      "\n",
      "Mutations in the PKLR gene on chromosome 1 cause PK deficiency.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (11 tok):\n",
      "R1\tp: 75.00 \tr: 31.58 \tf: 44.44\n",
      "R2\tp: 57.14 \tr: 22.22 \tf: 32.00\n",
      "RL\tp: 50.00 \tr: 21.05 \tf: 29.63\n",
      "ST\t68.25\t\tW2V\t41.16\n",
      "\n",
      "Mutations in the PKLR gene cause PK deficiency.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (13 tok):\n",
      "R1\tp: 60.00 \tr: 31.58 \tf: 41.38\n",
      "R2\tp: 44.44 \tr: 22.22 \tf: 29.63\n",
      "RL\tp: 40.00 \tr: 21.05 \tf: 27.59\n",
      "ST\t68.84\t\tW2V\t36.49\n",
      "\n",
      "Mutations in the PKLR gene are responsible for PK deficiency.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781910797105, 'ch05')\n",
      "The risk is further increased if minor psychotic symptoms pre-exist and if cannabis use starts early\n",
      "in adolescence. Research suggests that this effect of cannabis may be mediated by a particular gene.\n",
      "Those with a specific version of the catechol- O -methyltransferase (COMT) gene, carried by about a\n",
      "quarter of the general population, appear to be especially prone to psychosis after cannabis use.\n",
      "Delta-9-THC, the active component of cannabis, disrupts learning and recall in schizophrenia.\n",
      "Psychosocial risk factors. There is emerging evidence for the role of non-biological risk factors in\n",
      "schizophrenia, such as the effects of urban upbringing and of ethnicity, as noted in Chapter 3.\n",
      "\n",
      "Reference:\n",
      "Psychosocial risk factors are being re-established as important risk factors.\n",
      "\n",
      "google/pegasus-large (42 tok):\n",
      "R1\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "ST\t18.32\t\tW2V\t8.65\n",
      "\n",
      "Those with a specific version of the catechol- O -methyltransferase (COMT) gene, carried by about a\n",
      "quarter of the general population, appear to be especially prone to psychosis after cannabis use.\n",
      "\n",
      "google/pegasus-large (47 tok):\n",
      "R1\tp: 8.82 \tr: 27.27 \tf: 13.33\n",
      "R2\tp: 6.06 \tr: 20.00 \tf: 9.30\n",
      "RL\tp: 8.82 \tr: 27.27 \tf: 13.33\n",
      "ST\t35.03\t\tW2V\t31.26\n",
      "\n",
      "Those with a specific version of the catechol- O -methyltransferase (COMT) gene, carried by about a\n",
      "quarter of the general population, appear to be especially prone to psychosis after cannabis use.\n",
      "Psychosocial risk factors.\n",
      "\n",
      "google/pegasus-large (63 tok):\n",
      "R1\tp: 2.00 \tr: 9.09 \tf: 3.28\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 2.00 \tr: 9.09 \tf: 3.28\n",
      "ST\t32.21\t\tW2V\t18.45\n",
      "\n",
      "The risk is further increased if minor psychotic symptoms pre-exist and if cannabis use starts early\n",
      "in adolescence. Those with a specific version of the catechol- O -methyltransferase (COMT) gene,\n",
      "carried by about a quarter of the general population, appear to be especially prone to psychosis\n",
      "after cannabis use.\n",
      "\n",
      "google/pegasus-large (63 tok):\n",
      "R1\tp: 2.00 \tr: 9.09 \tf: 3.28\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 2.00 \tr: 9.09 \tf: 3.28\n",
      "ST\t31.06\t\tW2V\t18.28\n",
      "\n",
      "Those with a specific version of the catechol- O -methyltransferase (COMT) gene, carried by about a\n",
      "quarter of the general population, appear to be especially prone to psychosis after cannabis use.\n",
      "The risk is further increased if minor psychotic symptoms pre-exist and if cannabis use starts early\n",
      "in adolescence.\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (17 tok):\n",
      "R1\tp: 28.57 \tr: 36.36 \tf: 32.00\n",
      "R2\tp: 23.08 \tr: 30.00 \tf: 26.09\n",
      "RL\tp: 28.57 \tr: 36.36 \tf: 32.00\n",
      "ST\t57.14\t\tW2V\t45.81\n",
      "\n",
      "Psychosocial risk factors are emerging, including the effects of urban upbringing and of ethnicity.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (16 tok):\n",
      "R1\tp: 30.77 \tr: 36.36 \tf: 33.33\n",
      "R2\tp: 25.00 \tr: 30.00 \tf: 27.27\n",
      "RL\tp: 30.77 \tr: 36.36 \tf: 33.33\n",
      "ST\t57.21\t\tW2V\t48.37\n",
      "\n",
      "Psychosocial risk factors are emerging, including the effects of urban upbringing and ethnicity.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (18 tok):\n",
      "R1\tp: 38.46 \tr: 45.45 \tf: 41.67\n",
      "R2\tp: 16.67 \tr: 20.00 \tf: 18.18\n",
      "RL\tp: 30.77 \tr: 36.36 \tf: 33.33\n",
      "ST\t60.46\t\tW2V\t52.48\n",
      "\n",
      "Psychosocial risk factors, such as family history, urban upbringing and ethnicity, are emerging.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (13 tok):\n",
      "R1\tp: 40.00 \tr: 36.36 \tf: 38.10\n",
      "R2\tp: 33.33 \tr: 30.00 \tf: 31.58\n",
      "RL\tp: 40.00 \tr: 36.36 \tf: 38.10\n",
      "ST\t59.41\t\tW2V\t53.63\n",
      "\n",
      "Psychosocial risk factors are emerging, including urban upbringing and ethnicity.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781908541680, 'ch_4')\n",
      "Overweight/obesity as a whole predisposes to, or is associated with, numerous cardiac complications\n",
      "such as coronary heart disease (CHD), atrial fibrillation, heart failure and sudden cardiac death as\n",
      "a result of abnormalities in blood glucose, lipids, blood pressure, coagulation and inflammation.\n",
      "Independent of any of the other known cardiometabolic risk factors, obesity is associated with\n",
      "hypertension, tachycardia, left ventricular hypertrophy, increased collagen deposition, reduced\n",
      "cardiac contractility and increased end-diastolic pressure. The major circulatory complications are\n",
      "increased total and pulmonary blood volume, high cardiac output and elevated left ventricular end-\n",
      "diastolic pressure.\n",
      "\n",
      "Reference:\n",
      "Obesity significantly affects cardiometabolic status and risk.\n",
      "\n",
      "google/pegasus-large (25 tok):\n",
      "R1\tp: 4.76 \tr: 14.29 \tf: 7.14\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 4.76 \tr: 14.29 \tf: 7.14\n",
      "ST\t42.81\t\tW2V\t6.38\n",
      "\n",
      "The major circulatory complications are increased total and pulmonary blood volume, high cardiac\n",
      "output and elevated left ventricular end-diastolic pressure.\n",
      "\n",
      "google/pegasus-large (41 tok):\n",
      "R1\tp: 13.33 \tr: 57.14 \tf: 21.62\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 6.67 \tr: 28.57 \tf: 10.81\n",
      "ST\t59.81\t\tW2V\t19.95\n",
      "\n",
      "Independent of any of the other known cardiometabolic risk factors, obesity is associated with\n",
      "hypertension, tachycardia, left ventricular hypertrophy, increased collagen deposition, reduced\n",
      "cardiac contractility and increased end-diastolic pressure.\n",
      "\n",
      "google/pegasus-large (24 tok):\n",
      "R1\tp: 5.00 \tr: 14.29 \tf: 7.41\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 5.00 \tr: 14.29 \tf: 7.41\n",
      "ST\t42.56\t\tW2V\t-1.00\n",
      "\n",
      "The major circulatory complications are increased total pulmonary blood volume, high cardiac output\n",
      "and elevated left ventricular end-diastolic pressure.\n",
      "\n",
      "google/pegasus-large (41 tok):\n",
      "R1\tp: 13.33 \tr: 57.14 \tf: 21.62\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 6.67 \tr: 28.57 \tf: 10.81\n",
      "ST\t58.94\t\tW2V\t20.70\n",
      "\n",
      "Independent of any of the other known cardiometabolic risk factors, obesity is associated with\n",
      "hypertension, tachycardia, left ventricular hypertrophy, decreased collagen deposition, reduced\n",
      "cardiac contractility and increased end-diastolic pressure.\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (51 tok):\n",
      "R1\tp: 5.26 \tr: 28.57 \tf: 8.89\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 5.26 \tr: 28.57 \tf: 8.89\n",
      "ST\t56.47\t\tW2V\t6.21\n",
      "\n",
      "Overweight/obesity as a whole predisposes to numerous cardiac complications such as coronary heart\n",
      "disease (CHD), atrial fibrillation, heart failure and sudden cardiac death as a result of\n",
      "abnormalities in blood glucose, lipids, blood pressure, coagulation and inflammation.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (40 tok):\n",
      "R1\tp: 7.14 \tr: 28.57 \tf: 11.43\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 7.14 \tr: 28.57 \tf: 11.43\n",
      "ST\t53.07\t\tW2V\t6.14\n",
      "\n",
      "Overweight/obesity as a whole predisposes to, or is associated with, numerous cardiac complications\n",
      "such as coronary heart disease (CHD), atrial fibrillation, heart failure and sudden cardiac death.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (37 tok):\n",
      "R1\tp: 7.41 \tr: 28.57 \tf: 11.76\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 7.41 \tr: 28.57 \tf: 11.76\n",
      "ST\t55.20\t\tW2V\t4.38\n",
      "\n",
      "Overweight/obesity as a whole predisposes to, or is associated with, numerous cardiac complications\n",
      "such as coronary heart disease, atrial fibrillation, heart failure and sudden cardiac death.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (52 tok):\n",
      "R1\tp: 5.13 \tr: 28.57 \tf: 8.70\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 5.13 \tr: 28.57 \tf: 8.70\n",
      "ST\t56.91\t\tW2V\t5.12\n",
      "\n",
      "Overweight/obesity as a whole predisposes to numerous cardiac complications such as coronary heart\n",
      "disease (CHD), atrial fibrillation, heart failure and sudden cardiac death as a result of\n",
      "abnormalities in blood glucose, lipids, blood pressure, coagulation and inflammatory response.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781908541024, 'ch_12')\n",
      "The vast majority of primary brain tumors occur sporadically, but a small number appear to be\n",
      "familial. The etiology of sporadic brain tumors is unknown, but environmental factors are suspected.\n",
      "Most patients with a family history of primary brain tumors have a hereditary disease that is known\n",
      "to be associated with such tumors, such as tuberous sclerosis, neurofibromatosis, familial polyposis\n",
      "or Li-Fraumeni syndrome. However, some patients do not have any underlying or obvious hereditary\n",
      "disorder that would predispose them to primary brain tumors, but nevertheless give a striking\n",
      "history of these tumors in first-degree relatives. Usually, the tumors are found to be high-grade\n",
      "gliomas.\n",
      "\n",
      "Reference:\n",
      "There are several syndromes associated with an inherited predisposition to a variety of brain\n",
      "tumors. However, the vast majority of brain tumors are not inherited.\n",
      "\n",
      "google/pegasus-large (46 tok):\n",
      "R1\tp: 23.53 \tr: 32.00 \tf: 27.12\n",
      "R2\tp: 6.06 \tr: 8.33 \tf: 7.02\n",
      "RL\tp: 17.65 \tr: 24.00 \tf: 20.34\n",
      "ST\t71.47\t\tW2V\t34.97\n",
      "\n",
      "Most patients with a family history of primary brain tumors have a hereditary disease that is known\n",
      "to be associated with such tumors, such as tuberous sclerosis, neurofibromatosis, familial polyposis\n",
      "or Li-Fraumeni syndrome.\n",
      "\n",
      "google/pegasus-large (46 tok):\n",
      "R1\tp: 23.53 \tr: 32.00 \tf: 27.12\n",
      "R2\tp: 6.06 \tr: 8.33 \tf: 7.02\n",
      "RL\tp: 17.65 \tr: 24.00 \tf: 20.34\n",
      "ST\t71.18\t\tW2V\t34.97\n",
      "\n",
      "Most patients with a family history of primary brain tumors have a hereditary disease that is known\n",
      "to be associated with such tumors, such as tuberous sclerosis, Neurofibromatosis, familial polyposis\n",
      "or Li-Fraumeni syndrome.\n",
      "\n",
      "google/pegasus-large (49 tok):\n",
      "R1\tp: 22.86 \tr: 32.00 \tf: 26.67\n",
      "R2\tp: 5.88 \tr: 8.33 \tf: 6.90\n",
      "RL\tp: 17.14 \tr: 24.00 \tf: 20.00\n",
      "ST\t72.41\t\tW2V\t34.97\n",
      "\n",
      "Most patients with a family history of primary brain tumors have a hereditary disease that is known\n",
      "to be associated with such tumors, such as tuberous sclerosis, neurodegeneration, neurofibromatosis,\n",
      "familial polyposis or Li-Fraumeni syndrome.\n",
      "\n",
      "google/pegasus-large (37 tok):\n",
      "R1\tp: 24.24 \tr: 32.00 \tf: 27.59\n",
      "R2\tp: 3.12 \tr: 4.17 \tf: 3.57\n",
      "RL\tp: 15.15 \tr: 20.00 \tf: 17.24\n",
      "ST\t67.40\t\tW2V\t37.74\n",
      "\n",
      "However, some patients do not have any underlying or obvious hereditary disorder that would\n",
      "predispose them to primary brain tumors, but nevertheless give a striking history of these tumors in\n",
      "first-degree relatives.\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (19 tok):\n",
      "R1\tp: 47.06 \tr: 32.00 \tf: 38.10\n",
      "R2\tp: 25.00 \tr: 16.67 \tf: 20.00\n",
      "RL\tp: 35.29 \tr: 24.00 \tf: 28.57\n",
      "ST\t68.69\t\tW2V\t44.46\n",
      "\n",
      "The vast majority of primary brain tumors occur sporadically, but a small number appear to be\n",
      "familial.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (24 tok):\n",
      "R1\tp: 34.78 \tr: 32.00 \tf: 33.33\n",
      "R2\tp: 9.09 \tr: 8.33 \tf: 8.70\n",
      "RL\tp: 26.09 \tr: 24.00 \tf: 25.00\n",
      "ST\t72.56\t\tW2V\t46.39\n",
      "\n",
      "Most patients with a family history of primary brain tumors have a hereditary disease that is known\n",
      "to be associated with such tumors.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (18 tok):\n",
      "R1\tp: 50.00 \tr: 32.00 \tf: 39.02\n",
      "R2\tp: 26.67 \tr: 16.67 \tf: 20.51\n",
      "RL\tp: 37.50 \tr: 24.00 \tf: 29.27\n",
      "ST\t68.46\t\tW2V\t43.63\n",
      "\n",
      "The vast majority of primary brain tumors occur sporadically; a small number appear to be familial.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (10 tok):\n",
      "R1\tp: 66.67 \tr: 24.00 \tf: 35.29\n",
      "R2\tp: 50.00 \tr: 16.67 \tf: 25.00\n",
      "RL\tp: 66.67 \tr: 24.00 \tf: 35.29\n",
      "ST\t69.42\t\tW2V\t61.85\n",
      "\n",
      "The vast majority of primary brain tumors occur sporadically.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781910797211, 'ch04')\n",
      "Dopamine agonist versus levodopa. In younger patients, the issues of neuroprotection and dyskinesias\n",
      "should be considered. The results of four controlled dopamine-agonist monotherapy trials have been\n",
      "published and suggest that initiation of treatment with an agonist is beneficial in the early stages\n",
      "of Parkinson's disease. However, the results of the PD Med study, a multicenter real-life pragmatic\n",
      "study, reporting on quality of life-related outcomes in both young and old patients with Parkinson's\n",
      "disease, is likely to generate considerable controversy regarding the use of dopamine agonists and\n",
      "the choice of initial therapy. In total, 1620 patients with early Parkinson's disease were recruited\n",
      "and given one of three initial treatment regimens. levodopa formulation (528 patients). levodopa-\n",
      "sparing strategy - dopamine agonist (632 patients). levodopa-sparing strategy - MAOB inhibitor\n",
      "(selegiline; 460 patients). The study started in 2000 with a median follow-up of 3 years and maximum\n",
      "of 7 years. During this time the dopamine agonists varied, including ergot agonists that are no\n",
      "longer in widespread use. The randomization to levodopa or alternative regimens was at the\n",
      "discretion of the clinician and a large part of the study was conducted in centers for the care of\n",
      "the elderly. The findings suggest relatively small but persistent benefits of starting therapy with\n",
      "levodopa rather than the listed alternatives. Interestingly, initial treatment with a MAOB inhibitor\n",
      "appeared to be at least as effective as treatment with a dopamine agonist.\n",
      "\n",
      "Reference:\n",
      "Trial data indicate that treatment of Parkinson's disease could be initiated with levodopa, oral\n",
      "dopamine agonists or a monoamine oxidase B (MAOB) inhibitor. The PD MED study seems to suggest that\n",
      "initial therapy with levodopa offers a small but persistent benefit compared with the alternatives,\n",
      "and initial MAOB inhibitor treatment is at least as effective as a dopamine agonist.\n",
      "\n",
      "google/pegasus-large (59 tok):\n",
      "R1\tp: 36.73 \tr: 30.00 \tf: 33.03\n",
      "R2\tp: 14.58 \tr: 11.86 \tf: 13.08\n",
      "RL\tp: 20.41 \tr: 16.67 \tf: 18.35\n",
      "ST\t59.51\t\tW2V\t53.67\n",
      "\n",
      "However, the results of the PD Med study, a multicenter real-life pragmatic study, reporting on\n",
      "quality of life-related outcomes in both young and old patients with Parkinson's disease, is likely\n",
      "to generate considerable controversy regarding the use of dopamine agonists and the choice of\n",
      "initial therapy.\n",
      "\n",
      "google/pegasus-large (82 tok):\n",
      "R1\tp: 50.72 \tr: 58.33 \tf: 54.26\n",
      "R2\tp: 20.59 \tr: 23.73 \tf: 22.05\n",
      "RL\tp: 30.43 \tr: 35.00 \tf: 32.56\n",
      "ST\t72.56\t\tW2V\t73.41\n",
      "\n",
      "However, the results of the PD Med study, a multicenter real-life pragmatic study, reporting on\n",
      "quality of life-related outcomes in both young and old patients with Parkinson's disease, is likely\n",
      "to generate considerable controversy regarding the use of dopamine agonists and the choice of\n",
      "initial therapy. Interestingly, initial treatment with a MAOB inhibitor appeared to be at least as\n",
      "effective as treatment with a dopamine agonist.\n",
      "\n",
      "google/pegasus-large (82 tok):\n",
      "R1\tp: 30.88 \tr: 35.00 \tf: 32.81\n",
      "R2\tp: 10.45 \tr: 11.86 \tf: 11.11\n",
      "RL\tp: 19.12 \tr: 21.67 \tf: 20.31\n",
      "ST\t62.66\t\tW2V\t57.01\n",
      "\n",
      "However, the results of the PD Med study, a multicenter real-life pragmatic study, reporting on\n",
      "quality of life-related outcomes in both young and old patients with Parkinson's disease, is likely\n",
      "to generate considerable controversy regarding the use of dopamine agonists and the choice of\n",
      "initial therapy. In total, 1620 patients with early Parkinson's disease were recruited and given one\n",
      "of three initial treatment regimens.\n",
      "\n",
      "google/pegasus-large (35 tok):\n",
      "R1\tp: 45.16 \tr: 23.33 \tf: 30.77\n",
      "R2\tp: 16.67 \tr: 8.47 \tf: 11.24\n",
      "RL\tp: 19.35 \tr: 10.00 \tf: 13.19\n",
      "ST\t71.62\t\tW2V\t50.56\n",
      "\n",
      "The results of four controlled dopamine-agonist monotherapy trials have been published and suggest\n",
      "that initiation of treatment with an agonist is beneficial in the early stages of Parkinson's\n",
      "disease.\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (47 tok):\n",
      "R1\tp: 76.19 \tr: 53.33 \tf: 62.75\n",
      "R2\tp: 34.15 \tr: 23.73 \tf: 28.00\n",
      "RL\tp: 54.76 \tr: 38.33 \tf: 45.10\n",
      "ST\t84.80\t\tW2V\t73.95\n",
      "\n",
      "The results of the PD Med study suggest relatively small but persistent benefits of starting therapy\n",
      "with levodopa rather than the listed alternatives. Initial treatment with a MAOB inhibitor appeared\n",
      "to be at least as effective as treatment with a dopamine agonist.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (47 tok):\n",
      "R1\tp: 76.19 \tr: 53.33 \tf: 62.75\n",
      "R2\tp: 34.15 \tr: 23.73 \tf: 28.00\n",
      "RL\tp: 54.76 \tr: 38.33 \tf: 45.10\n",
      "ST\t85.66\t\tW2V\t74.83\n",
      "\n",
      "The results of the PD Med study suggest relatively small but persistent benefits of starting therapy\n",
      "with levodopa rather than the listed alternatives. Initial treatment with a MAOB inhibitor appears\n",
      "to be at least as effective as treatment with a dopamine agonist.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (26 tok):\n",
      "R1\tp: 60.87 \tr: 23.33 \tf: 33.73\n",
      "R2\tp: 31.82 \tr: 11.86 \tf: 17.28\n",
      "RL\tp: 52.17 \tr: 20.00 \tf: 28.92\n",
      "ST\t72.96\t\tW2V\t44.66\n",
      "\n",
      "The results of the PD Med study suggest relatively small but persistent benefits of starting therapy\n",
      "with levodopa rather than the listed alternatives.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (43 tok):\n",
      "R1\tp: 55.56 \tr: 33.33 \tf: 41.67\n",
      "R2\tp: 31.43 \tr: 18.64 \tf: 23.40\n",
      "RL\tp: 38.89 \tr: 23.33 \tf: 29.17\n",
      "ST\t82.31\t\tW2V\t49.37\n",
      "\n",
      "The results of the PD Med study suggest relatively small but persistent benefits of starting therapy\n",
      "with levodopa rather than the listed alternatives. Dopamine agonist therapy is beneficial in the\n",
      "early stages of Parkinson's disease.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781908541963, 'chapter5')\n",
      "A rapid deterioration may indicate the development of a complicating cholangiocarcinoma. The risk of\n",
      "this malignant transformation is about 6-15% over the course of the disease. Screening for malignant\n",
      "transformation is not effective in detecting early disease, and progression to cholangiocarcinoma is\n",
      "generally regarded as a contraindication to liver transplantation. Treatment. UDCA, 10-15 mg/kg/day,\n",
      "is recommended. This ameliorates pruritus, improves the liver biochemistry and histology and may\n",
      "alter the natural history of the disease. Immunosuppressive and antifibrotic therapies have not\n",
      "proved effective. Liver transplantation is used widely for advanced disease. The indications for\n",
      "transplantation are less precise than they are in PBC, but persistent jaundice of more than 3\n",
      "months' duration, in addition to evidence of liver failure or severe portal hypertension, are\n",
      "reasonable indications to proceed to liver transplantation. The results of liver transplantation are\n",
      "excellent in the absence of cholangiocarcinoma. PSC recurs in 8-15% of cases and is occasionally a\n",
      "cause of significant graft dysfunction.\n",
      "\n",
      "Reference:\n",
      "Primary sclerosing cholangitis is strongly associated with ulcerative colitis and is unpredictable;\n",
      "late disease can be managed effectively with liver transplantation unless complicated by\n",
      "cholangiocarcinoma.\n",
      "\n",
      "google/pegasus-large (32 tok):\n",
      "R1\tp: 29.17 \tr: 28.00 \tf: 28.57\n",
      "R2\tp: 4.35 \tr: 4.17 \tf: 4.26\n",
      "RL\tp: 20.83 \tr: 20.00 \tf: 20.41\n",
      "ST\t66.11\t\tW2V\t34.57\n",
      "\n",
      "Screening for malignant transformation is not effective in detecting early disease, and progression\n",
      "to cholangiocarcinoma is generally regarded as a contraindication to liver transplantation.\n",
      "\n",
      "google/pegasus-large (49 tok):\n",
      "R1\tp: 17.50 \tr: 28.00 \tf: 21.54\n",
      "R2\tp: 2.56 \tr: 4.17 \tf: 3.17\n",
      "RL\tp: 12.50 \tr: 20.00 \tf: 15.38\n",
      "ST\t62.57\t\tW2V\t37.15\n",
      "\n",
      "The risk of this malignant transformation is about 6-15% over the course of the disease. Screening\n",
      "for malignant transformation is not effective in detecting early disease, and progression to\n",
      "cholangiocarcinoma is generally regarded as a contraindication to liver transplantation.\n",
      "\n",
      "google/pegasus-large (58 tok):\n",
      "R1\tp: 14.58 \tr: 28.00 \tf: 19.18\n",
      "R2\tp: 2.13 \tr: 4.17 \tf: 2.82\n",
      "RL\tp: 10.42 \tr: 20.00 \tf: 13.70\n",
      "ST\t65.23\t\tW2V\t42.92\n",
      "\n",
      "The risk of this malignant transformation is about 6-15% over the course of the disease. Screening\n",
      "for malignant transformation is not effective in detecting early disease, and progression to\n",
      "cholangiocarcinoma is generally regarded as a contraindication to liver transplantation. Liver\n",
      "transplantation is used widely for advanced disease.\n",
      "\n",
      "google/pegasus-large (41 tok):\n",
      "R1\tp: 21.88 \tr: 28.00 \tf: 24.56\n",
      "R2\tp: 3.23 \tr: 4.17 \tf: 3.64\n",
      "RL\tp: 15.62 \tr: 20.00 \tf: 17.54\n",
      "ST\t67.31\t\tW2V\t42.75\n",
      "\n",
      "Screening for malignant transformation is not effective in detecting early disease, and progression\n",
      "to cholangiocarcinoma is generally regarded as a contraindication to liver transplantation. Liver\n",
      "transplantation is used widely for advanced disease.\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (18 tok):\n",
      "R1\tp: 25.00 \tr: 12.00 \tf: 16.22\n",
      "R2\tp: 9.09 \tr: 4.17 \tf: 5.71\n",
      "RL\tp: 25.00 \tr: 12.00 \tf: 16.22\n",
      "ST\t51.65\t\tW2V\t12.67\n",
      "\n",
      "The results of liver transplantation are excellent in the absence of cholangiocarcinoma.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (29 tok):\n",
      "R1\tp: 33.33 \tr: 28.00 \tf: 30.43\n",
      "R2\tp: 5.00 \tr: 4.17 \tf: 4.55\n",
      "RL\tp: 23.81 \tr: 20.00 \tf: 21.74\n",
      "ST\t64.82\t\tW2V\t34.80\n",
      "\n",
      "Screening for malignant transformation is not effective in detecting early disease, and progression\n",
      "to cholangiocarcinoma is a contraindication to liver transplantation.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (30 tok):\n",
      "R1\tp: 31.82 \tr: 28.00 \tf: 29.79\n",
      "R2\tp: 4.76 \tr: 4.17 \tf: 4.44\n",
      "RL\tp: 22.73 \tr: 20.00 \tf: 21.28\n",
      "ST\t65.83\t\tW2V\t27.85\n",
      "\n",
      "Screening for malignant transformation is not effective in detecting early disease, and progression\n",
      "to cholangiocarcinoma may be a contraindication to liver transplantation.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (13 tok):\n",
      "R1\tp: 16.67 \tr: 8.00 \tf: 10.81\n",
      "R2\tp: 9.09 \tr: 4.17 \tf: 5.71\n",
      "RL\tp: 16.67 \tr: 8.00 \tf: 10.81\n",
      "ST\t41.04\t\tW2V\t9.73\n",
      "\n",
      "The results of liver transplantation are excellent in the absence of PSC.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781910797426, 'ch03')\n",
      "Etiology and pathogenesis. Chronic gallbladder inflammation is attributed as an etiologic factor in\n",
      "gallbladder cancer along with molecular alterations in p53 and K-ras. Inflammation may occur as a\n",
      "result of gallstones, gallbladder polyps, chronic Salmonella infection, congenital biliary cysts,\n",
      "abnormal pancreaticobiliary duct junction, carcinogen exposure and certain drugs. There are\n",
      "molecular differences between gallbladder cancers associated with gallstones and those with an\n",
      "abnormal pancreaticobiliary junction. Epidemiology and risk factors. Gallbladder carcinoma is the\n",
      "fifth most common gastrointestinal (GI) cancer in the USA and is the most common GI cancer in Native\n",
      "Americans. Incidence and mortality are very high in certain Latin American countries, especially\n",
      "Chile. Risk factors for gallbladder cancer are outlined in Table 3.3. The majority of gallbladder\n",
      "cancers are adenocarcinomas.\n",
      "\n",
      "Reference:\n",
      "Gallbladder cancer is the most common gastrointestinal cancer in Native Americans in the USA and\n",
      "also has a very high incidence in certain Latin American countries, particularly Chile.\n",
      "\n",
      "google/pegasus-large (35 tok):\n",
      "R1\tp: 16.00 \tr: 14.29 \tf: 15.09\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 12.00 \tr: 10.71 \tf: 11.32\n",
      "ST\t42.33\t\tW2V\t0.74\n",
      "\n",
      "Inflammation may occur as a result of gallstones, gallbladder polyps, chronic Salmonella infection,\n",
      "congenital biliary cysts, abnormal pancreaticobiliary duct junction, carcinogen exposure and certain\n",
      "drugs.\n",
      "\n",
      "google/pegasus-large (21 tok):\n",
      "R1\tp: 11.76 \tr: 7.14 \tf: 8.89\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 11.76 \tr: 7.14 \tf: 8.89\n",
      "ST\t50.19\t\tW2V\t-0.29\n",
      "\n",
      "There are molecular differences between gallbladder cancers associated with gallstones and those\n",
      "with an abnormal pancreaticobiliary junction.\n",
      "\n",
      "google/pegasus-large (35 tok):\n",
      "R1\tp: 16.00 \tr: 14.29 \tf: 15.09\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 12.00 \tr: 10.71 \tf: 11.32\n",
      "ST\t42.59\t\tW2V\t0.74\n",
      "\n",
      "Inflammation may occur as a result of gallstones, gallbladder polyps, chronic Salmonella infection,\n",
      "congenital biliary cysts, abnormal pancreasobiliary duct junction, carcinogen exposure and certain\n",
      "drugs.\n",
      "\n",
      "google/pegasus-large (9 tok):\n",
      "R1\tp: 28.57 \tr: 7.14 \tf: 11.43\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 14.29 \tr: 3.57 \tf: 5.71\n",
      "ST\t59.44\t\tW2V\t35.31\n",
      "\n",
      "The majority of gallbladder cancers are adenocarcinomas.\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (28 tok):\n",
      "R1\tp: 65.22 \tr: 53.57 \tf: 58.82\n",
      "R2\tp: 54.55 \tr: 44.44 \tf: 48.98\n",
      "RL\tp: 56.52 \tr: 46.43 \tf: 50.98\n",
      "ST\t82.05\t\tW2V\t80.13\n",
      "\n",
      "Gallbladder cancer is the fifth most common gastrointestinal (GI) cancer in the USA and is the most\n",
      "common GI cancer in Native Americans.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (28 tok):\n",
      "R1\tp: 65.22 \tr: 53.57 \tf: 58.82\n",
      "R2\tp: 45.45 \tr: 37.04 \tf: 40.82\n",
      "RL\tp: 52.17 \tr: 42.86 \tf: 47.06\n",
      "ST\t78.45\t\tW2V\t78.88\n",
      "\n",
      "Gallbladder carcinoma is the fifth most common gastrointestinal (GI) cancer in the USA and is the\n",
      "most common GI cancer in Native Americans.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (27 tok):\n",
      "R1\tp: 68.18 \tr: 53.57 \tf: 60.00\n",
      "R2\tp: 57.14 \tr: 44.44 \tf: 50.00\n",
      "RL\tp: 59.09 \tr: 46.43 \tf: 52.00\n",
      "ST\t82.14\t\tW2V\t79.41\n",
      "\n",
      "Gallbladder cancer is the fifth most common gastrointestinal (GI) cancer in the USA and the most\n",
      "common GI cancer in Native Americans.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (27 tok):\n",
      "R1\tp: 68.18 \tr: 53.57 \tf: 60.00\n",
      "R2\tp: 47.62 \tr: 37.04 \tf: 41.67\n",
      "RL\tp: 54.55 \tr: 42.86 \tf: 48.00\n",
      "ST\t78.65\t\tW2V\t77.97\n",
      "\n",
      "Gallbladder carcinoma is the fifth most common gastrointestinal (GI) cancer in the USA and the most\n",
      "common GI cancer in Native Americans.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n",
      "(9781910797495, 'chp12')\n",
      "Acute headache. The immediate, important first step in assessing a new headache is determining\n",
      "whether the headache is a serious, potentially life-threatening medical event requiring emergency\n",
      "evaluation and management. All the possibilities highlighted in Table 12.1 must be entertained and\n",
      "discarded before considering the headache to be caused by a chronic headache condition. Brain\n",
      "imaging, including neurovascular studies, may be needed as well as cerebrospinal fluid (CSF)\n",
      "pressure measurement and analysis and further evaluation by a neurologist. Chronic headache.\n",
      "Assessment. As with all chronic pain, headache must be assessed systematically and classified\n",
      "according to its likely origin as well as its temporal pattern, aggravating and ameliorating factors\n",
      "and perpetuating factors and comorbidities. The headache diagnoses in Table 12.2 should be\n",
      "considered.\n",
      "\n",
      "Reference:\n",
      "In patients without history of chronic headaches, determine whether an acute new headache is a\n",
      "serious, potentially life-threatening condition.\n",
      "\n",
      "google/pegasus-large (25 tok):\n",
      "R1\tp: 20.00 \tr: 25.00 \tf: 22.22\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 16.00 \tr: 20.00 \tf: 17.78\n",
      "ST\t46.98\t\tW2V\t13.62\n",
      "\n",
      "All the possibilities highlighted in Table 12.1 must be entertained and discarded before considering\n",
      "the headache to be caused by a chronic headache condition.\n",
      "\n",
      "google/pegasus-large (35 tok):\n",
      "R1\tp: 14.29 \tr: 25.00 \tf: 18.18\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 11.43 \tr: 20.00 \tf: 14.55\n",
      "ST\t45.12\t\tW2V\t9.68\n",
      "\n",
      "All the possibilities highlighted in Table 12.1 must be entertained and discarded before considering\n",
      "the headache to be caused by a chronic headache condition. The headache diagnoses in Table 12.2\n",
      "should be considered.\n",
      "\n",
      "google/pegasus-large (35 tok):\n",
      "R1\tp: 17.14 \tr: 30.00 \tf: 21.82\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 11.43 \tr: 20.00 \tf: 14.55\n",
      "ST\t45.62\t\tW2V\t11.31\n",
      "\n",
      "All the possibilities highlighted in Table 12.1 must be entertained and discarded before considering\n",
      "the headache to be caused by a chronic headache condition. The headaches diagnoses in Table 12.2\n",
      "should be considered.\n",
      "\n",
      "google/pegasus-large (10 tok):\n",
      "R1\tp: 20.00 \tr: 10.00 \tf: 13.33\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 10.00 \tr: 5.00 \tf: 6.67\n",
      "ST\t42.03\t\tW2V\t-1.19\n",
      "\n",
      "The headache diagnoses in Table 12.2 should be considered.\n",
      "\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (32 tok):\n",
      "R1\tp: 35.71 \tr: 50.00 \tf: 41.67\n",
      "R2\tp: 25.93 \tr: 36.84 \tf: 30.43\n",
      "RL\tp: 32.14 \tr: 45.00 \tf: 37.50\n",
      "ST\t77.72\t\tW2V\t35.03\n",
      "\n",
      "The immediate, important first step in assessing a new headache is determining whether the headache\n",
      "is a serious, potentially life-threatening medical event requiring emergency evaluation and\n",
      "management.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (25 tok):\n",
      "R1\tp: 20.00 \tr: 25.00 \tf: 22.22\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 16.00 \tr: 20.00 \tf: 17.78\n",
      "ST\t46.98\t\tW2V\t13.62\n",
      "\n",
      "All the possibilities highlighted in Table 12.1 must be entertained and discarded before considering\n",
      "the headache to be caused by a chronic headache condition.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (24 tok):\n",
      "R1\tp: 20.83 \tr: 25.00 \tf: 22.73\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 16.67 \tr: 20.00 \tf: 18.18\n",
      "ST\t45.88\t\tW2V\t16.06\n",
      "\n",
      "All possibilities highlighted in Table 12.1 must be entertained and discarded before considering the\n",
      "headache to be caused by a chronic headache condition.\n",
      "\n",
      "/home/ubuntu/s3/fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/ (23 tok):\n",
      "R1\tp: 22.73 \tr: 25.00 \tf: 23.81\n",
      "R2\tp: 0.00 \tr: 0.00 \tf: 0.00\n",
      "RL\tp: 18.18 \tr: 20.00 \tf: 19.05\n",
      "ST\t65.17\t\tW2V\t14.99\n",
      "\n",
      "All possible causes of headache must be entertained and discarded before considering the headache to\n",
      "be caused by a chronic headache condition.\n",
      "\n",
      "\n",
      "####################################################################################################\n",
      "\n"
     ]
    }
   ],
   "source": [
    "print_examples([\n",
    "    'google/pegasus-large',\n",
    "    bucket_dir+'fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/'],\n",
    "    df_test)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "heading_collapsed": true,
    "id": "bKYnUXhvMszX"
   },
   "source": [
    "#### Summarize Test"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {
    "executionInfo": {
     "elapsed": 771,
     "status": "ok",
     "timestamp": 1610617165073,
     "user": {
      "displayName": "Marco Pietro Abrate",
      "photoUrl": "https://lh3.googleusercontent.com/a-/AOh14Gjh-8YF-8BlnrkN9mLZ0xfVOWfOh7kYncpYRv-Y=s64",
      "userId": "15422244832836998434"
     },
     "user_tz": -60
    },
    "hidden": true,
    "id": "t3EV4tDfQ1hM"
   },
   "outputs": [],
   "source": [
    "def summarize(model_name_or_path, df, batch_size):\n",
    "    model, tokenizer = import_model_tok(model_name_or_path)\n",
    "    model = model.to(device)\n",
    "\n",
    "    input_ids = tokenizer(df.text.tolist(), return_tensors='pt', padding=True).input_ids\n",
    "    input_ids = input_ids.split(batch_size)\n",
    "\n",
    "    summs = []\n",
    "\n",
    "    pbar = tqdm(total=len(input_ids), \n",
    "                position=0,\n",
    "                leave=True,\n",
    "                file=sys.stdout)\n",
    "    for batch in input_ids:\n",
    "\n",
    "        summ_enc = model.generate(\n",
    "            batch.to(device),\n",
    "            min_length = config.ONE_BULLET_MIN_LEN,\n",
    "            max_length = config.ONE_BULLET_MAX_LEN,\n",
    "            length_penalty = config.LENGTH_PENALTY,\n",
    "            num_beams = config.NUM_BEAMS,\n",
    "            no_repeat_ngram_size = config.NO_REPEAT_NGRAM_SIZE,\n",
    "            early_stopping = True)\n",
    "        summ = tokenizer.batch_decode(summ_enc, skip_special_tokens=True)\n",
    "        summs += summ\n",
    "\n",
    "        pbar.update(1)\n",
    "    pbar.close()\n",
    "\n",
    "    df['summary'] = summs\n",
    "    \n",
    "    df.to_csv(OUTPUT_PATH+model_name_or_path.replace('/', '?')+'.csv')\n",
    "    \n",
    "    return df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/"
    },
    "executionInfo": {
     "elapsed": 89831,
     "status": "ok",
     "timestamp": 1610617255307,
     "user": {
      "displayName": "Marco Pietro Abrate",
      "photoUrl": "https://lh3.googleusercontent.com/a-/AOh14Gjh-8YF-8BlnrkN9mLZ0xfVOWfOh7kYncpYRv-Y=s64",
      "userId": "15422244832836998434"
     },
     "user_tz": -60
    },
    "hidden": true,
    "id": "xQ0KCVkXMszZ",
    "outputId": "d55a74ed-6e68-4e49-8577-9e6125282fb5",
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "100%|██████████| 25/25 [02:07<00:00,  5.11s/it]\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th>bullets</th>\n",
       "      <th>text</th>\n",
       "      <th>num_bulls</th>\n",
       "      <th>summary</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>book</th>\n",
       "      <th>chapter</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th rowspan=\"5\" valign=\"top\">9781910797631</th>\n",
       "      <th>chp6</th>\n",
       "      <td>The treatment rather than the prevention of de...</td>\n",
       "      <td>Prevention and management. By far the most res...</td>\n",
       "      <td>2319</td>\n",
       "      <td>Universal programs have also sought to improve...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>chp6</th>\n",
       "      <td>For milder forms of depression, self-help, rel...</td>\n",
       "      <td>The forms of psychological therapy best suppor...</td>\n",
       "      <td>2319</td>\n",
       "      <td>Some complementary treatments may be useful - ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>chp6</th>\n",
       "      <td>There are a range of treatments that may be ef...</td>\n",
       "      <td>The effectiveness of individual treatments is ...</td>\n",
       "      <td>2319</td>\n",
       "      <td>The effectiveness of individual treatments is ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>chp6</th>\n",
       "      <td>Selective serotonin-reuptake inhibitor antidep...</td>\n",
       "      <td>Monitoring use of antidepressants. For people ...</td>\n",
       "      <td>2319</td>\n",
       "      <td>Communication between clinician and patient ab...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>chp6</th>\n",
       "      <td>Depression is complex, and understanding and h...</td>\n",
       "      <td>Suicidal ideas and acts may be increased in th...</td>\n",
       "      <td>2319</td>\n",
       "      <td>Careful consideration of treatment options and...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"5\" valign=\"top\">9781908541680</th>\n",
       "      <th>ch_4</th>\n",
       "      <td>Obesity significantly affects cardiometabolic ...</td>\n",
       "      <td>Overweight/obesity as a whole predisposes to, ...</td>\n",
       "      <td>2556</td>\n",
       "      <td>The major circulatory complications are increa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ch_4</th>\n",
       "      <td>Lipid disorders and hypertension are exacerbat...</td>\n",
       "      <td>Overweight/obesity as a whole predisposes to, ...</td>\n",
       "      <td>2556</td>\n",
       "      <td>The major circulatory complications are increa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ch_4</th>\n",
       "      <td>Weight loss rapidly and effectively reduces ca...</td>\n",
       "      <td>Overweight/obesity as a whole predisposes to, ...</td>\n",
       "      <td>2556</td>\n",
       "      <td>The major circulatory complications are increa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ch_4</th>\n",
       "      <td>The metabolic syndrome defines the clustering ...</td>\n",
       "      <td>'Metabolic syndrome' describes the clustering ...</td>\n",
       "      <td>2556</td>\n",
       "      <td>The International Diabetes Federation (IDF) up...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ch_4</th>\n",
       "      <td>Type 2 diabetes mellitus is the comorbidity mo...</td>\n",
       "      <td>Type 2 diabetes mellitus is a preventable dise...</td>\n",
       "      <td>2556</td>\n",
       "      <td>Management of obese patients at risk of or wit...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>242 rows × 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                 bullets  \\\n",
       "book          chapter                                                      \n",
       "9781910797631 chp6     The treatment rather than the prevention of de...   \n",
       "              chp6     For milder forms of depression, self-help, rel...   \n",
       "              chp6     There are a range of treatments that may be ef...   \n",
       "              chp6     Selective serotonin-reuptake inhibitor antidep...   \n",
       "              chp6     Depression is complex, and understanding and h...   \n",
       "...                                                                  ...   \n",
       "9781908541680 ch_4     Obesity significantly affects cardiometabolic ...   \n",
       "              ch_4     Lipid disorders and hypertension are exacerbat...   \n",
       "              ch_4     Weight loss rapidly and effectively reduces ca...   \n",
       "              ch_4     The metabolic syndrome defines the clustering ...   \n",
       "              ch_4     Type 2 diabetes mellitus is the comorbidity mo...   \n",
       "\n",
       "                                                                    text  \\\n",
       "book          chapter                                                      \n",
       "9781910797631 chp6     Prevention and management. By far the most res...   \n",
       "              chp6     The forms of psychological therapy best suppor...   \n",
       "              chp6     The effectiveness of individual treatments is ...   \n",
       "              chp6     Monitoring use of antidepressants. For people ...   \n",
       "              chp6     Suicidal ideas and acts may be increased in th...   \n",
       "...                                                                  ...   \n",
       "9781908541680 ch_4     Overweight/obesity as a whole predisposes to, ...   \n",
       "              ch_4     Overweight/obesity as a whole predisposes to, ...   \n",
       "              ch_4     Overweight/obesity as a whole predisposes to, ...   \n",
       "              ch_4     'Metabolic syndrome' describes the clustering ...   \n",
       "              ch_4     Type 2 diabetes mellitus is a preventable dise...   \n",
       "\n",
       "                       num_bulls  \\\n",
       "book          chapter              \n",
       "9781910797631 chp6          2319   \n",
       "              chp6          2319   \n",
       "              chp6          2319   \n",
       "              chp6          2319   \n",
       "              chp6          2319   \n",
       "...                          ...   \n",
       "9781908541680 ch_4          2556   \n",
       "              ch_4          2556   \n",
       "              ch_4          2556   \n",
       "              ch_4          2556   \n",
       "              ch_4          2556   \n",
       "\n",
       "                                                                 summary  \n",
       "book          chapter                                                     \n",
       "9781910797631 chp6     Universal programs have also sought to improve...  \n",
       "              chp6     Some complementary treatments may be useful - ...  \n",
       "              chp6     The effectiveness of individual treatments is ...  \n",
       "              chp6     Communication between clinician and patient ab...  \n",
       "              chp6     Careful consideration of treatment options and...  \n",
       "...                                                                  ...  \n",
       "9781908541680 ch_4     The major circulatory complications are increa...  \n",
       "              ch_4     The major circulatory complications are increa...  \n",
       "              ch_4     The major circulatory complications are increa...  \n",
       "              ch_4     The International Diabetes Federation (IDF) up...  \n",
       "              ch_4     Management of obese patients at risk of or wit...  \n",
       "\n",
       "[242 rows x 4 columns]"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "summarize(\n",
    "    'google/pegasus-large', df_test, 10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {
    "hidden": true,
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "100%|██████████| 25/25 [01:24<00:00,  3.37s/it]\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th>bullets</th>\n",
       "      <th>text</th>\n",
       "      <th>num_bulls</th>\n",
       "      <th>summary</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>book</th>\n",
       "      <th>chapter</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th rowspan=\"5\" valign=\"top\">9781910797631</th>\n",
       "      <th>chp6</th>\n",
       "      <td>The treatment rather than the prevention of de...</td>\n",
       "      <td>Prevention and management. By far the most res...</td>\n",
       "      <td>2319</td>\n",
       "      <td>The treatment of depression is the focus of mo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>chp6</th>\n",
       "      <td>For milder forms of depression, self-help, rel...</td>\n",
       "      <td>The forms of psychological therapy best suppor...</td>\n",
       "      <td>2319</td>\n",
       "      <td>Cognitive behavioral therapy (CBT), behavioral...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>chp6</th>\n",
       "      <td>There are a range of treatments that may be ef...</td>\n",
       "      <td>The effectiveness of individual treatments is ...</td>\n",
       "      <td>2319</td>\n",
       "      <td>Stepped care is a model of healthcare based on...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>chp6</th>\n",
       "      <td>Selective serotonin-reuptake inhibitor antidep...</td>\n",
       "      <td>Monitoring use of antidepressants. For people ...</td>\n",
       "      <td>2319</td>\n",
       "      <td>For people whose symptoms respond poorly to an...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>chp6</th>\n",
       "      <td>Depression is complex, and understanding and h...</td>\n",
       "      <td>Suicidal ideas and acts may be increased in th...</td>\n",
       "      <td>2319</td>\n",
       "      <td>Careful consideration of treatment options and...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"5\" valign=\"top\">9781908541680</th>\n",
       "      <th>ch_4</th>\n",
       "      <td>Obesity significantly affects cardiometabolic ...</td>\n",
       "      <td>Overweight/obesity as a whole predisposes to, ...</td>\n",
       "      <td>2556</td>\n",
       "      <td>Overweight/obesity as a whole predisposes to n...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ch_4</th>\n",
       "      <td>Lipid disorders and hypertension are exacerbat...</td>\n",
       "      <td>Overweight/obesity as a whole predisposes to, ...</td>\n",
       "      <td>2556</td>\n",
       "      <td>Overweight/obesity as a whole predisposes to n...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ch_4</th>\n",
       "      <td>Weight loss rapidly and effectively reduces ca...</td>\n",
       "      <td>Overweight/obesity as a whole predisposes to, ...</td>\n",
       "      <td>2556</td>\n",
       "      <td>Overweight/obesity as a whole predisposes to n...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ch_4</th>\n",
       "      <td>The metabolic syndrome defines the clustering ...</td>\n",
       "      <td>'Metabolic syndrome' describes the clustering ...</td>\n",
       "      <td>2556</td>\n",
       "      <td>'Metabolic syndrome' describes the clustering ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ch_4</th>\n",
       "      <td>Type 2 diabetes mellitus is the comorbidity mo...</td>\n",
       "      <td>Type 2 diabetes mellitus is a preventable dise...</td>\n",
       "      <td>2556</td>\n",
       "      <td>Aggressive early management confers the best c...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>242 rows × 4 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                 bullets  \\\n",
       "book          chapter                                                      \n",
       "9781910797631 chp6     The treatment rather than the prevention of de...   \n",
       "              chp6     For milder forms of depression, self-help, rel...   \n",
       "              chp6     There are a range of treatments that may be ef...   \n",
       "              chp6     Selective serotonin-reuptake inhibitor antidep...   \n",
       "              chp6     Depression is complex, and understanding and h...   \n",
       "...                                                                  ...   \n",
       "9781908541680 ch_4     Obesity significantly affects cardiometabolic ...   \n",
       "              ch_4     Lipid disorders and hypertension are exacerbat...   \n",
       "              ch_4     Weight loss rapidly and effectively reduces ca...   \n",
       "              ch_4     The metabolic syndrome defines the clustering ...   \n",
       "              ch_4     Type 2 diabetes mellitus is the comorbidity mo...   \n",
       "\n",
       "                                                                    text  \\\n",
       "book          chapter                                                      \n",
       "9781910797631 chp6     Prevention and management. By far the most res...   \n",
       "              chp6     The forms of psychological therapy best suppor...   \n",
       "              chp6     The effectiveness of individual treatments is ...   \n",
       "              chp6     Monitoring use of antidepressants. For people ...   \n",
       "              chp6     Suicidal ideas and acts may be increased in th...   \n",
       "...                                                                  ...   \n",
       "9781908541680 ch_4     Overweight/obesity as a whole predisposes to, ...   \n",
       "              ch_4     Overweight/obesity as a whole predisposes to, ...   \n",
       "              ch_4     Overweight/obesity as a whole predisposes to, ...   \n",
       "              ch_4     'Metabolic syndrome' describes the clustering ...   \n",
       "              ch_4     Type 2 diabetes mellitus is a preventable dise...   \n",
       "\n",
       "                       num_bulls  \\\n",
       "book          chapter              \n",
       "9781910797631 chp6          2319   \n",
       "              chp6          2319   \n",
       "              chp6          2319   \n",
       "              chp6          2319   \n",
       "              chp6          2319   \n",
       "...                          ...   \n",
       "9781908541680 ch_4          2556   \n",
       "              ch_4          2556   \n",
       "              ch_4          2556   \n",
       "              ch_4          2556   \n",
       "              ch_4          2556   \n",
       "\n",
       "                                                                 summary  \n",
       "book          chapter                                                     \n",
       "9781910797631 chp6     The treatment of depression is the focus of mo...  \n",
       "              chp6     Cognitive behavioral therapy (CBT), behavioral...  \n",
       "              chp6     Stepped care is a model of healthcare based on...  \n",
       "              chp6     For people whose symptoms respond poorly to an...  \n",
       "              chp6     Careful consideration of treatment options and...  \n",
       "...                                                                  ...  \n",
       "9781908541680 ch_4     Overweight/obesity as a whole predisposes to n...  \n",
       "              ch_4     Overweight/obesity as a whole predisposes to n...  \n",
       "              ch_4     Overweight/obesity as a whole predisposes to n...  \n",
       "              ch_4     'Metabolic syndrome' describes the clustering ...  \n",
       "              ch_4     Aggressive early management confers the best c...  \n",
       "\n",
       "[242 rows x 4 columns]"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "summarize(\n",
    "    bucket_dir+'fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/',\n",
    "    df_test, 10)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "xoxYNE9nOSYL"
   },
   "source": [
    "### **Evaluation**"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "mIcAg1ss4qIR"
   },
   "source": [
    "#### Evaluate summaries bullet by bullet"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [],
   "source": [
    "def evaluate_model_bullet_by_bullet(model_name_or_path):\n",
    "    df_eval = pd.read_csv(OUTPUT_PATH+model_name_or_path.replace('/', '?')+\\\n",
    "        '.csv').set_index(['book', 'chapter'])\n",
    "    \n",
    "    rouge_res =\\\n",
    "        df_eval[['bullets', 'summary']]\\\n",
    "        .apply(lambda row:\n",
    "        metric.compute(\n",
    "            predictions = [row[1]],\n",
    "            references = [row[0]],\n",
    "            rouge_types = config.ROUGE_TYPES,\n",
    "            use_agregator = False), axis=1)\n",
    "    for r in config.ROUGE_TYPES:\n",
    "        for i, prf in enumerate(['precision', 'recall', 'fmeasure']):\n",
    "            df_eval[r+'_'+prf] =\\\n",
    "                rouge_res.map(lambda score: 100*score[r][0][i])\n",
    "    \n",
    "    cosine_sim = lambda a, b: (np.dot(a, b) / (np.linalg.norm(a)*np.linalg.norm(b)))\n",
    "    df_eval['st_cosine_sim'] =\\\n",
    "        df_eval[['bullets', 'summary']]\\\n",
    "        .apply(lambda row:\n",
    "        100*cosine_sim(\n",
    "            sentence_distilroberta.encode(row[1]),\n",
    "            sentence_distilroberta.encode(row[0])), axis=1)\n",
    "    \n",
    "    def cosine_sim_w2v(s, b):\n",
    "        s = gensim.utils.simple_preprocess(s, deacc=True)\n",
    "        b = gensim.utils.simple_preprocess(b, deacc=True)\n",
    "        corpus = [s, b]\n",
    "        w2v = gensim.models.Word2Vec(\n",
    "            corpus,\n",
    "            min_count=1,\n",
    "            sg=1,\n",
    "            seed = config.SEED)\n",
    "        s_embed = np.mean([w2v.wv[word] for word in s], axis=0)\n",
    "        b_embed = np.mean([w2v.wv[word] for word in b], axis=0)\n",
    "        return cosine_sim(s_embed, b_embed)\n",
    "        \n",
    "    df_eval['w2v_cosine_sim'] =\\\n",
    "        df_eval[['bullets', 'summary']]\\\n",
    "        .apply(lambda row:\n",
    "        100*cosine_sim_w2v(row[1], row[0]), axis=1)\n",
    "            \n",
    "    df_eval.to_csv(OUTPUT_PATH+model_name_or_path.replace('/', '?')+'_bullet_by_bullet.csv')\n",
    "    \n",
    "    return df_eval"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {
    "executionInfo": {
     "elapsed": 2058,
     "status": "ok",
     "timestamp": 1610618121921,
     "user": {
      "displayName": "Marco Pietro Abrate",
      "photoUrl": "https://lh3.googleusercontent.com/a-/AOh14Gjh-8YF-8BlnrkN9mLZ0xfVOWfOh7kYncpYRv-Y=s64",
      "userId": "15422244832836998434"
     },
     "user_tz": -60
    },
    "id": "mCx3f697SXPm",
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th>bullets</th>\n",
       "      <th>text</th>\n",
       "      <th>num_bulls</th>\n",
       "      <th>summary</th>\n",
       "      <th>rouge1_precision</th>\n",
       "      <th>rouge1_recall</th>\n",
       "      <th>rouge1_fmeasure</th>\n",
       "      <th>rouge2_precision</th>\n",
       "      <th>rouge2_recall</th>\n",
       "      <th>rouge2_fmeasure</th>\n",
       "      <th>rougeL_precision</th>\n",
       "      <th>rougeL_recall</th>\n",
       "      <th>rougeL_fmeasure</th>\n",
       "      <th>st_cosine_sim</th>\n",
       "      <th>w2v_cosine_sim</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>book</th>\n",
       "      <th>chapter</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th rowspan=\"5\" valign=\"top\">9781910797631</th>\n",
       "      <th>chp6</th>\n",
       "      <td>The treatment rather than the prevention of de...</td>\n",
       "      <td>Prevention and management. By far the most res...</td>\n",
       "      <td>2319</td>\n",
       "      <td>The treatment of depression is the focus of mo...</td>\n",
       "      <td>31.666667</td>\n",
       "      <td>45.238095</td>\n",
       "      <td>37.254902</td>\n",
       "      <td>5.084746</td>\n",
       "      <td>7.317073</td>\n",
       "      <td>6.000000</td>\n",
       "      <td>18.333333</td>\n",
       "      <td>26.190476</td>\n",
       "      <td>21.568627</td>\n",
       "      <td>74.718189</td>\n",
       "      <td>56.480813</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>chp6</th>\n",
       "      <td>For milder forms of depression, self-help, rel...</td>\n",
       "      <td>The forms of psychological therapy best suppor...</td>\n",
       "      <td>2319</td>\n",
       "      <td>Cognitive behavioral therapy (CBT), behavioral...</td>\n",
       "      <td>34.285714</td>\n",
       "      <td>25.000000</td>\n",
       "      <td>28.915663</td>\n",
       "      <td>5.882353</td>\n",
       "      <td>4.255319</td>\n",
       "      <td>4.938272</td>\n",
       "      <td>22.857143</td>\n",
       "      <td>16.666667</td>\n",
       "      <td>19.277108</td>\n",
       "      <td>59.411645</td>\n",
       "      <td>49.238643</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>chp6</th>\n",
       "      <td>There are a range of treatments that may be ef...</td>\n",
       "      <td>The effectiveness of individual treatments is ...</td>\n",
       "      <td>2319</td>\n",
       "      <td>Stepped care is a model of healthcare based on...</td>\n",
       "      <td>46.428571</td>\n",
       "      <td>40.625000</td>\n",
       "      <td>43.333333</td>\n",
       "      <td>18.518519</td>\n",
       "      <td>16.129032</td>\n",
       "      <td>17.241379</td>\n",
       "      <td>25.000000</td>\n",
       "      <td>21.875000</td>\n",
       "      <td>23.333333</td>\n",
       "      <td>59.683144</td>\n",
       "      <td>47.046337</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>chp6</th>\n",
       "      <td>Selective serotonin-reuptake inhibitor antidep...</td>\n",
       "      <td>Monitoring use of antidepressants. For people ...</td>\n",
       "      <td>2319</td>\n",
       "      <td>For people whose symptoms respond poorly to an...</td>\n",
       "      <td>17.647059</td>\n",
       "      <td>12.000000</td>\n",
       "      <td>14.285714</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>17.647059</td>\n",
       "      <td>12.000000</td>\n",
       "      <td>14.285714</td>\n",
       "      <td>63.006651</td>\n",
       "      <td>14.004882</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>chp6</th>\n",
       "      <td>Depression is complex, and understanding and h...</td>\n",
       "      <td>Suicidal ideas and acts may be increased in th...</td>\n",
       "      <td>2319</td>\n",
       "      <td>Careful consideration of treatment options and...</td>\n",
       "      <td>18.750000</td>\n",
       "      <td>12.000000</td>\n",
       "      <td>14.634146</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>12.500000</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>9.756098</td>\n",
       "      <td>41.225263</td>\n",
       "      <td>20.472382</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"5\" valign=\"top\">9781908541680</th>\n",
       "      <th>ch_4</th>\n",
       "      <td>Obesity significantly affects cardiometabolic ...</td>\n",
       "      <td>Overweight/obesity as a whole predisposes to, ...</td>\n",
       "      <td>2556</td>\n",
       "      <td>Overweight/obesity as a whole predisposes to n...</td>\n",
       "      <td>5.263158</td>\n",
       "      <td>28.571429</td>\n",
       "      <td>8.888889</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>5.263158</td>\n",
       "      <td>28.571429</td>\n",
       "      <td>8.888889</td>\n",
       "      <td>56.471467</td>\n",
       "      <td>6.213561</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ch_4</th>\n",
       "      <td>Lipid disorders and hypertension are exacerbat...</td>\n",
       "      <td>Overweight/obesity as a whole predisposes to, ...</td>\n",
       "      <td>2556</td>\n",
       "      <td>Overweight/obesity as a whole predisposes to n...</td>\n",
       "      <td>10.526316</td>\n",
       "      <td>30.769231</td>\n",
       "      <td>15.686275</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>5.263158</td>\n",
       "      <td>15.384615</td>\n",
       "      <td>7.843137</td>\n",
       "      <td>63.739228</td>\n",
       "      <td>19.027236</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ch_4</th>\n",
       "      <td>Weight loss rapidly and effectively reduces ca...</td>\n",
       "      <td>Overweight/obesity as a whole predisposes to, ...</td>\n",
       "      <td>2556</td>\n",
       "      <td>Overweight/obesity as a whole predisposes to n...</td>\n",
       "      <td>15.789474</td>\n",
       "      <td>33.333333</td>\n",
       "      <td>21.428571</td>\n",
       "      <td>2.702703</td>\n",
       "      <td>5.882353</td>\n",
       "      <td>3.703704</td>\n",
       "      <td>10.526316</td>\n",
       "      <td>22.222222</td>\n",
       "      <td>14.285714</td>\n",
       "      <td>57.366836</td>\n",
       "      <td>19.447146</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ch_4</th>\n",
       "      <td>The metabolic syndrome defines the clustering ...</td>\n",
       "      <td>'Metabolic syndrome' describes the clustering ...</td>\n",
       "      <td>2556</td>\n",
       "      <td>'Metabolic syndrome' describes the clustering ...</td>\n",
       "      <td>40.909091</td>\n",
       "      <td>60.000000</td>\n",
       "      <td>48.648649</td>\n",
       "      <td>19.047619</td>\n",
       "      <td>28.571429</td>\n",
       "      <td>22.857143</td>\n",
       "      <td>36.363636</td>\n",
       "      <td>53.333333</td>\n",
       "      <td>43.243243</td>\n",
       "      <td>81.833279</td>\n",
       "      <td>42.788023</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ch_4</th>\n",
       "      <td>Type 2 diabetes mellitus is the comorbidity mo...</td>\n",
       "      <td>Type 2 diabetes mellitus is a preventable dise...</td>\n",
       "      <td>2556</td>\n",
       "      <td>Aggressive early management confers the best c...</td>\n",
       "      <td>17.857143</td>\n",
       "      <td>17.241379</td>\n",
       "      <td>17.543860</td>\n",
       "      <td>3.703704</td>\n",
       "      <td>3.571429</td>\n",
       "      <td>3.636364</td>\n",
       "      <td>14.285714</td>\n",
       "      <td>13.793103</td>\n",
       "      <td>14.035088</td>\n",
       "      <td>46.131501</td>\n",
       "      <td>19.523028</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>242 rows × 15 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                 bullets  \\\n",
       "book          chapter                                                      \n",
       "9781910797631 chp6     The treatment rather than the prevention of de...   \n",
       "              chp6     For milder forms of depression, self-help, rel...   \n",
       "              chp6     There are a range of treatments that may be ef...   \n",
       "              chp6     Selective serotonin-reuptake inhibitor antidep...   \n",
       "              chp6     Depression is complex, and understanding and h...   \n",
       "...                                                                  ...   \n",
       "9781908541680 ch_4     Obesity significantly affects cardiometabolic ...   \n",
       "              ch_4     Lipid disorders and hypertension are exacerbat...   \n",
       "              ch_4     Weight loss rapidly and effectively reduces ca...   \n",
       "              ch_4     The metabolic syndrome defines the clustering ...   \n",
       "              ch_4     Type 2 diabetes mellitus is the comorbidity mo...   \n",
       "\n",
       "                                                                    text  \\\n",
       "book          chapter                                                      \n",
       "9781910797631 chp6     Prevention and management. By far the most res...   \n",
       "              chp6     The forms of psychological therapy best suppor...   \n",
       "              chp6     The effectiveness of individual treatments is ...   \n",
       "              chp6     Monitoring use of antidepressants. For people ...   \n",
       "              chp6     Suicidal ideas and acts may be increased in th...   \n",
       "...                                                                  ...   \n",
       "9781908541680 ch_4     Overweight/obesity as a whole predisposes to, ...   \n",
       "              ch_4     Overweight/obesity as a whole predisposes to, ...   \n",
       "              ch_4     Overweight/obesity as a whole predisposes to, ...   \n",
       "              ch_4     'Metabolic syndrome' describes the clustering ...   \n",
       "              ch_4     Type 2 diabetes mellitus is a preventable dise...   \n",
       "\n",
       "                       num_bulls  \\\n",
       "book          chapter              \n",
       "9781910797631 chp6          2319   \n",
       "              chp6          2319   \n",
       "              chp6          2319   \n",
       "              chp6          2319   \n",
       "              chp6          2319   \n",
       "...                          ...   \n",
       "9781908541680 ch_4          2556   \n",
       "              ch_4          2556   \n",
       "              ch_4          2556   \n",
       "              ch_4          2556   \n",
       "              ch_4          2556   \n",
       "\n",
       "                                                                 summary  \\\n",
       "book          chapter                                                      \n",
       "9781910797631 chp6     The treatment of depression is the focus of mo...   \n",
       "              chp6     Cognitive behavioral therapy (CBT), behavioral...   \n",
       "              chp6     Stepped care is a model of healthcare based on...   \n",
       "              chp6     For people whose symptoms respond poorly to an...   \n",
       "              chp6     Careful consideration of treatment options and...   \n",
       "...                                                                  ...   \n",
       "9781908541680 ch_4     Overweight/obesity as a whole predisposes to n...   \n",
       "              ch_4     Overweight/obesity as a whole predisposes to n...   \n",
       "              ch_4     Overweight/obesity as a whole predisposes to n...   \n",
       "              ch_4     'Metabolic syndrome' describes the clustering ...   \n",
       "              ch_4     Aggressive early management confers the best c...   \n",
       "\n",
       "                       rouge1_precision  rouge1_recall  rouge1_fmeasure  \\\n",
       "book          chapter                                                     \n",
       "9781910797631 chp6            31.666667      45.238095        37.254902   \n",
       "              chp6            34.285714      25.000000        28.915663   \n",
       "              chp6            46.428571      40.625000        43.333333   \n",
       "              chp6            17.647059      12.000000        14.285714   \n",
       "              chp6            18.750000      12.000000        14.634146   \n",
       "...                                 ...            ...              ...   \n",
       "9781908541680 ch_4             5.263158      28.571429         8.888889   \n",
       "              ch_4            10.526316      30.769231        15.686275   \n",
       "              ch_4            15.789474      33.333333        21.428571   \n",
       "              ch_4            40.909091      60.000000        48.648649   \n",
       "              ch_4            17.857143      17.241379        17.543860   \n",
       "\n",
       "                       rouge2_precision  rouge2_recall  rouge2_fmeasure  \\\n",
       "book          chapter                                                     \n",
       "9781910797631 chp6             5.084746       7.317073         6.000000   \n",
       "              chp6             5.882353       4.255319         4.938272   \n",
       "              chp6            18.518519      16.129032        17.241379   \n",
       "              chp6             0.000000       0.000000         0.000000   \n",
       "              chp6             0.000000       0.000000         0.000000   \n",
       "...                                 ...            ...              ...   \n",
       "9781908541680 ch_4             0.000000       0.000000         0.000000   \n",
       "              ch_4             0.000000       0.000000         0.000000   \n",
       "              ch_4             2.702703       5.882353         3.703704   \n",
       "              ch_4            19.047619      28.571429        22.857143   \n",
       "              ch_4             3.703704       3.571429         3.636364   \n",
       "\n",
       "                       rougeL_precision  rougeL_recall  rougeL_fmeasure  \\\n",
       "book          chapter                                                     \n",
       "9781910797631 chp6            18.333333      26.190476        21.568627   \n",
       "              chp6            22.857143      16.666667        19.277108   \n",
       "              chp6            25.000000      21.875000        23.333333   \n",
       "              chp6            17.647059      12.000000        14.285714   \n",
       "              chp6            12.500000       8.000000         9.756098   \n",
       "...                                 ...            ...              ...   \n",
       "9781908541680 ch_4             5.263158      28.571429         8.888889   \n",
       "              ch_4             5.263158      15.384615         7.843137   \n",
       "              ch_4            10.526316      22.222222        14.285714   \n",
       "              ch_4            36.363636      53.333333        43.243243   \n",
       "              ch_4            14.285714      13.793103        14.035088   \n",
       "\n",
       "                       st_cosine_sim  w2v_cosine_sim  \n",
       "book          chapter                                 \n",
       "9781910797631 chp6         74.718189       56.480813  \n",
       "              chp6         59.411645       49.238643  \n",
       "              chp6         59.683144       47.046337  \n",
       "              chp6         63.006651       14.004882  \n",
       "              chp6         41.225263       20.472382  \n",
       "...                              ...             ...  \n",
       "9781908541680 ch_4         56.471467        6.213561  \n",
       "              ch_4         63.739228       19.027236  \n",
       "              ch_4         57.366836       19.447146  \n",
       "              ch_4         81.833279       42.788023  \n",
       "              ch_4         46.131501       19.523028  \n",
       "\n",
       "[242 rows x 15 columns]"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "evaluate_model_bullet_by_bullet('google/pegasus-large')\n",
    "\n",
    "evaluate_model_bullet_by_bullet(\n",
    "    bucket_dir+'fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Evaluate summaries grouping bullets"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {
    "executionInfo": {
     "elapsed": 1296,
     "status": "ok",
     "timestamp": 1610618120072,
     "user": {
      "displayName": "Marco Pietro Abrate",
      "photoUrl": "https://lh3.googleusercontent.com/a-/AOh14Gjh-8YF-8BlnrkN9mLZ0xfVOWfOh7kYncpYRv-Y=s64",
      "userId": "15422244832836998434"
     },
     "user_tz": -60
    },
    "id": "NN-p4XvvxPLi"
   },
   "outputs": [],
   "source": [
    "def evaluate_model_grouping_bullets(model_name_or_path):\n",
    "    df_eval = pd.read_csv(OUTPUT_PATH+model_name_or_path.replace('/', '?')+\\\n",
    "        '.csv').set_index(['book', 'chapter'])\n",
    "    \n",
    "    df_eval = df_eval.groupby(['book', 'chapter'], sort=False).agg({\n",
    "        'text': lambda t: ' '.join(list(t)),\n",
    "        'bullets': lambda b: ' '.join(list(b)),\n",
    "        'summary': lambda s: ' '.join(list(s))})\n",
    "    \n",
    "    rouge_res =\\\n",
    "        df_eval[['bullets', 'summary']]\\\n",
    "        .apply(lambda row:\n",
    "        metric.compute(\n",
    "            predictions = [row[1]],\n",
    "            references = [row[0]],\n",
    "            rouge_types = config.ROUGE_TYPES,\n",
    "            use_agregator = False), axis=1)\n",
    "    for r in config.ROUGE_TYPES:\n",
    "        for i, prf in enumerate(['precision', 'recall', 'fmeasure']):\n",
    "            df_eval[r+'_'+prf] =\\\n",
    "                rouge_res.map(lambda score: 100*score[r][0][i])\n",
    "            \n",
    "    cosine_sim = lambda a, b: (np.dot(a, b) / (np.linalg.norm(a)*np.linalg.norm(b)))\n",
    "    df_eval['st_cosine_sim'] =\\\n",
    "    df_eval[['bullets', 'summary']]\\\n",
    "        .apply(lambda row:\n",
    "        100*cosine_sim(\n",
    "            sentence_distilroberta.encode(row[1]),\n",
    "            sentence_distilroberta.encode(row[0])), axis=1)\n",
    "    \n",
    "    def cosine_sim_w2v(s, b):\n",
    "        s = gensim.utils.simple_preprocess(s, deacc=True)\n",
    "        b = gensim.utils.simple_preprocess(b, deacc=True)\n",
    "        corpus = [s, b]\n",
    "        w2v = gensim.models.Word2Vec(\n",
    "            corpus,\n",
    "            min_count=1,\n",
    "            sg=1,\n",
    "            seed = config.SEED)\n",
    "        s_embed = np.mean([w2v.wv[word] for word in s], axis=0)\n",
    "        b_embed = np.mean([w2v.wv[word] for word in b], axis=0)\n",
    "        return cosine_sim(s_embed, b_embed)\n",
    "        \n",
    "    df_eval['w2v_cosine_sim'] =\\\n",
    "        df_eval[['bullets', 'summary']]\\\n",
    "        .apply(lambda row:\n",
    "        100*cosine_sim_w2v(row[1], row[0]), axis=1)\n",
    "            \n",
    "    df_eval.to_csv(OUTPUT_PATH+model_name_or_path.replace('/', '?')+'_grouped.csv')\n",
    "    \n",
    "    return df_eval"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th>text</th>\n",
       "      <th>bullets</th>\n",
       "      <th>summary</th>\n",
       "      <th>rouge1_precision</th>\n",
       "      <th>rouge1_recall</th>\n",
       "      <th>rouge1_fmeasure</th>\n",
       "      <th>rouge2_precision</th>\n",
       "      <th>rouge2_recall</th>\n",
       "      <th>rouge2_fmeasure</th>\n",
       "      <th>rougeL_precision</th>\n",
       "      <th>rougeL_recall</th>\n",
       "      <th>rougeL_fmeasure</th>\n",
       "      <th>st_cosine_sim</th>\n",
       "      <th>w2v_cosine_sim</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>book</th>\n",
       "      <th>chapter</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>9781910797631</th>\n",
       "      <th>chp6</th>\n",
       "      <td>Prevention and management. By far the most res...</td>\n",
       "      <td>The treatment rather than the prevention of de...</td>\n",
       "      <td>The treatment of depression is the focus of mo...</td>\n",
       "      <td>41.025641</td>\n",
       "      <td>37.209302</td>\n",
       "      <td>39.024390</td>\n",
       "      <td>10.322581</td>\n",
       "      <td>9.356725</td>\n",
       "      <td>9.815951</td>\n",
       "      <td>22.435897</td>\n",
       "      <td>20.348837</td>\n",
       "      <td>21.341463</td>\n",
       "      <td>77.454841</td>\n",
       "      <td>86.020589</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781910797426</th>\n",
       "      <th>ch03</th>\n",
       "      <td>Epidemiology and risk factors. Gallstones are ...</td>\n",
       "      <td>The prevalence of gallstones is greater in peo...</td>\n",
       "      <td>Gallstones are a significant cause of mortalit...</td>\n",
       "      <td>49.019608</td>\n",
       "      <td>39.062500</td>\n",
       "      <td>43.478261</td>\n",
       "      <td>21.782178</td>\n",
       "      <td>17.322835</td>\n",
       "      <td>19.298246</td>\n",
       "      <td>34.313725</td>\n",
       "      <td>27.343750</td>\n",
       "      <td>30.434783</td>\n",
       "      <td>79.712456</td>\n",
       "      <td>71.898705</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781908541277</th>\n",
       "      <th>ch_12</th>\n",
       "      <td>Nearly 1 in 3 patients reports significant con...</td>\n",
       "      <td>Depression and anxiety are common in patients ...</td>\n",
       "      <td>Depression is the most prevalent psychiatric c...</td>\n",
       "      <td>54.545455</td>\n",
       "      <td>60.402685</td>\n",
       "      <td>57.324841</td>\n",
       "      <td>29.268293</td>\n",
       "      <td>32.432432</td>\n",
       "      <td>30.769231</td>\n",
       "      <td>41.818182</td>\n",
       "      <td>46.308725</td>\n",
       "      <td>43.949045</td>\n",
       "      <td>77.712244</td>\n",
       "      <td>89.286613</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781910797907</th>\n",
       "      <th>chp6</th>\n",
       "      <td>When to transfuse. There is no set standard wi...</td>\n",
       "      <td>The decision for transfusion therapy relates t...</td>\n",
       "      <td>There is no set standard with regard to transf...</td>\n",
       "      <td>45.774648</td>\n",
       "      <td>49.618321</td>\n",
       "      <td>47.619048</td>\n",
       "      <td>15.602837</td>\n",
       "      <td>16.923077</td>\n",
       "      <td>16.236162</td>\n",
       "      <td>26.760563</td>\n",
       "      <td>29.007634</td>\n",
       "      <td>27.838828</td>\n",
       "      <td>76.956862</td>\n",
       "      <td>83.728826</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781908541277</th>\n",
       "      <th>ch_8</th>\n",
       "      <td>Modern antiepileptic drugs. After a hiatus of ...</td>\n",
       "      <td>Sixteen new antiepileptic drugs (AEDs) have be...</td>\n",
       "      <td>After a hiatus of nearly 20 years, 16 new AEDs...</td>\n",
       "      <td>29.411765</td>\n",
       "      <td>28.846154</td>\n",
       "      <td>29.126214</td>\n",
       "      <td>4.000000</td>\n",
       "      <td>3.921569</td>\n",
       "      <td>3.960396</td>\n",
       "      <td>23.529412</td>\n",
       "      <td>23.076923</td>\n",
       "      <td>23.300971</td>\n",
       "      <td>62.181133</td>\n",
       "      <td>46.673253</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781910797006</th>\n",
       "      <th>ch08</th>\n",
       "      <td>Acute exacerbations of chronic obstructive pul...</td>\n",
       "      <td>Acute exacerbations of COPD are common and pla...</td>\n",
       "      <td>Acute exacerbations of chronic obstructive pul...</td>\n",
       "      <td>32.191781</td>\n",
       "      <td>52.808989</td>\n",
       "      <td>40.000000</td>\n",
       "      <td>15.862069</td>\n",
       "      <td>26.136364</td>\n",
       "      <td>19.742489</td>\n",
       "      <td>21.917808</td>\n",
       "      <td>35.955056</td>\n",
       "      <td>27.234043</td>\n",
       "      <td>73.715782</td>\n",
       "      <td>82.787955</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781910797105</th>\n",
       "      <th>ch06</th>\n",
       "      <td>Morphological findings. MRI studies confirmed ...</td>\n",
       "      <td>People with schizophrenia exhibit gray matter ...</td>\n",
       "      <td>MRI studies confirmed the previous findings of...</td>\n",
       "      <td>48.543689</td>\n",
       "      <td>48.543689</td>\n",
       "      <td>48.543689</td>\n",
       "      <td>15.686275</td>\n",
       "      <td>15.686275</td>\n",
       "      <td>15.686275</td>\n",
       "      <td>28.155340</td>\n",
       "      <td>28.155340</td>\n",
       "      <td>28.155340</td>\n",
       "      <td>73.356146</td>\n",
       "      <td>75.353748</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9783318068207</th>\n",
       "      <th>hh-5</th>\n",
       "      <td>The recent improvements in terms of available ...</td>\n",
       "      <td>Comprehensive genomic profiles offer a complet...</td>\n",
       "      <td>Comprehensive genomic profiling (CGP) offers a...</td>\n",
       "      <td>59.375000</td>\n",
       "      <td>46.721311</td>\n",
       "      <td>52.293578</td>\n",
       "      <td>29.473684</td>\n",
       "      <td>23.140496</td>\n",
       "      <td>25.925926</td>\n",
       "      <td>43.750000</td>\n",
       "      <td>34.426230</td>\n",
       "      <td>38.532110</td>\n",
       "      <td>84.886581</td>\n",
       "      <td>86.692703</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781910797105</th>\n",
       "      <th>ch04</th>\n",
       "      <td>Studies in twins involve probands with schizop...</td>\n",
       "      <td>Identical twins show a 45% concordance rate. H...</td>\n",
       "      <td>The offspring of unaffected MZ co-twins are at...</td>\n",
       "      <td>29.670330</td>\n",
       "      <td>38.028169</td>\n",
       "      <td>33.333333</td>\n",
       "      <td>6.666667</td>\n",
       "      <td>8.571429</td>\n",
       "      <td>7.500000</td>\n",
       "      <td>16.483516</td>\n",
       "      <td>21.126761</td>\n",
       "      <td>18.518519</td>\n",
       "      <td>81.507498</td>\n",
       "      <td>62.482452</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781910797006</th>\n",
       "      <th>ch03</th>\n",
       "      <td>The characteristic symptom of COPD is breathle...</td>\n",
       "      <td>Usually (in 80% of patients) there is a signif...</td>\n",
       "      <td>The characteristic symptom of COPD is breathle...</td>\n",
       "      <td>44.366197</td>\n",
       "      <td>36.416185</td>\n",
       "      <td>40.000000</td>\n",
       "      <td>17.021277</td>\n",
       "      <td>13.953488</td>\n",
       "      <td>15.335463</td>\n",
       "      <td>27.464789</td>\n",
       "      <td>22.543353</td>\n",
       "      <td>24.761905</td>\n",
       "      <td>74.553555</td>\n",
       "      <td>77.810550</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781908541406</th>\n",
       "      <th>ch_6</th>\n",
       "      <td>Dysfunction of cytosolic enzymes and other pla...</td>\n",
       "      <td>Thrombocytopenia may occur with some inherited...</td>\n",
       "      <td>Thrombotic thrombocytopenia due to congenital ...</td>\n",
       "      <td>38.461538</td>\n",
       "      <td>35.714286</td>\n",
       "      <td>37.037037</td>\n",
       "      <td>9.708738</td>\n",
       "      <td>9.009009</td>\n",
       "      <td>9.345794</td>\n",
       "      <td>22.115385</td>\n",
       "      <td>20.535714</td>\n",
       "      <td>21.296296</td>\n",
       "      <td>81.662786</td>\n",
       "      <td>56.578755</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781908541277</th>\n",
       "      <th>ch_6</th>\n",
       "      <td>The diagnosis of epilepsy relies on the correc...</td>\n",
       "      <td>A witness's account is essential for accurate ...</td>\n",
       "      <td>The diagnosis of epilepsy relies on the correc...</td>\n",
       "      <td>43.243243</td>\n",
       "      <td>69.565217</td>\n",
       "      <td>53.333333</td>\n",
       "      <td>18.367347</td>\n",
       "      <td>29.670330</td>\n",
       "      <td>22.689076</td>\n",
       "      <td>29.054054</td>\n",
       "      <td>46.739130</td>\n",
       "      <td>35.833333</td>\n",
       "      <td>81.965548</td>\n",
       "      <td>89.188361</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781910797815</th>\n",
       "      <th>chp3</th>\n",
       "      <td>The MPNs vary markedly in morphologic and clin...</td>\n",
       "      <td>The World Health Organization diagnostic crite...</td>\n",
       "      <td>Thrombocytosis and erythrocytosis are major di...</td>\n",
       "      <td>48.076923</td>\n",
       "      <td>43.352601</td>\n",
       "      <td>45.592705</td>\n",
       "      <td>20.645161</td>\n",
       "      <td>18.604651</td>\n",
       "      <td>19.571865</td>\n",
       "      <td>26.282051</td>\n",
       "      <td>23.699422</td>\n",
       "      <td>24.924012</td>\n",
       "      <td>71.033967</td>\n",
       "      <td>90.337062</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781910797310</th>\n",
       "      <th>chp3</th>\n",
       "      <td>Tumor size (T) is the primary descriptive and ...</td>\n",
       "      <td>Better subclassification of early-stage NSCLC ...</td>\n",
       "      <td>Tumor size is the primary descriptive and most...</td>\n",
       "      <td>28.409091</td>\n",
       "      <td>29.411765</td>\n",
       "      <td>28.901734</td>\n",
       "      <td>1.149425</td>\n",
       "      <td>1.190476</td>\n",
       "      <td>1.169591</td>\n",
       "      <td>14.772727</td>\n",
       "      <td>15.294118</td>\n",
       "      <td>15.028902</td>\n",
       "      <td>65.472806</td>\n",
       "      <td>52.986348</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781910797426</th>\n",
       "      <th>ch12</th>\n",
       "      <td>Etiology and pathogenesis. Cancers of the ampu...</td>\n",
       "      <td>Tumor types that occur in the ampullary and pe...</td>\n",
       "      <td>Cancers of the ampulla of Vater, the intrapanc...</td>\n",
       "      <td>42.553191</td>\n",
       "      <td>45.454545</td>\n",
       "      <td>43.956044</td>\n",
       "      <td>13.978495</td>\n",
       "      <td>14.942529</td>\n",
       "      <td>14.444444</td>\n",
       "      <td>28.723404</td>\n",
       "      <td>30.681818</td>\n",
       "      <td>29.670330</td>\n",
       "      <td>81.221396</td>\n",
       "      <td>57.167000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781908541024</th>\n",
       "      <th>ch_13</th>\n",
       "      <td>Although half of all primary and metastatic br...</td>\n",
       "      <td>Neurocognitive outcome is of particular concer...</td>\n",
       "      <td>The elderly represent the fastest growing segm...</td>\n",
       "      <td>28.125000</td>\n",
       "      <td>43.548387</td>\n",
       "      <td>34.177215</td>\n",
       "      <td>6.315789</td>\n",
       "      <td>9.836066</td>\n",
       "      <td>7.692308</td>\n",
       "      <td>15.625000</td>\n",
       "      <td>24.193548</td>\n",
       "      <td>18.987342</td>\n",
       "      <td>64.516574</td>\n",
       "      <td>64.719629</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781910797617</th>\n",
       "      <th>chp6</th>\n",
       "      <td>The expanded genetic characterization of acute...</td>\n",
       "      <td>A wide range of targeted agencies for the trea...</td>\n",
       "      <td>The expanded genetic characterization of acute...</td>\n",
       "      <td>36.756757</td>\n",
       "      <td>38.418079</td>\n",
       "      <td>37.569061</td>\n",
       "      <td>10.869565</td>\n",
       "      <td>11.363636</td>\n",
       "      <td>11.111111</td>\n",
       "      <td>20.000000</td>\n",
       "      <td>20.903955</td>\n",
       "      <td>20.441989</td>\n",
       "      <td>75.757277</td>\n",
       "      <td>88.485336</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781908541994</th>\n",
       "      <th>ch02</th>\n",
       "      <td>Pathophysiology, etiology and modifying factor...</td>\n",
       "      <td>Four main factors are implicated in the etiolo...</td>\n",
       "      <td>Acne is a hormonally mediated disease, with an...</td>\n",
       "      <td>29.032258</td>\n",
       "      <td>32.727273</td>\n",
       "      <td>30.769231</td>\n",
       "      <td>11.475410</td>\n",
       "      <td>12.962963</td>\n",
       "      <td>12.173913</td>\n",
       "      <td>14.516129</td>\n",
       "      <td>16.363636</td>\n",
       "      <td>15.384615</td>\n",
       "      <td>67.471182</td>\n",
       "      <td>41.407356</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781910797471</th>\n",
       "      <th>ch05</th>\n",
       "      <td>A 67-year-old man with diabetes mellitus, hype...</td>\n",
       "      <td>Assessment of functional class, based on exerc...</td>\n",
       "      <td>A 67-year-old man with diabetes mellitus, hype...</td>\n",
       "      <td>41.139241</td>\n",
       "      <td>51.587302</td>\n",
       "      <td>45.774648</td>\n",
       "      <td>12.738854</td>\n",
       "      <td>16.000000</td>\n",
       "      <td>14.184397</td>\n",
       "      <td>24.050633</td>\n",
       "      <td>30.158730</td>\n",
       "      <td>26.760563</td>\n",
       "      <td>73.311019</td>\n",
       "      <td>87.382334</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781910797105</th>\n",
       "      <th>ch08</th>\n",
       "      <td>Four developments have helped to revive the do...</td>\n",
       "      <td>Positive symptoms are hypothesized to be due t...</td>\n",
       "      <td>The dopamine hypothesis has been revived by a ...</td>\n",
       "      <td>35.227273</td>\n",
       "      <td>42.465753</td>\n",
       "      <td>38.509317</td>\n",
       "      <td>5.747126</td>\n",
       "      <td>6.944444</td>\n",
       "      <td>6.289308</td>\n",
       "      <td>18.181818</td>\n",
       "      <td>21.917808</td>\n",
       "      <td>19.875776</td>\n",
       "      <td>75.691462</td>\n",
       "      <td>74.347800</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781912776207</th>\n",
       "      <th>ch4</th>\n",
       "      <td>Accurate diagnosis and subtyping of PTCL is ch...</td>\n",
       "      <td>Detailed immunophenotypic analysis is necessar...</td>\n",
       "      <td>Accurate diagnosis and subtyping of PTCL is ch...</td>\n",
       "      <td>24.719101</td>\n",
       "      <td>36.666667</td>\n",
       "      <td>29.530201</td>\n",
       "      <td>11.363636</td>\n",
       "      <td>16.949153</td>\n",
       "      <td>13.605442</td>\n",
       "      <td>14.606742</td>\n",
       "      <td>21.666667</td>\n",
       "      <td>17.449664</td>\n",
       "      <td>71.452951</td>\n",
       "      <td>50.848681</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781910797495</th>\n",
       "      <th>chp12</th>\n",
       "      <td>Acute headache. The immediate, important first...</td>\n",
       "      <td>In patients without history of chronic headach...</td>\n",
       "      <td>The immediate, important first step in assessi...</td>\n",
       "      <td>39.622642</td>\n",
       "      <td>23.333333</td>\n",
       "      <td>29.370629</td>\n",
       "      <td>13.461538</td>\n",
       "      <td>7.865169</td>\n",
       "      <td>9.929078</td>\n",
       "      <td>28.301887</td>\n",
       "      <td>16.666667</td>\n",
       "      <td>20.979021</td>\n",
       "      <td>70.631951</td>\n",
       "      <td>49.200192</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781912776726</th>\n",
       "      <th>ch2</th>\n",
       "      <td>The signs and symptoms of glioblastoma result ...</td>\n",
       "      <td>The signs and symptoms of glioblastoma result ...</td>\n",
       "      <td>The signs and symptoms of glioblastoma result ...</td>\n",
       "      <td>55.089820</td>\n",
       "      <td>52.272727</td>\n",
       "      <td>53.644315</td>\n",
       "      <td>25.301205</td>\n",
       "      <td>24.000000</td>\n",
       "      <td>24.633431</td>\n",
       "      <td>35.329341</td>\n",
       "      <td>33.522727</td>\n",
       "      <td>34.402332</td>\n",
       "      <td>74.675697</td>\n",
       "      <td>96.129704</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781910797815</th>\n",
       "      <th>chp2</th>\n",
       "      <td>The myeloproliferative neoplasms (MPNs) are ra...</td>\n",
       "      <td>The incidence of the myeloproliferative neopla...</td>\n",
       "      <td>The myeloproliferative neoplasms (MPNs) are ra...</td>\n",
       "      <td>44.545455</td>\n",
       "      <td>40.495868</td>\n",
       "      <td>42.424242</td>\n",
       "      <td>19.266055</td>\n",
       "      <td>17.500000</td>\n",
       "      <td>18.340611</td>\n",
       "      <td>35.454545</td>\n",
       "      <td>32.231405</td>\n",
       "      <td>33.766234</td>\n",
       "      <td>75.727808</td>\n",
       "      <td>82.670760</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781910797433</th>\n",
       "      <th>ch05</th>\n",
       "      <td>Surgery is the cornerstone of management for b...</td>\n",
       "      <td>Surgery is one of the cornerstones of treatmen...</td>\n",
       "      <td>Surgery is the cornerstone of management for b...</td>\n",
       "      <td>39.603960</td>\n",
       "      <td>39.215686</td>\n",
       "      <td>39.408867</td>\n",
       "      <td>4.000000</td>\n",
       "      <td>3.960396</td>\n",
       "      <td>3.980100</td>\n",
       "      <td>24.752475</td>\n",
       "      <td>24.509804</td>\n",
       "      <td>24.630542</td>\n",
       "      <td>84.197742</td>\n",
       "      <td>74.402571</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781910797617</th>\n",
       "      <th>chp1</th>\n",
       "      <td>Acute myeloid leukemia (AML) is a hematologic ...</td>\n",
       "      <td>Acute myeloid leukemia (AML) is a relatively r...</td>\n",
       "      <td>Acute myeloid leukemia (AML) is a hematologic ...</td>\n",
       "      <td>53.398058</td>\n",
       "      <td>33.742331</td>\n",
       "      <td>41.353383</td>\n",
       "      <td>19.607843</td>\n",
       "      <td>12.345679</td>\n",
       "      <td>15.151515</td>\n",
       "      <td>34.951456</td>\n",
       "      <td>22.085890</td>\n",
       "      <td>27.067669</td>\n",
       "      <td>87.871474</td>\n",
       "      <td>82.759547</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781908541963</th>\n",
       "      <th>chapter3</th>\n",
       "      <td>Alcoholic liver disease (ALD) is a common caus...</td>\n",
       "      <td>Alcoholic liver disease (ALD) is a common caus...</td>\n",
       "      <td>Alcoholic liver disease (ALD) is a common caus...</td>\n",
       "      <td>32.894737</td>\n",
       "      <td>40.322581</td>\n",
       "      <td>36.231884</td>\n",
       "      <td>18.666667</td>\n",
       "      <td>22.950820</td>\n",
       "      <td>20.588235</td>\n",
       "      <td>28.947368</td>\n",
       "      <td>35.483871</td>\n",
       "      <td>31.884058</td>\n",
       "      <td>81.027627</td>\n",
       "      <td>51.491308</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781908541796</th>\n",
       "      <th>chapter1</th>\n",
       "      <td>Lymphoma is a malignancy of lymphocytes and th...</td>\n",
       "      <td>The epidemiology of lymphoma is difficult to s...</td>\n",
       "      <td>Lymphoma encompasses a broad range of lymphoid...</td>\n",
       "      <td>37.000000</td>\n",
       "      <td>29.838710</td>\n",
       "      <td>33.035714</td>\n",
       "      <td>10.101010</td>\n",
       "      <td>8.130081</td>\n",
       "      <td>9.009009</td>\n",
       "      <td>26.000000</td>\n",
       "      <td>20.967742</td>\n",
       "      <td>23.214286</td>\n",
       "      <td>81.090528</td>\n",
       "      <td>73.773026</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781908541963</th>\n",
       "      <th>chapter5</th>\n",
       "      <td>Autoimmune liver diseases. Three liver disease...</td>\n",
       "      <td>Autoimmune liver disease can target the hepato...</td>\n",
       "      <td>Autoimmune liver diseases include autoimmune h...</td>\n",
       "      <td>46.268657</td>\n",
       "      <td>37.349398</td>\n",
       "      <td>41.333333</td>\n",
       "      <td>19.696970</td>\n",
       "      <td>15.853659</td>\n",
       "      <td>17.567568</td>\n",
       "      <td>29.850746</td>\n",
       "      <td>24.096386</td>\n",
       "      <td>26.666667</td>\n",
       "      <td>81.381470</td>\n",
       "      <td>67.097825</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781910797907</th>\n",
       "      <th>chp2</th>\n",
       "      <td>Despite being the best studied of the glycolyt...</td>\n",
       "      <td>Gaps remain in our understanding of the epidem...</td>\n",
       "      <td>More than 600 cases of pyruvate kinase (PK) de...</td>\n",
       "      <td>49.315068</td>\n",
       "      <td>48.648649</td>\n",
       "      <td>48.979592</td>\n",
       "      <td>25.000000</td>\n",
       "      <td>24.657534</td>\n",
       "      <td>24.827586</td>\n",
       "      <td>32.876712</td>\n",
       "      <td>32.432432</td>\n",
       "      <td>32.653061</td>\n",
       "      <td>85.362822</td>\n",
       "      <td>75.645065</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781908541666</th>\n",
       "      <th>ch_13</th>\n",
       "      <td>Diabetic pregnancy is associated with an incre...</td>\n",
       "      <td>Diabetic pregnancy is associated with fetal mo...</td>\n",
       "      <td>Diabetic pregnancy is associated with an incre...</td>\n",
       "      <td>31.654676</td>\n",
       "      <td>53.658537</td>\n",
       "      <td>39.819005</td>\n",
       "      <td>15.217391</td>\n",
       "      <td>25.925926</td>\n",
       "      <td>19.178082</td>\n",
       "      <td>23.021583</td>\n",
       "      <td>39.024390</td>\n",
       "      <td>28.959276</td>\n",
       "      <td>88.159752</td>\n",
       "      <td>85.004187</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781912776153</th>\n",
       "      <th>chp3</th>\n",
       "      <td>Syncope is a significant healthcare problem, r...</td>\n",
       "      <td>Syncope can be benign, such as vasovagal (neur...</td>\n",
       "      <td>Syncope is a significant healthcare problem, r...</td>\n",
       "      <td>67.391304</td>\n",
       "      <td>53.142857</td>\n",
       "      <td>59.424920</td>\n",
       "      <td>48.905109</td>\n",
       "      <td>38.505747</td>\n",
       "      <td>43.086817</td>\n",
       "      <td>42.753623</td>\n",
       "      <td>33.714286</td>\n",
       "      <td>37.699681</td>\n",
       "      <td>86.016065</td>\n",
       "      <td>89.006799</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781908541468</th>\n",
       "      <th>ch_14</th>\n",
       "      <td>Renal replacement therapy and transplantation....</td>\n",
       "      <td>Most patients will require several modalities ...</td>\n",
       "      <td>All patients should be offered all suitable ch...</td>\n",
       "      <td>40.566038</td>\n",
       "      <td>39.814815</td>\n",
       "      <td>40.186916</td>\n",
       "      <td>9.523810</td>\n",
       "      <td>9.345794</td>\n",
       "      <td>9.433962</td>\n",
       "      <td>20.754717</td>\n",
       "      <td>20.370370</td>\n",
       "      <td>20.560748</td>\n",
       "      <td>78.428084</td>\n",
       "      <td>70.372969</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781910797662</th>\n",
       "      <th>ch09</th>\n",
       "      <td>The mortality and morbidity of bladder cancer ...</td>\n",
       "      <td>Public health preventative measures are likely...</td>\n",
       "      <td>Improved diagnosis, earlier treatment and impr...</td>\n",
       "      <td>28.318584</td>\n",
       "      <td>32.323232</td>\n",
       "      <td>30.188679</td>\n",
       "      <td>4.464286</td>\n",
       "      <td>5.102041</td>\n",
       "      <td>4.761905</td>\n",
       "      <td>14.159292</td>\n",
       "      <td>16.161616</td>\n",
       "      <td>15.094340</td>\n",
       "      <td>82.256985</td>\n",
       "      <td>59.492385</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781910797211</th>\n",
       "      <th>ch04</th>\n",
       "      <td>Levodopa is a precursor of dopamine and restor...</td>\n",
       "      <td>Levodopa restores the dopamine lost due to deg...</td>\n",
       "      <td>Levodopa restores the dopamine lost due to deg...</td>\n",
       "      <td>65.816327</td>\n",
       "      <td>49.425287</td>\n",
       "      <td>56.455142</td>\n",
       "      <td>31.794872</td>\n",
       "      <td>23.846154</td>\n",
       "      <td>27.252747</td>\n",
       "      <td>41.326531</td>\n",
       "      <td>31.034483</td>\n",
       "      <td>35.448578</td>\n",
       "      <td>78.673643</td>\n",
       "      <td>94.396794</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781908541727</th>\n",
       "      <th>ch03</th>\n",
       "      <td>Blurred vision. The most common causes of blur...</td>\n",
       "      <td>Most patients with blurred vision have benign,...</td>\n",
       "      <td>It is essential to be able to clinically triag...</td>\n",
       "      <td>51.754386</td>\n",
       "      <td>42.753623</td>\n",
       "      <td>46.825397</td>\n",
       "      <td>17.699115</td>\n",
       "      <td>14.598540</td>\n",
       "      <td>16.000000</td>\n",
       "      <td>25.438596</td>\n",
       "      <td>21.014493</td>\n",
       "      <td>23.015873</td>\n",
       "      <td>83.158141</td>\n",
       "      <td>70.681083</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9783318068207</th>\n",
       "      <th>hh-8</th>\n",
       "      <td>In the era of personalized medicine, tissue sa...</td>\n",
       "      <td>Different sample types (histological or cytolo...</td>\n",
       "      <td>Cytological and histological specimens are the...</td>\n",
       "      <td>32.203390</td>\n",
       "      <td>33.928571</td>\n",
       "      <td>33.043478</td>\n",
       "      <td>1.724138</td>\n",
       "      <td>1.818182</td>\n",
       "      <td>1.769912</td>\n",
       "      <td>20.338983</td>\n",
       "      <td>21.428571</td>\n",
       "      <td>20.869565</td>\n",
       "      <td>71.958637</td>\n",
       "      <td>43.385014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781908541024</th>\n",
       "      <th>ch_12</th>\n",
       "      <td>The vast majority of primary brain tumors occu...</td>\n",
       "      <td>There are several syndromes associated with an...</td>\n",
       "      <td>The vast majority of primary brain tumors occu...</td>\n",
       "      <td>41.732283</td>\n",
       "      <td>38.970588</td>\n",
       "      <td>40.304183</td>\n",
       "      <td>9.523810</td>\n",
       "      <td>8.888889</td>\n",
       "      <td>9.195402</td>\n",
       "      <td>18.110236</td>\n",
       "      <td>16.911765</td>\n",
       "      <td>17.490494</td>\n",
       "      <td>74.483132</td>\n",
       "      <td>81.031632</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781910797105</th>\n",
       "      <th>ch05</th>\n",
       "      <td>Developmental theories and environmental facto...</td>\n",
       "      <td>Like genetic factors, environmental factors ar...</td>\n",
       "      <td>The 'neurodevelopmental hypothesis' of schizop...</td>\n",
       "      <td>31.944444</td>\n",
       "      <td>36.507937</td>\n",
       "      <td>34.074074</td>\n",
       "      <td>15.492958</td>\n",
       "      <td>17.741935</td>\n",
       "      <td>16.541353</td>\n",
       "      <td>25.000000</td>\n",
       "      <td>28.571429</td>\n",
       "      <td>26.666667</td>\n",
       "      <td>80.225450</td>\n",
       "      <td>69.052237</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781908541420</th>\n",
       "      <th>ch_6</th>\n",
       "      <td>Combination therapy. A series of clinical tria...</td>\n",
       "      <td>Drugs used in the management of asthma can be ...</td>\n",
       "      <td>Combinations of an inhaled corticosteroid and ...</td>\n",
       "      <td>34.666667</td>\n",
       "      <td>44.444444</td>\n",
       "      <td>38.951311</td>\n",
       "      <td>8.053691</td>\n",
       "      <td>10.344828</td>\n",
       "      <td>9.056604</td>\n",
       "      <td>20.000000</td>\n",
       "      <td>25.641026</td>\n",
       "      <td>22.471910</td>\n",
       "      <td>72.441578</td>\n",
       "      <td>80.655372</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781908541680</th>\n",
       "      <th>ch_8</th>\n",
       "      <td>Behavioral therapy - the collective name for t...</td>\n",
       "      <td>Behavioral therapy, alongside diet and lifesty...</td>\n",
       "      <td>Cognitive behavioral therapy (CBT) is one of t...</td>\n",
       "      <td>38.888889</td>\n",
       "      <td>39.622642</td>\n",
       "      <td>39.252336</td>\n",
       "      <td>13.207547</td>\n",
       "      <td>13.461538</td>\n",
       "      <td>13.333333</td>\n",
       "      <td>35.185185</td>\n",
       "      <td>35.849057</td>\n",
       "      <td>35.514019</td>\n",
       "      <td>80.766618</td>\n",
       "      <td>49.175903</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781910797457</th>\n",
       "      <th>chp8</th>\n",
       "      <td>Antiandrogens. When the serum PSA level rises ...</td>\n",
       "      <td>After an initial response to androgen ablation...</td>\n",
       "      <td>Antiandrogens may transiently reduce PSA, but ...</td>\n",
       "      <td>38.759690</td>\n",
       "      <td>31.645570</td>\n",
       "      <td>34.843206</td>\n",
       "      <td>7.031250</td>\n",
       "      <td>5.732484</td>\n",
       "      <td>6.315789</td>\n",
       "      <td>21.705426</td>\n",
       "      <td>17.721519</td>\n",
       "      <td>19.512195</td>\n",
       "      <td>81.383657</td>\n",
       "      <td>67.861736</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781910797815</th>\n",
       "      <th>chp7</th>\n",
       "      <td>Pacritinib is an inhibitor of both JAK2 and FL...</td>\n",
       "      <td>The Janus kinase 2 inhibitor pacritinib was su...</td>\n",
       "      <td>Pacritinib is an inhibitor of both JAK2 and FL...</td>\n",
       "      <td>35.802469</td>\n",
       "      <td>40.845070</td>\n",
       "      <td>38.157895</td>\n",
       "      <td>2.500000</td>\n",
       "      <td>2.857143</td>\n",
       "      <td>2.666667</td>\n",
       "      <td>16.049383</td>\n",
       "      <td>18.309859</td>\n",
       "      <td>17.105263</td>\n",
       "      <td>72.270256</td>\n",
       "      <td>61.197352</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9783318066685</th>\n",
       "      <th>ch4</th>\n",
       "      <td>Several gene therapy drugs are now approved by...</td>\n",
       "      <td>Gene therapy, using gene-modified cells or in ...</td>\n",
       "      <td>Several gene therapy drugs are now approved by...</td>\n",
       "      <td>34.939759</td>\n",
       "      <td>34.523810</td>\n",
       "      <td>34.730539</td>\n",
       "      <td>10.303030</td>\n",
       "      <td>10.179641</td>\n",
       "      <td>10.240964</td>\n",
       "      <td>17.469880</td>\n",
       "      <td>17.261905</td>\n",
       "      <td>17.365269</td>\n",
       "      <td>62.347168</td>\n",
       "      <td>86.098439</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9781908541680</th>\n",
       "      <th>ch_4</th>\n",
       "      <td>Overweight/obesity as a whole predisposes to, ...</td>\n",
       "      <td>Obesity significantly affects cardiometabolic ...</td>\n",
       "      <td>Overweight/obesity as a whole predisposes to n...</td>\n",
       "      <td>20.731707</td>\n",
       "      <td>41.463415</td>\n",
       "      <td>27.642276</td>\n",
       "      <td>4.907975</td>\n",
       "      <td>9.876543</td>\n",
       "      <td>6.557377</td>\n",
       "      <td>14.024390</td>\n",
       "      <td>28.048780</td>\n",
       "      <td>18.699187</td>\n",
       "      <td>67.844188</td>\n",
       "      <td>67.674166</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                     text  \\\n",
       "book          chapter                                                       \n",
       "9781910797631 chp6      Prevention and management. By far the most res...   \n",
       "9781910797426 ch03      Epidemiology and risk factors. Gallstones are ...   \n",
       "9781908541277 ch_12     Nearly 1 in 3 patients reports significant con...   \n",
       "9781910797907 chp6      When to transfuse. There is no set standard wi...   \n",
       "9781908541277 ch_8      Modern antiepileptic drugs. After a hiatus of ...   \n",
       "9781910797006 ch08      Acute exacerbations of chronic obstructive pul...   \n",
       "9781910797105 ch06      Morphological findings. MRI studies confirmed ...   \n",
       "9783318068207 hh-5      The recent improvements in terms of available ...   \n",
       "9781910797105 ch04      Studies in twins involve probands with schizop...   \n",
       "9781910797006 ch03      The characteristic symptom of COPD is breathle...   \n",
       "9781908541406 ch_6      Dysfunction of cytosolic enzymes and other pla...   \n",
       "9781908541277 ch_6      The diagnosis of epilepsy relies on the correc...   \n",
       "9781910797815 chp3      The MPNs vary markedly in morphologic and clin...   \n",
       "9781910797310 chp3      Tumor size (T) is the primary descriptive and ...   \n",
       "9781910797426 ch12      Etiology and pathogenesis. Cancers of the ampu...   \n",
       "9781908541024 ch_13     Although half of all primary and metastatic br...   \n",
       "9781910797617 chp6      The expanded genetic characterization of acute...   \n",
       "9781908541994 ch02      Pathophysiology, etiology and modifying factor...   \n",
       "9781910797471 ch05      A 67-year-old man with diabetes mellitus, hype...   \n",
       "9781910797105 ch08      Four developments have helped to revive the do...   \n",
       "9781912776207 ch4       Accurate diagnosis and subtyping of PTCL is ch...   \n",
       "9781910797495 chp12     Acute headache. The immediate, important first...   \n",
       "9781912776726 ch2       The signs and symptoms of glioblastoma result ...   \n",
       "9781910797815 chp2      The myeloproliferative neoplasms (MPNs) are ra...   \n",
       "9781910797433 ch05      Surgery is the cornerstone of management for b...   \n",
       "9781910797617 chp1      Acute myeloid leukemia (AML) is a hematologic ...   \n",
       "9781908541963 chapter3  Alcoholic liver disease (ALD) is a common caus...   \n",
       "9781908541796 chapter1  Lymphoma is a malignancy of lymphocytes and th...   \n",
       "9781908541963 chapter5  Autoimmune liver diseases. Three liver disease...   \n",
       "9781910797907 chp2      Despite being the best studied of the glycolyt...   \n",
       "9781908541666 ch_13     Diabetic pregnancy is associated with an incre...   \n",
       "9781912776153 chp3      Syncope is a significant healthcare problem, r...   \n",
       "9781908541468 ch_14     Renal replacement therapy and transplantation....   \n",
       "9781910797662 ch09      The mortality and morbidity of bladder cancer ...   \n",
       "9781910797211 ch04      Levodopa is a precursor of dopamine and restor...   \n",
       "9781908541727 ch03      Blurred vision. The most common causes of blur...   \n",
       "9783318068207 hh-8      In the era of personalized medicine, tissue sa...   \n",
       "9781908541024 ch_12     The vast majority of primary brain tumors occu...   \n",
       "9781910797105 ch05      Developmental theories and environmental facto...   \n",
       "9781908541420 ch_6      Combination therapy. A series of clinical tria...   \n",
       "9781908541680 ch_8      Behavioral therapy - the collective name for t...   \n",
       "9781910797457 chp8      Antiandrogens. When the serum PSA level rises ...   \n",
       "9781910797815 chp7      Pacritinib is an inhibitor of both JAK2 and FL...   \n",
       "9783318066685 ch4       Several gene therapy drugs are now approved by...   \n",
       "9781908541680 ch_4      Overweight/obesity as a whole predisposes to, ...   \n",
       "\n",
       "                                                                  bullets  \\\n",
       "book          chapter                                                       \n",
       "9781910797631 chp6      The treatment rather than the prevention of de...   \n",
       "9781910797426 ch03      The prevalence of gallstones is greater in peo...   \n",
       "9781908541277 ch_12     Depression and anxiety are common in patients ...   \n",
       "9781910797907 chp6      The decision for transfusion therapy relates t...   \n",
       "9781908541277 ch_8      Sixteen new antiepileptic drugs (AEDs) have be...   \n",
       "9781910797006 ch08      Acute exacerbations of COPD are common and pla...   \n",
       "9781910797105 ch06      People with schizophrenia exhibit gray matter ...   \n",
       "9783318068207 hh-5      Comprehensive genomic profiles offer a complet...   \n",
       "9781910797105 ch04      Identical twins show a 45% concordance rate. H...   \n",
       "9781910797006 ch03      Usually (in 80% of patients) there is a signif...   \n",
       "9781908541406 ch_6      Thrombocytopenia may occur with some inherited...   \n",
       "9781908541277 ch_6      A witness's account is essential for accurate ...   \n",
       "9781910797815 chp3      The World Health Organization diagnostic crite...   \n",
       "9781910797310 chp3      Better subclassification of early-stage NSCLC ...   \n",
       "9781910797426 ch12      Tumor types that occur in the ampullary and pe...   \n",
       "9781908541024 ch_13     Neurocognitive outcome is of particular concer...   \n",
       "9781910797617 chp6      A wide range of targeted agencies for the trea...   \n",
       "9781908541994 ch02      Four main factors are implicated in the etiolo...   \n",
       "9781910797471 ch05      Assessment of functional class, based on exerc...   \n",
       "9781910797105 ch08      Positive symptoms are hypothesized to be due t...   \n",
       "9781912776207 ch4       Detailed immunophenotypic analysis is necessar...   \n",
       "9781910797495 chp12     In patients without history of chronic headach...   \n",
       "9781912776726 ch2       The signs and symptoms of glioblastoma result ...   \n",
       "9781910797815 chp2      The incidence of the myeloproliferative neopla...   \n",
       "9781910797433 ch05      Surgery is one of the cornerstones of treatmen...   \n",
       "9781910797617 chp1      Acute myeloid leukemia (AML) is a relatively r...   \n",
       "9781908541963 chapter3  Alcoholic liver disease (ALD) is a common caus...   \n",
       "9781908541796 chapter1  The epidemiology of lymphoma is difficult to s...   \n",
       "9781908541963 chapter5  Autoimmune liver disease can target the hepato...   \n",
       "9781910797907 chp2      Gaps remain in our understanding of the epidem...   \n",
       "9781908541666 ch_13     Diabetic pregnancy is associated with fetal mo...   \n",
       "9781912776153 chp3      Syncope can be benign, such as vasovagal (neur...   \n",
       "9781908541468 ch_14     Most patients will require several modalities ...   \n",
       "9781910797662 ch09      Public health preventative measures are likely...   \n",
       "9781910797211 ch04      Levodopa restores the dopamine lost due to deg...   \n",
       "9781908541727 ch03      Most patients with blurred vision have benign,...   \n",
       "9783318068207 hh-8      Different sample types (histological or cytolo...   \n",
       "9781908541024 ch_12     There are several syndromes associated with an...   \n",
       "9781910797105 ch05      Like genetic factors, environmental factors ar...   \n",
       "9781908541420 ch_6      Drugs used in the management of asthma can be ...   \n",
       "9781908541680 ch_8      Behavioral therapy, alongside diet and lifesty...   \n",
       "9781910797457 chp8      After an initial response to androgen ablation...   \n",
       "9781910797815 chp7      The Janus kinase 2 inhibitor pacritinib was su...   \n",
       "9783318066685 ch4       Gene therapy, using gene-modified cells or in ...   \n",
       "9781908541680 ch_4      Obesity significantly affects cardiometabolic ...   \n",
       "\n",
       "                                                                  summary  \\\n",
       "book          chapter                                                       \n",
       "9781910797631 chp6      The treatment of depression is the focus of mo...   \n",
       "9781910797426 ch03      Gallstones are a significant cause of mortalit...   \n",
       "9781908541277 ch_12     Depression is the most prevalent psychiatric c...   \n",
       "9781910797907 chp6      There is no set standard with regard to transf...   \n",
       "9781908541277 ch_8      After a hiatus of nearly 20 years, 16 new AEDs...   \n",
       "9781910797006 ch08      Acute exacerbations of chronic obstructive pul...   \n",
       "9781910797105 ch06      MRI studies confirmed the previous findings of...   \n",
       "9783318068207 hh-5      Comprehensive genomic profiling (CGP) offers a...   \n",
       "9781910797105 ch04      The offspring of unaffected MZ co-twins are at...   \n",
       "9781910797006 ch03      The characteristic symptom of COPD is breathle...   \n",
       "9781908541406 ch_6      Thrombotic thrombocytopenia due to congenital ...   \n",
       "9781908541277 ch_6      The diagnosis of epilepsy relies on the correc...   \n",
       "9781910797815 chp3      Thrombocytosis and erythrocytosis are major di...   \n",
       "9781910797310 chp3      Tumor size is the primary descriptive and most...   \n",
       "9781910797426 ch12      Cancers of the ampulla of Vater, the intrapanc...   \n",
       "9781908541024 ch_13     The elderly represent the fastest growing segm...   \n",
       "9781910797617 chp6      The expanded genetic characterization of acute...   \n",
       "9781908541994 ch02      Acne is a hormonally mediated disease, with an...   \n",
       "9781910797471 ch05      A 67-year-old man with diabetes mellitus, hype...   \n",
       "9781910797105 ch08      The dopamine hypothesis has been revived by a ...   \n",
       "9781912776207 ch4       Accurate diagnosis and subtyping of PTCL is ch...   \n",
       "9781910797495 chp12     The immediate, important first step in assessi...   \n",
       "9781912776726 ch2       The signs and symptoms of glioblastoma result ...   \n",
       "9781910797815 chp2      The myeloproliferative neoplasms (MPNs) are ra...   \n",
       "9781910797433 ch05      Surgery is the cornerstone of management for b...   \n",
       "9781910797617 chp1      Acute myeloid leukemia (AML) is a hematologic ...   \n",
       "9781908541963 chapter3  Alcoholic liver disease (ALD) is a common caus...   \n",
       "9781908541796 chapter1  Lymphoma encompasses a broad range of lymphoid...   \n",
       "9781908541963 chapter5  Autoimmune liver diseases include autoimmune h...   \n",
       "9781910797907 chp2      More than 600 cases of pyruvate kinase (PK) de...   \n",
       "9781908541666 ch_13     Diabetic pregnancy is associated with an incre...   \n",
       "9781912776153 chp3      Syncope is a significant healthcare problem, r...   \n",
       "9781908541468 ch_14     All patients should be offered all suitable ch...   \n",
       "9781910797662 ch09      Improved diagnosis, earlier treatment and impr...   \n",
       "9781910797211 ch04      Levodopa restores the dopamine lost due to deg...   \n",
       "9781908541727 ch03      It is essential to be able to clinically triag...   \n",
       "9783318068207 hh-8      Cytological and histological specimens are the...   \n",
       "9781908541024 ch_12     The vast majority of primary brain tumors occu...   \n",
       "9781910797105 ch05      The 'neurodevelopmental hypothesis' of schizop...   \n",
       "9781908541420 ch_6      Combinations of an inhaled corticosteroid and ...   \n",
       "9781908541680 ch_8      Cognitive behavioral therapy (CBT) is one of t...   \n",
       "9781910797457 chp8      Antiandrogens may transiently reduce PSA, but ...   \n",
       "9781910797815 chp7      Pacritinib is an inhibitor of both JAK2 and FL...   \n",
       "9783318066685 ch4       Several gene therapy drugs are now approved by...   \n",
       "9781908541680 ch_4      Overweight/obesity as a whole predisposes to n...   \n",
       "\n",
       "                        rouge1_precision  rouge1_recall  rouge1_fmeasure  \\\n",
       "book          chapter                                                      \n",
       "9781910797631 chp6             41.025641      37.209302        39.024390   \n",
       "9781910797426 ch03             49.019608      39.062500        43.478261   \n",
       "9781908541277 ch_12            54.545455      60.402685        57.324841   \n",
       "9781910797907 chp6             45.774648      49.618321        47.619048   \n",
       "9781908541277 ch_8             29.411765      28.846154        29.126214   \n",
       "9781910797006 ch08             32.191781      52.808989        40.000000   \n",
       "9781910797105 ch06             48.543689      48.543689        48.543689   \n",
       "9783318068207 hh-5             59.375000      46.721311        52.293578   \n",
       "9781910797105 ch04             29.670330      38.028169        33.333333   \n",
       "9781910797006 ch03             44.366197      36.416185        40.000000   \n",
       "9781908541406 ch_6             38.461538      35.714286        37.037037   \n",
       "9781908541277 ch_6             43.243243      69.565217        53.333333   \n",
       "9781910797815 chp3             48.076923      43.352601        45.592705   \n",
       "9781910797310 chp3             28.409091      29.411765        28.901734   \n",
       "9781910797426 ch12             42.553191      45.454545        43.956044   \n",
       "9781908541024 ch_13            28.125000      43.548387        34.177215   \n",
       "9781910797617 chp6             36.756757      38.418079        37.569061   \n",
       "9781908541994 ch02             29.032258      32.727273        30.769231   \n",
       "9781910797471 ch05             41.139241      51.587302        45.774648   \n",
       "9781910797105 ch08             35.227273      42.465753        38.509317   \n",
       "9781912776207 ch4              24.719101      36.666667        29.530201   \n",
       "9781910797495 chp12            39.622642      23.333333        29.370629   \n",
       "9781912776726 ch2              55.089820      52.272727        53.644315   \n",
       "9781910797815 chp2             44.545455      40.495868        42.424242   \n",
       "9781910797433 ch05             39.603960      39.215686        39.408867   \n",
       "9781910797617 chp1             53.398058      33.742331        41.353383   \n",
       "9781908541963 chapter3         32.894737      40.322581        36.231884   \n",
       "9781908541796 chapter1         37.000000      29.838710        33.035714   \n",
       "9781908541963 chapter5         46.268657      37.349398        41.333333   \n",
       "9781910797907 chp2             49.315068      48.648649        48.979592   \n",
       "9781908541666 ch_13            31.654676      53.658537        39.819005   \n",
       "9781912776153 chp3             67.391304      53.142857        59.424920   \n",
       "9781908541468 ch_14            40.566038      39.814815        40.186916   \n",
       "9781910797662 ch09             28.318584      32.323232        30.188679   \n",
       "9781910797211 ch04             65.816327      49.425287        56.455142   \n",
       "9781908541727 ch03             51.754386      42.753623        46.825397   \n",
       "9783318068207 hh-8             32.203390      33.928571        33.043478   \n",
       "9781908541024 ch_12            41.732283      38.970588        40.304183   \n",
       "9781910797105 ch05             31.944444      36.507937        34.074074   \n",
       "9781908541420 ch_6             34.666667      44.444444        38.951311   \n",
       "9781908541680 ch_8             38.888889      39.622642        39.252336   \n",
       "9781910797457 chp8             38.759690      31.645570        34.843206   \n",
       "9781910797815 chp7             35.802469      40.845070        38.157895   \n",
       "9783318066685 ch4              34.939759      34.523810        34.730539   \n",
       "9781908541680 ch_4             20.731707      41.463415        27.642276   \n",
       "\n",
       "                        rouge2_precision  rouge2_recall  rouge2_fmeasure  \\\n",
       "book          chapter                                                      \n",
       "9781910797631 chp6             10.322581       9.356725         9.815951   \n",
       "9781910797426 ch03             21.782178      17.322835        19.298246   \n",
       "9781908541277 ch_12            29.268293      32.432432        30.769231   \n",
       "9781910797907 chp6             15.602837      16.923077        16.236162   \n",
       "9781908541277 ch_8              4.000000       3.921569         3.960396   \n",
       "9781910797006 ch08             15.862069      26.136364        19.742489   \n",
       "9781910797105 ch06             15.686275      15.686275        15.686275   \n",
       "9783318068207 hh-5             29.473684      23.140496        25.925926   \n",
       "9781910797105 ch04              6.666667       8.571429         7.500000   \n",
       "9781910797006 ch03             17.021277      13.953488        15.335463   \n",
       "9781908541406 ch_6              9.708738       9.009009         9.345794   \n",
       "9781908541277 ch_6             18.367347      29.670330        22.689076   \n",
       "9781910797815 chp3             20.645161      18.604651        19.571865   \n",
       "9781910797310 chp3              1.149425       1.190476         1.169591   \n",
       "9781910797426 ch12             13.978495      14.942529        14.444444   \n",
       "9781908541024 ch_13             6.315789       9.836066         7.692308   \n",
       "9781910797617 chp6             10.869565      11.363636        11.111111   \n",
       "9781908541994 ch02             11.475410      12.962963        12.173913   \n",
       "9781910797471 ch05             12.738854      16.000000        14.184397   \n",
       "9781910797105 ch08              5.747126       6.944444         6.289308   \n",
       "9781912776207 ch4              11.363636      16.949153        13.605442   \n",
       "9781910797495 chp12            13.461538       7.865169         9.929078   \n",
       "9781912776726 ch2              25.301205      24.000000        24.633431   \n",
       "9781910797815 chp2             19.266055      17.500000        18.340611   \n",
       "9781910797433 ch05              4.000000       3.960396         3.980100   \n",
       "9781910797617 chp1             19.607843      12.345679        15.151515   \n",
       "9781908541963 chapter3         18.666667      22.950820        20.588235   \n",
       "9781908541796 chapter1         10.101010       8.130081         9.009009   \n",
       "9781908541963 chapter5         19.696970      15.853659        17.567568   \n",
       "9781910797907 chp2             25.000000      24.657534        24.827586   \n",
       "9781908541666 ch_13            15.217391      25.925926        19.178082   \n",
       "9781912776153 chp3             48.905109      38.505747        43.086817   \n",
       "9781908541468 ch_14             9.523810       9.345794         9.433962   \n",
       "9781910797662 ch09              4.464286       5.102041         4.761905   \n",
       "9781910797211 ch04             31.794872      23.846154        27.252747   \n",
       "9781908541727 ch03             17.699115      14.598540        16.000000   \n",
       "9783318068207 hh-8              1.724138       1.818182         1.769912   \n",
       "9781908541024 ch_12             9.523810       8.888889         9.195402   \n",
       "9781910797105 ch05             15.492958      17.741935        16.541353   \n",
       "9781908541420 ch_6              8.053691      10.344828         9.056604   \n",
       "9781908541680 ch_8             13.207547      13.461538        13.333333   \n",
       "9781910797457 chp8              7.031250       5.732484         6.315789   \n",
       "9781910797815 chp7              2.500000       2.857143         2.666667   \n",
       "9783318066685 ch4              10.303030      10.179641        10.240964   \n",
       "9781908541680 ch_4              4.907975       9.876543         6.557377   \n",
       "\n",
       "                        rougeL_precision  rougeL_recall  rougeL_fmeasure  \\\n",
       "book          chapter                                                      \n",
       "9781910797631 chp6             22.435897      20.348837        21.341463   \n",
       "9781910797426 ch03             34.313725      27.343750        30.434783   \n",
       "9781908541277 ch_12            41.818182      46.308725        43.949045   \n",
       "9781910797907 chp6             26.760563      29.007634        27.838828   \n",
       "9781908541277 ch_8             23.529412      23.076923        23.300971   \n",
       "9781910797006 ch08             21.917808      35.955056        27.234043   \n",
       "9781910797105 ch06             28.155340      28.155340        28.155340   \n",
       "9783318068207 hh-5             43.750000      34.426230        38.532110   \n",
       "9781910797105 ch04             16.483516      21.126761        18.518519   \n",
       "9781910797006 ch03             27.464789      22.543353        24.761905   \n",
       "9781908541406 ch_6             22.115385      20.535714        21.296296   \n",
       "9781908541277 ch_6             29.054054      46.739130        35.833333   \n",
       "9781910797815 chp3             26.282051      23.699422        24.924012   \n",
       "9781910797310 chp3             14.772727      15.294118        15.028902   \n",
       "9781910797426 ch12             28.723404      30.681818        29.670330   \n",
       "9781908541024 ch_13            15.625000      24.193548        18.987342   \n",
       "9781910797617 chp6             20.000000      20.903955        20.441989   \n",
       "9781908541994 ch02             14.516129      16.363636        15.384615   \n",
       "9781910797471 ch05             24.050633      30.158730        26.760563   \n",
       "9781910797105 ch08             18.181818      21.917808        19.875776   \n",
       "9781912776207 ch4              14.606742      21.666667        17.449664   \n",
       "9781910797495 chp12            28.301887      16.666667        20.979021   \n",
       "9781912776726 ch2              35.329341      33.522727        34.402332   \n",
       "9781910797815 chp2             35.454545      32.231405        33.766234   \n",
       "9781910797433 ch05             24.752475      24.509804        24.630542   \n",
       "9781910797617 chp1             34.951456      22.085890        27.067669   \n",
       "9781908541963 chapter3         28.947368      35.483871        31.884058   \n",
       "9781908541796 chapter1         26.000000      20.967742        23.214286   \n",
       "9781908541963 chapter5         29.850746      24.096386        26.666667   \n",
       "9781910797907 chp2             32.876712      32.432432        32.653061   \n",
       "9781908541666 ch_13            23.021583      39.024390        28.959276   \n",
       "9781912776153 chp3             42.753623      33.714286        37.699681   \n",
       "9781908541468 ch_14            20.754717      20.370370        20.560748   \n",
       "9781910797662 ch09             14.159292      16.161616        15.094340   \n",
       "9781910797211 ch04             41.326531      31.034483        35.448578   \n",
       "9781908541727 ch03             25.438596      21.014493        23.015873   \n",
       "9783318068207 hh-8             20.338983      21.428571        20.869565   \n",
       "9781908541024 ch_12            18.110236      16.911765        17.490494   \n",
       "9781910797105 ch05             25.000000      28.571429        26.666667   \n",
       "9781908541420 ch_6             20.000000      25.641026        22.471910   \n",
       "9781908541680 ch_8             35.185185      35.849057        35.514019   \n",
       "9781910797457 chp8             21.705426      17.721519        19.512195   \n",
       "9781910797815 chp7             16.049383      18.309859        17.105263   \n",
       "9783318066685 ch4              17.469880      17.261905        17.365269   \n",
       "9781908541680 ch_4             14.024390      28.048780        18.699187   \n",
       "\n",
       "                        st_cosine_sim  w2v_cosine_sim  \n",
       "book          chapter                                  \n",
       "9781910797631 chp6          77.454841       86.020589  \n",
       "9781910797426 ch03          79.712456       71.898705  \n",
       "9781908541277 ch_12         77.712244       89.286613  \n",
       "9781910797907 chp6          76.956862       83.728826  \n",
       "9781908541277 ch_8          62.181133       46.673253  \n",
       "9781910797006 ch08          73.715782       82.787955  \n",
       "9781910797105 ch06          73.356146       75.353748  \n",
       "9783318068207 hh-5          84.886581       86.692703  \n",
       "9781910797105 ch04          81.507498       62.482452  \n",
       "9781910797006 ch03          74.553555       77.810550  \n",
       "9781908541406 ch_6          81.662786       56.578755  \n",
       "9781908541277 ch_6          81.965548       89.188361  \n",
       "9781910797815 chp3          71.033967       90.337062  \n",
       "9781910797310 chp3          65.472806       52.986348  \n",
       "9781910797426 ch12          81.221396       57.167000  \n",
       "9781908541024 ch_13         64.516574       64.719629  \n",
       "9781910797617 chp6          75.757277       88.485336  \n",
       "9781908541994 ch02          67.471182       41.407356  \n",
       "9781910797471 ch05          73.311019       87.382334  \n",
       "9781910797105 ch08          75.691462       74.347800  \n",
       "9781912776207 ch4           71.452951       50.848681  \n",
       "9781910797495 chp12         70.631951       49.200192  \n",
       "9781912776726 ch2           74.675697       96.129704  \n",
       "9781910797815 chp2          75.727808       82.670760  \n",
       "9781910797433 ch05          84.197742       74.402571  \n",
       "9781910797617 chp1          87.871474       82.759547  \n",
       "9781908541963 chapter3      81.027627       51.491308  \n",
       "9781908541796 chapter1      81.090528       73.773026  \n",
       "9781908541963 chapter5      81.381470       67.097825  \n",
       "9781910797907 chp2          85.362822       75.645065  \n",
       "9781908541666 ch_13         88.159752       85.004187  \n",
       "9781912776153 chp3          86.016065       89.006799  \n",
       "9781908541468 ch_14         78.428084       70.372969  \n",
       "9781910797662 ch09          82.256985       59.492385  \n",
       "9781910797211 ch04          78.673643       94.396794  \n",
       "9781908541727 ch03          83.158141       70.681083  \n",
       "9783318068207 hh-8          71.958637       43.385014  \n",
       "9781908541024 ch_12         74.483132       81.031632  \n",
       "9781910797105 ch05          80.225450       69.052237  \n",
       "9781908541420 ch_6          72.441578       80.655372  \n",
       "9781908541680 ch_8          80.766618       49.175903  \n",
       "9781910797457 chp8          81.383657       67.861736  \n",
       "9781910797815 chp7          72.270256       61.197352  \n",
       "9783318066685 ch4           62.347168       86.098439  \n",
       "9781908541680 ch_4          67.844188       67.674166  "
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "evaluate_model_grouping_bullets('google/pegasus-large')\n",
    "\n",
    "evaluate_model_grouping_bullets(\n",
    "    bucket_dir+'fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "id": "GlnC1NYkRrQH"
   },
   "source": [
    "#### Plot evaluation bullet by bullet"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 398
    },
    "executionInfo": {
     "elapsed": 965,
     "status": "ok",
     "timestamp": 1610618147643,
     "user": {
      "displayName": "Marco Pietro Abrate",
      "photoUrl": "https://lh3.googleusercontent.com/a-/AOh14Gjh-8YF-8BlnrkN9mLZ0xfVOWfOh7kYncpYRv-Y=s64",
      "userId": "15422244832836998434"
     },
     "user_tz": -60
    },
    "id": "lQdQyFl6REbV",
    "outputId": "3fee75aa-7cf0-4994-bbd0-11f4d84eb551",
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 720x432 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plot_evaluation_bullet_by_bullet(\n",
    "    'google/pegasus-large')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 720x432 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plot_evaluation_bullet_by_bullet(\n",
    "    bucket_dir+'fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Plot evaluation grouping bullets"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {
    "id": "y7chlVU7UsZa"
   },
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 720x432 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plot_evaluation_grouping_bullets(\n",
    "    'google/pegasus-large')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAnUAAAF9CAYAAABiTJ6kAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjMuNCwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy8QVMy6AAAACXBIWXMAAAsTAAALEwEAmpwYAAA/y0lEQVR4nO3de3xU9Z3/8deHGAwIRIhcwyUpl4SYCGoQKVoVvK63Lt57UVtbra7Y1rWKa3cZqv2JrnWrra3brS64XvGytYpbrSha7warTQzhEsMtXI2QhAIS4Pv745yEYZhAJpnJzJy8n4/HeUzme77nnM/MdzL55Hu+53vMOYeIiIiIpLduyQ5ARERERDpOSZ2IiIhIACipExEREQkAJXUiIiIiAaCkTkRERCQAlNSJiIiIBICSOhHpNGY2x8xWJDmGkJlpLqeDMLOFZrYw2XGISNspqRPpQszsZDNzB1geTXaM8WBmX/GTt/HJjiVSc1IZtuwys7Vm9riZjU52fK0xs25+7F9PdiwiEt0hyQ5ARJLiIWBhlPLPOjmORPkKMBNYAXwcse4OYHYnxxPNTcAG4FDgaOB7wKlmVuyc25jUyKLrhveezgX+kNxQRCQaJXUiXdN7zrlA9MrFyjm3C9iV7DiA551zy5ufmFkl8ABwBfDvSYtKRNKWTr+KyH7M7If+qcEJUdad4q+72n/ez8zuMrO/mlm9mW03s0Vm9q02HsuZWShK+X7j78zsSjN72T9dudPMVpnZr8ysT3gd4M/+0/8OO80Z8tdHHVNnZmeZ2dtm9ncza/CPMzGiTp6/rzvM7GIzqzCzHWa21MwubsvrPYA3/MdREcc8zMz+n5lV+695nZk9aGb9IuqNN7MXzGyDH1OtmT1nZsPD6qwwszlRXvsBxxmaWR7Q5D+9Iuw9XeivzzCzW82sysy2mdkWM/vYzP6pPW+EiLSPeupEuqZeZnZElPJG59yXwFPAL4BvAB9G1PkGsBN42n/+FeBS4Bngd0AWMA34HzPr7px7OI5xXw8sBf4DqAeOAa4GjgJO8uu8iXd6dYYfz1/88r+1tlM/IXsSWAKEgO7AD4A3zGyqc+7tiE3OAr4DPAhswTt1+oSZfeycW9rO15bvP9aFxXUosAA4Evg9sBgYA/wTMMnMJjrndphZf+BVP5Z7gc+BIcDpwDBgVTtjarYJrwdxLt77+Tu/fIP/+G/+Msc/fhZQBJyI1/soIp3BOadFi5YusgAnA+4Ay5VhdV8B1gLdwsq6A18AfwgrOxTIiDiO4SUjSyLK5wArIsocEIoSa7S6PaPUu8Lfx6SwslMjX0/YupD31dfy/BD/da4GDg8rHwo0AmVhZXn+frcCuWHlA4Evgbvb0AYhfx8TgCOAXOBsoBrYDYwPq3szXgJdGrGPc/x9/MB/fn7zPg9y7BXAnIO9J37ZQmBhxPvkWtn+r8D8ZH++tWjp6otOv4p0TfcCp0VZXg6r8zgwGDglrOxMoC/wWHOBc+5L59xuADPr7p8WzMHrORoTfmq0o5xz2/zjdDOzbL+38U1/9X6nituoFO91/qdzbkvYsdbgvQfHmtmQiG3+6JyrDau7AagCRsZw3A/wesDWAC/iJccXO+c+DqtzGVAGrDCzI5oX4D3g78BUv15z3Of5vXudbQtwpJmNTcKxRcSn068iXdNi59yrB6nzHPBbvNOtC/yyb+D1Xr3QXMnMDPgh3unKMXi9dOEOBxo6HjKY2XHAz4ET8E7xRR6nPfL8x8VR1lX6j/l4vXnNVkapuxnoF6W8NVf4+8wGvomXMDdF1CkAeuAlf9EM8B/fxDt9/FPgRjP7C/AS8Lhz7vMYYmqvnwLPA5VmthQvoX/GOfd6JxxbRHxK6kQkKudcg5m9CEwzs+vwvi/OBZ52zu0Iq/oT4C683ruf4yUgu4B/AH5M+y/Iygh/4g/Wfx3vFOLN/uN2v96fOnCc9tjdSnlkQnsg7zj/6lczew7vNfyPmY11zjUnkAa8izdeLZot4J83hcvM7N/xTuWeitcb+29mdmpY719rF0NktFLeJs65t81sZNixvw5cZ2YPO+eu6si+RaTtlNSJyIE8DlyIl6D19JfHIupcBrzhnNvnalczm0rbbMY7pRvpKxHPz/ePf7ZzbkXYcQqibBvLHSNq/Mdopw7HRtRJCOecM7ObgE/wErgf+KuWA33b0KvavJ+PgI+A283sKGARXgL8Db9KW9/rqLs/yLHr8T4vj5vZIXhjIr9rZne59l88IiIx0Jg6ETmQl/B6g76Bl7ytB16LqLObiB4q/2rMtvbQLGPfcXv4U4lMinIcIo+Fd5VrpK3+Y7QEJtIivNOgV0dMjTIE77ToorCes4RxzpXjja37jpnl+sVPAIVm9u3I+v40Iv38n/v6p8HDLcbryQx/D5bhXTXbI2w/eXg9aweLbzewgyjvqZnlRNTdBVT4T9vSBiISB+qpE+majjezHVHKNznnWi6WcM59aWbP4iU3GcADzRdFhPkDXs/Q43inR4cA1+BdTdq/DbH8Fm8+uRfxkpo84PtAOd54s2Z/wksqXjKz/wT24J0OjjaO7VNgG3CtmW3FGwdY4ZyriKzonNtlZj/GG5P2npk9zN4pTTLxxgt2ljvxXtPN/nHvxTulOdfM/gF4By+pHQlcgDeWbQ7e+LzpZva/eL17h+BNM9Mbr/es2W+Bi4FXzewxvPa5Di8BPLYN8X2Id9eLm/Au8NjonHsNWGxmb/nrN+CNBbweb4qYj9rzRohIOyT78lstWrR03sLBpzR5L8o2p4St32/KDLwEYhbeGLcdeAnC9cCV/jZ5YXXnsP80JYZ3+6m1/vYf+MeMVncq8D7elZ+b/Dr9iTItCl7SU4E3JUjLeqJM3+GX/wPwNl4y2Ig3pcvxEXXy/H3dEWX7hYRNAXKANgj5+xjVyvqFfgwD/edZwG3+a9mB13P6CXA3MNyvczTwKN5p4u14c939BZgWZf/X+vW+9Pd5UbT3JNrrwZsv7w3//XfN64Fb8RLOz/0YPwN+1fwatGjR0jmLORfL0BMRERERSUUaUyciIiISAErqRERERAJASZ2IiIhIACipExEREQmATkvqzOxhM9toZhVhZf3M7M9mtsx/7OuXm5ndb2bLzexvZnZMZ8UpIiIiko467epXM/sa3oSgjzjniv2yu4EvnHOzzWwG3szpt/jzMU3Hm2JgInCfc27iwY5xxBFHuLy8vIS9BhEREZF4WbRo0efOubbM59kmnTb5sHPuTX/m8nDn482bBTAXb16kW/zyR5yXcb5nZoeb2WDn3LoDHSMvL4+ysrK4xi0iIiKSCGa2Mp77S/YdJQaGJWrrgYH+z7l4s9E3W+OX7ZfUmdnVwNUAQ4cOpby8HIBBgwbRo0cPamq8Wzb26dOH4cOHU1Hhnf3NyMigqKiI6upqtm3bBsCoUaOor69n06ZNAAwZMoTMzExWrvTe8+zsbHJzc6msrAQgMzOTwsJCli1bxo4d3uT8Y8aMoa6ujrq6Ou+F5ObSrVs3Vq/2Xk7fvn0ZOHAgVVVVAHTv3p2CggKWLFnCzp07ASgsLGTDhg1s3rwZgGHDhrFnzx5qa2sByMnJIScnh6VLvdspZmVlMXr0aKqqqmhqagKgqKiI2tpa6uvrARgxYgRNTU2sXevd7ah///5kZ2ezfPlyAHr27MnIkSOprKxk927vhgHFxcWsWrWKhoYGAPLz89m+fTvr168HYMCAAfTu3Zvq6moAevXqRX5+PhUVFd4kiGYUFxdTU1PD1q3eXZtGjhxJY2MjGzduVDupndROaie1k9qpS7dTvHXq5MN+T92LYadftzjnDg9bv9k519e/XdBs59xbfvkC4Bbn3AG74UpLS5166kRERCQdmNki51xpvPaX7KtfN5jZYAD/caNfXgsMC6s31C8TERERkSiSffr1j3g3op7tPz4fVn69mT2Jd6FE/cHG07WmqamJNWvWtHQ/S/tkZWUxdOhQMjMzkx2KiIiIRNFpSZ2ZPYF3UcQRZrYG7wbes4F5ZnYVsBK42K/+Et6Vr8vxbmz9nfYed82aNfTu3Zu8vDzMrAOvoOtyzlFXV8eaNWvIz89PdjgiIiISRWde/XpZK6umRqnrgH+Kx3F37NihhK6DzIycnJyWgZ8iIiKSepI9pq5TKKHrOL2HIiIiqa1LJHVBVFZWxg033NDq+rVr13LhhRd2YkQiIiKSTMm+UEJ8u3fvJiMjo831S0tLKS1t/SroIUOG8Mwzz8QjNBEREUkD6qnrBCtWrKCwsJBvfvObjB07lgsvvJBt27aRl5fHLbfcwjHHHMPTTz/NK6+8wqRJkzjmmGO46KKLWiZE/PDDD/nqV7/KuHHjOO6442hsbGThwoWcc845ALzxxhuMHz+e8ePHc/TRR9PY2MiKFSsoLi4GvHGF3/nOdygpKeHoo4/m9ddfB2DOnDlMmzaNM888k9GjR3PzzTcn5w0SERGRDutSPXWzXviUyrUNcd1n0ZA+zDz3yIPWW7JkCQ899BCTJ0/mu9/9Lr/5zW8Ab/btjz76iM8//5xp06bx6quvcthhh3HXXXdx7733MmPGDC655BKeeuopJkyYQENDAz169Nhn3/fccw8PPPAAkydPZuvWrWRlZe2z/oEHHsDMKC8vp6qqitNPP71ltu+PP/6Yv/71rxx66KEUFBQwffp0hg0bhoiIiKQX9dR1kmHDhjF58mQAvvWtb/HWW28BcMkllwDw3nvvUVlZyeTJkxk/fjxz585l5cqVLFmyhMGDBzNhwgTAu03JIYfsm4tPnjyZG2+8kfvvv58tW7bst/6tt97iW9/6FuDd4mXEiBEtSd3UqVPJzs4mKyuLoqKilluZiIiISHrpUj11belRS5TIq0ebnx922GGANxfcaaedxhNPPLFPveZ72R7IjBkzOPvss3nppZeYPHkyL7/88n69da059NBDW37OyMhg165dbdpOREQkHcU6m0Nn3k61o9RT10lWrVrFu+++C8Djjz/OCSecsM/6448/nrfffrvlBsZ///vfWbp0KQUFBaxbt44PP/wQgMbGxv0Sr+rqakpKSrjllluYMGFCy82Ym5144ok89thjACxdupRVq1ZRUFCQkNcpIiKSypxzUZfW1qUTJXWdpKCggAceeICxY8eyefNmrr322n3W9+/fnzlz5nDZZZdx1FFHMWnSJKqqqujevTtPPfUU06dPZ9y4cZx22mn73fLsl7/8JcXFxRx11FFkZmZy1lln7bP+uuuuY8+ePZSUlHDJJZcwZ86cfXroREREJP1ZumWhB1JaWurKysr2KVu8eDFjx45NUkSeFStWcM4551BRUZHUODoqFd5LERGRRDCzTu+ZM7NFzrnW5yeLkXrqRERERAJASV0nyMvLS/teOhEREUltSupEREREAkBJnYiIiEgAKKkTERERCQAldSIiIiIBoKQuTc2ZM4frr78egFAoxD333JPkiERERCSZlNR1Mucce/bsSXYYIiIiEjBK6jrBihUrKCgo4PLLL6e4uJjbb7+dCRMmcNRRRzFz5syWeo888ghHHXUU48aN49vf/jYAL7zwAhMnTuToo4/m1FNPZcOGDcl6GSIiIpLCDkl2AJ3q/2bA+vL47nNQCZw1+6DVli1bxty5c2loaOCZZ57hgw8+wDnHeeedx5tvvklOTg533HEH77zzDkcccQRffPEFACeccALvvfceZsbvf/977r77bn7xi1/E9zWIiIhI2utaSV0SjRgxguOPP56bbrqJV155haOPPhqArVu3smzZMj755BMuuugijjjiCAD69esHwJo1a7jkkktYt24dO3fuJD8/P2mvQURERFJX10rq2tCjliiHHXYY4I2pu/XWW7nmmmv2Wf+rX/0q6nbTp0/nxhtv5LzzzmPhwoWEQqFEhyoiIiJpSGPqOtkZZ5zBww8/zNatWwGora1l48aNTJkyhaeffpq6ujqAltOv9fX15ObmAjB37tzkBC0iIiIpr2v11KWA008/ncWLFzNp0iQAevXqxaOPPsqRRx7JbbfdxkknnURGRgZHH300c+bMIRQKcdFFF9G3b1+mTJlCTU1Nkl+BiIiIpCJzziU7hrgpLS11ZWVl+5QtXryYsWPHJimiYNF7KSIiQWVmdHZOZGaLnHOl8dqfTr+KiIiIBICSOhEREZEAUFInIiIiEgBK6kREREQCQEmdiIiISAAoqRMREREJACV1neD+++9n7NixfPOb30x2KCIi0kZmFtMikmyafLgT/OY3v+HVV19l6NChyQ5lP7t37yYjIyPZYYiIpJxoc5YlYy4zkbZST12C/eAHP+Czzz7jrLPOIjs7myuuuIITTzyRESNG8Nxzz3HzzTdTUlLCmWeeSVNTEwCLFi3ipJNO4thjj+WMM85g3bp1APzXf/0XEyZMYNy4cVxwwQVs27YNgKeffpri4mLGjRvH1772NQDmzJnD9ddf3xLHOeecw8KFCwHvLhb//M//zLhx43j33Xd59NFHOe644xg/fjzXXHMNu3fv7sR3SEREROKhS/XU3fXBXVR9URXXfRb2K+SW425pdf2DDz7In/70J15//XV+/etf8+qrr/L6669TWVnJpEmTePbZZ7n77rv5x3/8R+bPn8/ZZ5/N9OnTef755+nfvz9PPfUUt912Gw8//DDTpk3j+9//PgA//elPeeihh5g+fTo/+9nPePnll8nNzWXLli0Hjfnvf/87EydO5Be/+AWLFy/mrrvu4u233yYzM5PrrruOxx57jMsvvzxeb5GIiIh0gi6V1KWCs846i8zMTEpKSti9ezdnnnkmACUlJaxYsYIlS5ZQUVHBaaedBninRwcPHgxARUUFP/3pT9myZQtbt27ljDPOAGDy5MlceeWVXHzxxUybNu2gMWRkZHDBBRcAsGDBAhYtWsSECRMA2L59OwMGDIj76xYREZHE6lJJ3YF61DrLoYceCkC3bt3IzMxsGVzbrVs3du3ahXOOI488knfffXe/ba+88kr+8Ic/MG7cOObMmdNyOvXBBx/k/fffZ/78+Rx77LEsWrSIQw45hD179rRsu2PHjpafs7KyWsbROee44ooruPPOOxP1kkVERKQTaExdiikoKGDTpk0tSV1TUxOffvopAI2NjQwePJimpiYee+yxlm2qq6uZOHEiP/vZz+jfvz+rV68mLy+Pjz/+mD179rB69Wo++OCDqMebOnUqzzzzDBs3bgTgiy++YOXKlQl+lSIiIhJvXaqnLh10796dZ555hhtuuIH6+np27drFj370I4488khuv/12Jk6cSP/+/Zk4cSKNjY0A/OQnP2HZsmU455g6dSrjxo0DID8/n6KiIsaOHcsxxxwT9XhFRUXccccdnH766ezZs4fMzEweeOABRowY0WmvWURERDrOgnRpdmlpqSsrK9unbPHixYwdOzZJEQWL3ksR6eo0pUlwJaNtzWyRc640XvvT6VcRERGRAFBSJyIiIoHTr1+/mO8I0ta6/fr1S/Kri05j6kRERCRwNm/enLDTqal6W7gu0VOn8Q8dp/dQREQktQU+qcvKyqKurk5JSQc456irqyMrKyvZoYiIiEgrAn/6dejQoaxZs4ZNmzYlO5S0lpWVxdChQ5MdhoiIiLQi8EldZmYm+fn5yQ5DREREJKECf/pVREREpCtQUiciIiISAErqRERERAJASZ2IiIhIACipExEREQkAJXUiItKlxXI7KWj7raRS+XZSEkwpMaWJmf0Y+B7ggHLgO8Bg4EkgB1gEfNs5tzNpQYqISCB1xdtJSTAlvafOzHKBG4BS51wxkAFcCtwF/IdzbhSwGbgqeVGKiIiIpLakJ3W+Q4AeZnYI0BNYB0wBnvHXzwW+npzQRERERFJf0pM651wtcA+wCi+Zq8c73brFObfLr7YGyE1OhCIiIiKpL+lj6sysL3A+kA9sAZ4Gzoxh+6uBq8G7z2t5eTkAgwYNokePHtTU1ADQp08fhg8fTkVFBQAZGRkUFRVRXV3Ntm3bABg1ahT19fUt94kdMmQImZmZrFy5EoDs7Gxyc3OprKwEvFuQFRYWsmzZMnbs2AHAmDFjqKuro66uDoDc3Fy6devG6tWrAejbty8DBw6kqqoKgO7du1NQUMCSJUvYudMbMlhYWMiGDRvYvHkzAMOGDWPPnj3U1tYCkJOTQ05ODkuXLgW8+7KOHj2aqqoqmpqaACgqKqK2tpb6+noARowYQVNTE2vXrgWgf//+ZGdns3z5cgB69uzJyJEjqaysZPfu3QAUFxezatUqGhoaAMjPz2f79u2sX78egAEDBtC7d2+qq6sB6NWrF/n5+VRUVOCcw8woLi6mpqaGrVu3AjBy5EgaGxvZuHGj2kntpHZSO6VEOwEtfzsS0U7btm1TOyXh9ym8XRPx+1RZWdnhdoo3S9Tg0DYHYHYRcKZz7ir/+eXAJOAiYJBzbpeZTQJCzrkzDrSv0tJSV1ZWlvCYRUQkOMwsoRdKJPvvbFeVDu1qZoucc6VxCAlIgdOveKddjzeznuZdJjQVqAReBy7061wBPJ+k+ERERERSXtKTOufc+3gXRHyEN51JN+B3wC3AjWa2HG9ak4eSFqSIiIhIikv6mDoA59xMYGZE8WfAcUkIR0RERCTtJL2nTkREREQ6TkmdiIiISAAoqRMREREJgJQYUyciIpIsbmYfCGUnbt8inURJnYiIdGk2qyGx85mFErJrkf0oqRMRkS5twNcHUDK3pOX5k+c8CcClL17aUnbtuGu5bvx1TJk3hU3bvbsFjO03lnnnziP0Tohnlz3bUnfBRQuorKtk+mvTGfD1AZ30KkRS4I4S8aQ7SoiISKzS4c4DErt0aNcg3lFCRERERDpISZ2IiIhIACipExEREQkAJXUiIiIiAaCkTkRERCQANKWJiIiIBE5XnFRaSZ2IiIgETlecVFqnX0VEREQCQEmdiIiISAAoqRMREREJACV1IiIiIgGgCyVERKTLM7OE7Ldv374J2a9INErqRESkS4vlCslE3iRe4mvA1wdQMrek5fmT5zwJwKUvXtpSdu24a7lu/HVMmTeFTds3ATC231jmnTuP0Dshnl32bEvdBRctoLKukumvTWfA1wd00quIjQXpw1laWurKysqSHYaIiASUkrr0kci2ite+zWyRc640DiEBGlMnIiIiEghK6kREREQCQEmdiIiISAAoqUsjoVAo2SGIiIhIilJSl0ZmzZqV7BBEREQkRSmpExEREQkAJXUpLhQKYWYtE2M2/6xTsSIiIhJO89SlEc2PJCKSXPoeTh+ap05ERERE0pKSujQyc+bMZIcgIiIiKUpJXRx01vg2jaMTERGR1iipiwNNNSIiIiLJpqROREREJACU1LWTphoRERGRVKIpTeJAl7iLiHQN+r5PH5rSRERERETSkpK6ONBUIyIiIpJsSuriQOPoREREJNkOSXYA6SRvxvyYt1kx++wERCIiIiKyLyV1MWgtQcubMV/Jm4iIiCSVTr+KiIiIBICSOhEREZEAUFInIiIiEgBK6kREREQCQEmdiIiISAAoqRMREREJACV1IiIiIgGgpE5EREQkAJTUiYiIiASA7ighIiIShZnFVO6cS2Q4IgelpE5ERCQKJWmSbnT6VURERCQAlNSJiIiIBEBKJHVmdriZPWNmVWa22MwmmVk/M/uzmS3zH/smO04RERFJH2aWkKVv39RMSVIiqQPuA/7knCsExgGLgRnAAufcaGCB/1xERETkoJxzMS2xbPPFF18k+dVFl/QLJcwsG/gacCWAc24nsNPMzgdO9qvNBRYCt3R+hEkQym7HNvXxj0NERETSRtKTOiAf2AT8t5mNAxYBPwQGOufW+XXWAwOjbWxmVwNXAwwdOpTy8nIABg0aRI8ePaipqQGgT58+DB8+nIqKCgAyMjIoKiqiurqabdu2ATBq1Cjq6+vZtGkTAEOGDCEzM5OVK1cCkJ2dTW5uLpWVlQBkZmZSWFgI0HLcMWPGUFdXR11dHQC5ubl069aN1atXA9C3b18GDhxIVVUVAN27d6egoIAlS5awc+dOAApv+5wNGzawefNmAIYNG8aePXvod38+5Re8RU5ODjk5OSxduhSArKwsRgNVVVU0NTUBUFRURG1tLfX1XrI3YsQImpqaWLt2LQD9+/cnOzub5cuXA9CzZ09GjhxJZWUlu3fvBqC4uJhVq1bR0NDgNVR+Ptu3b2f9+vUADBgwgN69e1NdXQ1Ar169yM/Pp6KiAuccZkZxcTE1NTVs3boVgJEjR9LY2MjGjRs7vZ2WLVvGjh074tdOhYVR26m2thYgejuNHq12UjupndROaqcUbCeADRs2dGo7xZsl+5JtMysF3gMmO+feN7P7gAZgunPu8LB6m51zBzyJXVpa6srKyhIabzR5M+azYvbZiT9QKFs9ciIiIglgZp0+jY2ZLXLOlcZrf6nQU7cGWOOce99//gze+LkNZjbYObfOzAYDG5MWYYCVzC2JeZvyK8oTEImIiIh0RNKTOufcejNbbWYFzrklwFSg0l+uAGb7j88nMczAai1BK5lbouRNREQkjSQ9qfNNBx4zs+7AZ8B38K7MnWdmVwErgYuTGJ+IiIhISkuJpM459zEQ7Zzy1E4ORURERCQtpco8dSIiIiLSAUrqRERERAJASZ2IiIhIACipExEREQkAJXUiIiIiAaCkTkRERCQAlNSJiIiIBICSOhEREZEAUFInIiIiEgBK6kREREQCQEmdiIiISAC0K6kzs6PM7AIz6+k/P9TMlCCKiIiIJElMiZiZ9TOz14GPgXnAIH/VA8A98Q1NRERERNoq1t61e4A9QB6wLaz8GeCMOMUkIiIiIjE6JMb6pwPnO+dWmVl4+VJgeNyiEhEREZGYxNpT1w/YHKW8N14PnoiIiIgkQaxJ3UfAmVHKLwfe73g4IiIiItIesZ5+nQX8wcyGAhnAt83sSOB8YEq8gxMRERGRtompp84592fgXGAS3unWW/CugD3DOfd2/MMTERERkbaItacO59xrwGsJiEVERERE2kkTBouIiIgEQKyTDzeZ2c4oy5dmVm9mH5rZ9xMVrIiIiIhEF+vp158A/wq8Arzrl00CTgN+AYwGHjCz3c65h+MWpYiIiIgcUKxJ3XHA7c65X4aV3W9mPwKOc859w8wqgRsAJXUiIiIinSTWMXXnAC9EKX/RX4e/flRHghIRERGR2MSa1O0AJkYpP85f17zPHVHqiIiIiEiCxJrU/R540MxCZnaWmZ1pZrOA3wL/5dc5BSiPZ5AiyRAKhZIdgoiISJvFmtTdBoSA7wHzgZeAq/yyn/p1/he4JD7hiSTPrFmzkh2CiIhIm8V0oYRzzgH3AveaWR+/rCGizrr4hSciIiIibdHuyYedcw2RCZ1IuguFQpgZZgbQ8rNOxYqISKqLqafOzGoA19p659xXOhyRSBKFQqGWBM7M8DqnRUREUl+s89T9PuJ5JnAscAJwX1wiEhEREZGYxTqm7ufRys3sFmBoXCISSREzZ85MdggiIiJt1u4xdRGeAb4Zp32JpASNo5OO0OdHRDpbvJK6o4GdcdqXiEja05Q4ItLZYr1Q4neRRcAQ4FTggXgFJSIiIiKxifVCidERz/cAG4HrgLlxiagrmT0CdmyJbZtQdtvrZh0OM1bGtn8RabdQKLRPD13z1DgzZ87U6VgRSbhYL5Q4JVGBpJJxs16hfntTTNvkzZjfpnrZPTL5ZObp3pMdWyBUH2N0MYglARQREZG0FmtPHQBmdggw0n9a7ZzbFb+Qkq9+exMrZp+dkH23NfkTkfSjeQ5FJJliHVOXAfwbcBOQhTembpuZ3QP8zDm3J/4hSjxMfmIyDTtjuwFIydySNtft070Pb1/2dqxhiYiISJzE2lMXAv4JuBV4wy87GZiJdyXtv8UrMImvhp0NlF9RnrD9x5IAinQFmudQRDpbrEndlcA1zrmnw8o+MbN1wC9QUiciAmieOhHpfLHOUzcA+GuU8r8C/TsejohIYinZEpGgijWpWw5Mi1I+DajueDgiIomlSYFFJKhiPf16N/CQmR0N/MUv+xpwIfCdeAYmIvEXfnWmpJ/2jF1N5FhaEUktsc5TN9fMPgduAW73iz8FzgX+HufYRCTOZs2a1SWTuqBMCtxaglYyt0TJm4jEPKVJL+A159z8sLJjgZ8DpwEZ8Q1PRKTjNH+ciHQFbRpTZ2ZDzOwtoB6oN7O7zKy7fy/Yd4FtwAkJjFNE2ikUCmFmLb1TzT+nUw+ViIgcXFsvlLgT6AP8EC+Juwl4DegJFDnnpjnn3k1MiCLSEaFQCOdcS+9U889dKalTYisiXUFbT79OAS5zzr1lZs8Ba4BXnXOhhEUmIhInOv0qIl1BW3vqBuNPWeKcWwtsB+YlKigRSQzd5UBEJLja2lPXDdgV9nwPXmInImmkK51uzJsxP2p59uTLWl23YvbZiQxJRCShYrn69Wkz2+n/nAU8Ymb7JHbOudPjFllXEcre+/PVC73H3528t+ykGXDKrXBPAWxd75UNHgfXvAl/vAE+mru37o1VsO5jeOLSBActkvpaS9DyZih5E+nKmsfWtnVdOg3XaGtSNzfi+aPxDsTMMoAyoNY5d46Z5QNPAjnAIuDbzrmdB9pHWgrVt63spiX7l513v7eE6zN47/bhCaOIiIikVZIWqzYldc65zrhbxA+BxXhX2QLcBfyHc+5JM3sQuAr4bSfEISIiIpJ2Yr1NWEKY2VDgbLxJjG80r/9zCvANv8pcIEQnJnXhY25euN6bgu/cX7/VUvbDqaP58WljOO7nr7Kx8UsAinP78OL0E7n1ub/xxAerW+q+/y9TKV9Tz/ceKeuk6EVERKSrSYmkDvglcDPQ23+eA2xxzjVfnLEGyO3MgKKNuYlW9sFtp+5Xdue0o7hz2lH7lA0symLF7LNbHaDdGcLvG/nkOU8CcOmLe8ffXTvuWq4bfx1T5k1h0/ZNAIztN5Z5584j9E6IZ5c921J3wUULqKyrZPpr0zspehERETmQpCd1ZnYOsNE5t8jMTm7H9lcDVwMMHTqU8nLv/oeDBg2iR48e1NTUANCnTx+GDx9ORUUFABkZGRQVFVFdXc22bdsAGDVqFPX13ni08vJyhgwZQmZmJitXrgQgOzub3NxcKisrAcjMzKSwsJBly5axY8cOAMaMGUNdXR11dXUA5Obm0q1bN1av3ttz19TURFVVFSWQ8HFvze8HwMJzFrJ27VoAcppyyM7O5vFjHgegZ8+ejBw5ksrKSu4bex8AxcXFrFq1ivLyci7ofQE3XXAT27dvZ/369Wyo3sDYAWN5/6L3qa6u5hsffYOamhry8/OpqKjAOYeZUVxcTE1NDVu3bgVg5MiRNDY2snHjRqBj7bRpk5d4JqKd+vbty8CBA6mqqgKge/fuFBQUsGTJEnbu9IZ2FhYWsmHDBjZv3gzAsGHD2LNnD7W1td57nJNDTk4OS5cuBSArK4vRo0dTVVVFU1MTAEVFRdTW1rZ87kaMGEFTU1NLO/Xv35/s7GyWL1++Xzvt3r17n3ZqaGgAID8/v6WdAAYMGEDv3r2prq4GoFevXl26nQC++OKLQLUTeL/rQWon/T6pnbpCO8WbJXvAoJndCXwbb8qULLwxdf8LnAEMcs7tMrNJQMg5d8aB9lVaWurKyjp+ijPRvWktPX6h7OgXRcRL2P4TfcNv3VC8/cInxpXEy5sxP3BXv+r3TyQ9mdki51xpvPaX9J4659ytwK0Afk/dTc65b5rZ08CFeFfAXgE835lxJepLP1VOv0rqmDVrlpI6ERHpsKQndQdwC/Ckmd0B/BV4KMnxpL1E99SJdEntGUKRyB56EemyUiqpc84tBBb6P38GHJfMeEQSJRQKMWvWrJbnzRNezpw5U7126aa1BC3RwytERCKkVFIn0lXoBvMiIhJv3ZIdgIiIiIh0nJI6kSSbOXNmskMQEZEAUFInkmQaQyciIvGgpE5EREQkAJTUiYiIiASArn5NtkTeJizr8MTtW0RERFKKkrpkinUOK817JSIiIq3Q6VcRERGRAFBSJyIiIhIASupEREREAkBJnYiIiEgAKKkTERERCQBd/dqFlMwtSdi++3Tvk7B9i4iIyMEpqesiyq8oj6l+ydySmLcRERGR5NHpV5Ek071fRUQkHpTUiSTZrFmzkh2CiIgEgJI6ERERkQBQUieSBKFQCDPDzABaftapWBERaS9dKNGKvBnzE7Lf7B6ZCdmvpJdQKNSSwJkZzrnkBiQiImlPSV0UK2afHVP9vBnzY95GUkd7Eni1t4iIpBolddLltZagdVayPnPmzIQfQ0REgk9j6kSSTOPoREQkHtRTJyLSVrNHwI4tba8fym573azDYcbKWCMSEWmhpE4kgNpzSzjdQaQNdmyBUH1i9h1LAigiEoWSOpEAai1B0+3fRESCS2PqRERERAJAPXUinaU9p9cSdapPUtrkJybTsLMhpm1iOeXep3sf3r7s7VjDEpEUp6ROpLO0lqCFspW8yT4adjYk9DR5e8ZcikjqU1InImlt3KxXqN/eFNM2sUw4nd0jk09mnh5rWCIinU5JnYiktfrtTQmdJDpRtwwUEYk3XSghIiIiEgBK6kREREQCQKdfu7gDDZhubZ3mORMREUk9Suq6OCVoIiIiwaDTryIiIiIBoKROREREJACU1ImIiIgEgMbUiYjEIvx2b1cv9B5/d/LespNmwCm3wj0FsHW9VzZ4HFzzJvzxBvho7t66N1bBuo/hiUsTHLSIdAVK6kREYhHtlm7Rym5asn/Zefd7S7g+g73t23NvYBGRMErqRCTthd/14YXrTwDg3F+/1VL2w6mj+fFpYzju56+ysfFLAIpz+/Di9BO59bm/8cQHq1vqvv8vUylfU8/3HinrpOijC59S6MlzngTg0hf39uhdO+5arht/HVPmTWHT9k0AjO03lnnnziP0Tohnlz3bUnfBRQuorKtk+mvTOyl6EUkGJXUikvai3SYsWtkHt526X9md047izmlH7VM2sCirZftk3SYs2nRD0cpeu/i1/cpCXw0R+mpon7IBPQe0bH+g+SlFJH0pqRORtKf7s4qIKKkTkQCI1isXL8lKGNWbJiKxUlInIhKLTrqgIZF3e1HCKBJMSupERGIR7UrXuOxXV7+KSMdo8mERERGRAFBPXSo60H/sra1LVO+BiIiIpAUldalICZqIiIjESKdfRURERAJASZ2IiIhIACipExEREQkAJXUiIiIiAaCkTkRERCQAkn71q5kNAx4BBgIO+J1z7j4z6wc8BeQBK4CLnXObkxWniAiQuEmCsw5PzH5FpMtIelIH7AL+2Tn3kZn1BhaZ2Z+BK4EFzrnZZjYDmAHcksQ4D3gPyNbWJfKelCLSyWKZbiiUremJRKRTJT2pc86tA9b5Pzea2WIgFzgfONmvNhdYSJKTOiVoIiIikqqSntSFM7M84GjgfWCgn/ABrMc7PRttm6uBqwGGDh1Kebl3E+xBgwbRo0cPampqAOjTpw/Dhw+noqICgIyMDIqKiqiurmbbtm0AjBo1ivr6ejZt2gTAkCFDyMzMZOXKlQBkZ2eTm5tLZWUlAJmZmRQWFrJs2TJ27NgBwJgxY6irq6Ourg6A3NxcunXrxurVqwHo27cvAwcOpKqqCoDu3btTUFDAkiVL2LlzJwCFhYVs2LCBzZu9s83Dhg1jz5491NbWApCTk0NOTg5Lly4FICsri9GjR1NVVUVTUxMARUVF1NbWUl/v9RSMGDGCpqYm1q5dC0D//v3Jzs5m+fLlAPTs2ZORI0dSWVnJ7t27ASguLmbVqlU0NDQAkJ+fz/bt21m/fj0AAwYMoHfv3lRXVwPQq1cv8vPzqaiowDmHmVFcXExNTQ1bt24FYOTIkTQ2NrJx48aUbyeg5fOUyHbKCDtOZ7RTTU1N4NrpQL3oHdWrezd2794d++8TpGw7wd7PnL739L2ndkpeO8WbOecSsuNYmVkv4A3g586558xsi3Pu8LD1m51zfQ+0j9LSUldWVpbgSKWryJsxv3N6ZzvxNF3J3BLKryjvlGOlqnRo15K5JXEOZl99uvfh7cveTugxROTgzGyRc640XvtLiZ46M8sEngUec8495xdvMLPBzrl1ZjYY2Ji8CEVEOk+sibeSdRGBFEjqzMyAh4DFzrl7w1b9EbgCmO0/Pp+E8ERS2uQnJtOwsyGmbWLpBVKPjohI+kh6UgdMBr4NlJvZx37Zv+Alc/PM7CpgJXBxcsKToBg36xXqtzfFtE0sY7Wye2TyyczTYw2rQxp2NiS0hybRpwFFRCR+kp7UOefeAqyV1VM7MxYJtvrtTQkdS5XIwfoiIiIHoztKiIiIiARA0nvqRAJn9gjYsSW2bWK5S0HW4TBjZWz7FxGRwFNSJxJvO7YkdoqSRN2mSkRE0ppOv4qIiIgEgJI6ERERkQBQUiciIiISAErqRERERAJASZ2IiIhIACipExEREQkATWkiItIRB5piprV1iZzyRkS6LCV1IiId0YkJ2oHuxdvaukTeG1hEUouSOpFECO+huXqh9/i7k/eWnTQDTrkV7imAreu9ssHj4Jo34Y83wEdz99a9sQrWfQxPXJrgoCXVKUETkQNRUiddSt6M+S0/v3D9CQCc++u3Wsp+OHU0Pz5tDMf9/FU2Nn4JQHFuH16cfiK3Pvc3nvhgdUvd9/9lKuVr6vneI2X7Hyha7020spuW7F923v3eEq7P4L3bR5zSC++hefKcJwG49MW9CeC1467luvHXMWXeFDZt3wTA2H5jmXfuPELvhHh22bMtdRdctIDKukqmvzZ9/7hERCSlmXMu2THETWlpqSsri/IHVgQvoVsx++zE7z+UnfjbhPn7L5lbktDem0TvP5HCE/i2SuTnQ0Qkkpktcs6Vxmt/6qkTSXMHGmfVlSlBE5GuRkmddCnt6b1plwNdERlnie6pExGR9KCkTrqURJ9+bZHo068iIiIRNPmwiIiISAAoqRMREREJACV1IiIiIgGgpE5EREQkAJTUiYiIiASAkjoRERGRAFBSJyIiIhIASupEREREAkBJnYiIiEgAKKkTERERCQAldSIiIiIBoHu/iqS5krklCdt3n+59ErZvERGJLyV1IokQyk7cvrMOb/mx/IrymDYtmVsS8zYiIpIelNSJxFuoPsb62bFvIyIiEkFJnXQpeTPmJ2zf2T0yE7ZvERGRg1FSJ13Gitlnx1Q/b8b8mLcRERFJFl39KiIiIhIASupEREREAkBJnYiIiEgAKKkTERERCQAldSIiIiIBoKROREREJACU1ImIiIgEgJI6ERERkQBQUiciIiISAErqRERERAJASZ2IiIhIACipExEREQkAJXUiIiIiAaCkTkRERCQAlNSJiIiIBICSOhEREZEAUFInIiIiEgBK6kREREQCQEmdiIiISAAoqRMREREJAHPOJTuGVpnZmcB9QAbwe+fc7APVLy0tdWVlZZ0SmwRH3oz5MW+zYvbZsR8olN2Obepj3wYomVsS8zblV5S361giItI+ZrbIOVcat/2lalJnZhnAUuA0YA3wIXCZc66ytW2U1ImIiEi6iHdSl8qnX48DljvnPnPO7QSeBM5PckwiIiIiKSmVk7pcYHXY8zV+mYiIiIhEOCTZAXSUmV0NXA0wdOhQysu9cUGDBg2iR48e1NTUANCnTx+GDx9ORUUFABkZGRQVFVFdXc22bdsAGDVqFPX19WzatAmAIUOGkJmZycqVKwHIzs4mNzeXykrvDHBmZiaFhYUsW7aMHTt2ADBmzBjq6uqoq6sDIDc3l27durF6tZef9u3bl4EDB1JVVQVA9+7dKSgoYMmSJezcuROAwsJCNmzYwObNmwEYNmwYe/bsoba2FoCcnBxycnJYunQpAFlZWYwePZqqqiqampoAKCoqora2lvp6b0zWiBEjaGpqYu3atQD079+f7Oxsli9fDkDPnj0ZOXIklZWV7N69G4Di4mJWrVpFQ0MDAPn5+Wzfvp3169cDMGDAAHr37k11dTUAvXr1Ij8/n4qKCpxzmBnFxcXU1NSwdetWAEaOHEljYyMbN25UO6md1E5qJ7WT2qlLt1O8pfKYuklAyDl3hv/8VgDn3J2tbaMxdSIiIpIuutKYug+B0WaWb2bdgUuBPyY5JhEREZGUlLKnX51zu8zseuBlvClNHnbOfZrksERERERSUsomdQDOuZeAl5Idh4iIiEiqS+XTryIiIiLSRkrqRERERAJASZ2IiIhIACipExEREQkAJXUiIiIiAaCkTkRERCQAUvaOEu1hZpuAlcmOI4GOAD5PdhASd2rXYFK7BpPaNbiS0bYjnHP947WzQCV1QWdmZfG8nYikBrVrMKldg0ntGlxBaFudfhUREREJACV1IiIiIgGgpC69/C7ZAUhCqF2DSe0aTGrX4Er7ttWYOhEREZEAUE+diIiISAAoqRMREekEZjbHzF5NdhzSeczsSjPb1VnHU1LXhZhZlpn9t5n91cx2mtnyZMckHWdmJ5rZs2a2xsy2m9kyMwuZ2aHJjk06xsxONjNnZkOTHUuymVkPM7vd/3xvN7MvzOxDM7vBX7/Cf69aXQ6y/0lm9r9mtsHMdphZtZk9ambHxPFl/BC4KI77S2lm9l0zazKz3hHlnxyg/GH/5/PN7CUzW29m28zsUzP7oZmZv/4f/XYtauXYvzGzlWbWap5jZsPN7LdmVmNmX5pZrZm9bGZfbz5OHDwF5MZpXwelpC6BzKx7smOIkAHsxBsM+mSSY0lbKdiuk4Fq4BtAEXALcB3wyyTGlJZSsG1lr98ClwM/wfucnwI8ABzur58ADPaX4/yy88PKBre2YzP7DvAXvO/HbwJjgUuAFcB98XoBzrl659zmeO0vDSwADgG+1lxgZv2BYmBdlPISoLkn82TgXeAf/fr/DtwJ3Oyvf8Hfx/cjD2pmPfG+Dx9yzu2JFpiZjQc+BiYCN/rHPhX4I/AfQHasLzYa59x259yGeOyrrQfUEqcFWAg8BNyO92FbDxwPvAlsBzYDjwMDwrYJAcsj9nMC4IC8sLLL8P5w7wDeAc7x65wQVmcU8CywxT/WK0BJK7Hud1wt6d+uYdvcCNQl+71L9SXV2xbvD5sDhib7vUr24r9H17exbl7ke32AukP8NnqwlfV9w34uAOYDW/3lBWBU2Po+wH/7n6MvgdXAvWHr5wCvRj4Hrsa7G1IDXlIxMCKG04C3/c9krX+MnGS3SRvbYnnEe3AJ8AnwqyjlLvK1R+zrfmBR2PM78O4AcWhEvSuBXUBuK/sxP4Zy4JAo63s1lwO9gf8ENvltWgacHlH/X4DP/PWbgJeBHuGxRIltMvARsA1YBEyI2GfM3/vOOfXUJcDFQH9gKl43+yvAGrz/HM/F+4/jmVh2aGbHAo8BTwDjgLuJ6IUxs4HAW8BG4ES8P0xLgIX+f0DSMenWrocDf48lni4s3dq2q1oHnGlm/eK834uBQ/EShP04v2fNzHrgfTaygJP8pRfwp7Ae3juAY/B6CEfjJSqLD3L8CXi9jmcDZ+D1GN3TvNLMpgDP451dOQr4Ol7S+lwcTxEm0gK8361mU4HXgNejlFe4A/dqHc6+32u/B/oC0yLqfR+Y75yrbWU/4/Dey7ucc/uNd3PObQ0rfxivXb4FjMdLrl80s0IAM5sGzMA7tT4aLwH/vwO8BvDOkt7pb3MM3nfAPDM7xN9n+78bkp3FB2nB+69/KdDNf3473h+H7mF1xuH9N/I1/3mIg/zXj/fH4S8RdX5A2H+i/n7ei/LfSDXwoyix7ndcLenfrv76sXj/8bepV6MrL6netqinLvy9mYzXm7Ub+BveMJKv40/NFVE3j7b31P0GqG9DvavwelWOCCsbiNd7drn//HlgzgH2MYf9e+o2EtbThDd8Yl3EZ3R2xH6G+69vfLLbpQ3v28XAnub3Da/n7jwgB6/HKrz8Pw6wn5OBJuDciPL/A14Lez7Wf2/OPkhMDjjmILGP8uv9Q0T5R8DD/s8/9r9DMlvZx5Xs31O3z7HxTgE7oMB/ftDvhtYW9dTF3yK39xz+kXgNs7N5pXPuE6DeX9dWRcB7EWXvRjyfABxrZlubF6AR78ttdAzHkujSol3NbDReb8KTzrlfxxBLV5YWbdvVOefeBkbi9VzMxUuongH+2MEeq7ZueyRQ6ZxrueG783qVlrD3s/Eb4EIzqzCz+8zsrAMN1PdVOee+DHu+Fu+1NZsA/Cjic1Lpr0uHz8lr/uMUMxuB9/l+wzlXB1SElY/E69Xbj5kdD/wBCDnnXohY/TvgZDMb5T//PrCKA/eWtbXNmy/CeDOi/E32tvk8IBNYad7Vzd+OvAAkCod3+rfZWv+xud3b/d1wyEEOLLGL9ZTXHvb/gGVGqecOsp9ueL8Q10dZVx9jTLK/lG9XMysG/ozXW3Bt28IU0qBtxeO8U2Lv+MsvzOxbwP/gDbh/o527XQL0MbOhzrk1HYzvZTMbjne67mTgUaDczKY653a3stnOiOeOfT9f3YC78F5npPUdibczOOc+N7NP8E6v9gI+cs41f75fDyvfRZQ2NLOT8cYu3umc+39RDvEC3vvwfTP7V7yLae53rVwg4VviPxbh9bq1m3Ou1j8VewowBfhX4C4zm+icW93KZnsiPg/N3xXdwh7b9d2gnrrE+hQ4PvyKOjMbh3dVTYVftBEYYGYZYdtFXkJfCUyKKDs+4nkZ3n8Oa5xzyyOWTR19IbKPlGtXM5uA94U4D7jW+f31ErOUa1s5oObxagM6sI+n8Qa4/zTaSjPr6//4KVBkZkeErRuId/FE82cD59wXzrknnHPX4I2TO4m9PT7tUQYcGeUzstw5t7UD++1MzePqmsfTNXs9rPx951xj+EZmdjbwEl4PXbSErjnRfxjvtObFeOPuHjpIPM0XSdzSPI4t4ri9/PJP/aKvRVT5Gvu2+ZfOuT85527GGxPZE29oQHu1/7uhPefItbR6/n0h8Puw5wPxxjY9jjfY+gS8sSBvhtUpwBsj8nO87ueL8K6iCR+fcyxe78DPgDF44xGW+nUmhx1rLd5VNyfiddOe4O/3q2HHK8Ib7PkgXhf1eH/pnuj3J12XVG9XvC+YBrwvtkHhS7Lfu1Rf0qBtT/a3OT3sd7V56Zns96+T2+oNvHGJpcAI/EQA78rAIyLq5tHGMXV+/e/5bfqkv988vER9VnPbAz3wxvQt8Ncdi5eULMf//vTbbpr/GRmNd4VnI5Dtr59DlKtfI2L5FuDCnp+CN5bsXr/dRwJn4iUuPZLdLm18f8/y26OBsCtH8RKw3X75rIhtLsLrxfwZ+36v9Y+y/zx/P18Az7cxpmP8z84ivARsNFAIXIP3+3y4X28e3tQ2Z/jr7/PjKvTXX4V3ynec/7n8rh/LVH/9lUS5+jUilqH++3Oy/7xNf8+jvq5kN3aQFiL+QPhl4dMjbCFiegS/znf9D9F2vHEAl9L69Ahf4o3NaR7oeWxYnRF4A7SbL71eidf9nx9WZ4W/XeSSF+/3IyhLqrcr3h+GaG3qkv3epfqSBm17cmttCxyf7Pevk9tqBt5cchvxpiBZ5b9XRVHq5hFDUudvcwLeuK2Nflt8BjxC2MUIeMnaS+yd0uRF9p3S5F/xenC24p0me4N9p7CZQ4xJnV92It7UJ414wwUW411Nvd90HKm4AIfhJUJfEvHPCF6vlANOjChf2MrnfkUrx/g/DnKBRCufk//E+7u4Ey+R+hPeP2Hm1+nDAaY0wUvi38FLELf57X9V2PoriTGp88sO+vc82tIctKQZM7ucvXMVbUlyOBInatfgUtuKSKLpQok0YWY34XX1f4F3ZcxdwNP645De1K7BpbYVkc6mpC59HAX8M9APb5byR4GZSY1I4kHtGlxqWxHpVDr9KiIiIhIAmtJEREREJACU1ImIiIgEgJI6ERERkQBQUiciIiISAErqRERERAJASZ2IiIhIAPx/HZG+hPlxW7YAAAAASUVORK5CYII=\n",
      "text/plain": [
       "<Figure size 720x432 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plot_evaluation_grouping_bullets(\n",
    "    bucket_dir+'fine-tuning/ft_pegasus_para_wordembed_gas64_lr5e-05/checkpoint-686/')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "accelerator": "GPU",
  "colab": {
   "collapsed_sections": [
    "P95DxvqWi_2Y",
    "tvSGvNzvKbvP",
    "S0FByNNOIRvG",
    "JFd0ppeJyX1o",
    "dllOnKR9Os5i",
    "U2mpXoSaQiQE",
    "k0qONrX4Qkkm",
    "JiYIkI5xN2VA",
    "KV669nVZQnzT",
    "WIiEnpvbMkJa",
    "fSqOx7kdMoNJ",
    "UTUY8QgQa2WM",
    "bKYnUXhvMszX",
    "mIcAg1ss4qIR",
    "GlnC1NYkRrQH"
   ],
   "name": "assign_bullets_para.ipynb",
   "provenance": []
  },
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.9"
  },
  "widgets": {
   "application/vnd.jupyter.widget-state+json": {
    "01e3a51fe914437187fb471f042cbc4e": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "HBoxModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "HBoxModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "HBoxView",
      "box_style": "",
      "children": [
       "IPY_MODEL_a503362a1d6c49958365ce7e93f4d67d",
       "IPY_MODEL_1249b68a0e2c459eae68dfede2dc5b34"
      ],
      "layout": "IPY_MODEL_9b00208076e345faaa7c1d3b38df79c4"
     }
    },
    "0795dec75e4f4a9cad293877eddef047": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "HBoxModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "HBoxModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "HBoxView",
      "box_style": "",
      "children": [
       "IPY_MODEL_cdd09db5faa14b609970f2a3d37dc430",
       "IPY_MODEL_efc306b702aa4dc0a5e6257cc71ac3aa"
      ],
      "layout": "IPY_MODEL_ec56f7bbfb29414f89c168dfdddd3465"
     }
    },
    "37bb8348b38e45b981c8e2c580de608b": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "HBoxModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "HBoxModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "HBoxView",
      "box_style": "",
      "children": [
       "IPY_MODEL_4c2fd32ed07b47a89011f42fe95af039",
       "IPY_MODEL_5d0caa7b27f044cb851b38b299d0de86"
      ],
      "layout": "IPY_MODEL_88830eabf77a4c4aa1130c37dc2ffa5d"
     }
    },
    "8ef14e9327d84807a95686427993ebcd": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "HBoxModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "HBoxModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "HBoxView",
      "box_style": "",
      "children": [
       "IPY_MODEL_3c8709747e444e2e99d5f5d4bd0c4513",
       "IPY_MODEL_8a9da00575624af09987d6936e79f41b"
      ],
      "layout": "IPY_MODEL_e0202968e0864b7ea3ce26fabdde768d"
     }
    },
    "a77961a700f2489f8af86af7aecb7a36": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "HBoxModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "HBoxModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "HBoxView",
      "box_style": "",
      "children": [
       "IPY_MODEL_23e74f006e7d44e7aee69e3a3394a37d",
       "IPY_MODEL_aa51b0fd1e9648719c0c2b39f252a199"
      ],
      "layout": "IPY_MODEL_66be567c4a0a41e086ac00af108ec408"
     }
    },
    "addb9bfe4b084b61a77f19962f2919d1": {
     "model_module": "@jupyter-widgets/controls",
     "model_name": "HBoxModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "HBoxModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "HBoxView",
      "box_style": "",
      "children": [
       "IPY_MODEL_e6baed9b364643e2a628ec2fa20eda17",
       "IPY_MODEL_1af98602915a4304a38cb231c85076b4"
      ],
      "layout": "IPY_MODEL_0fee59c682d04276b99c86a112570588"
     }
    }
   }
  }
 },
 "nbformat": 4,
 "nbformat_minor": 1
}
